-- phpMyAdmin SQL Dump
-- version 4.7.9
-- https://www.phpmyadmin.net/
--
-- Host: 127.0.0.1
-- Generation Time: Oct 29, 2019 at 06:46 PM
-- Server version: 10.1.31-MariaDB
-- PHP Version: 7.2.3

SET SQL_MODE = "NO_AUTO_VALUE_ON_ZERO";
SET AUTOCOMMIT = 0;
START TRANSACTION;
SET time_zone = "+00:00";


/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8mb4 */;

--
-- Database: `online_medicine_center_db`
--

-- --------------------------------------------------------

--
-- Table structure for table `medicines`
--

CREATE TABLE `medicines` (
  `id` bigint(20) UNSIGNED NOT NULL,
  `medicine_id` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `medicine_name` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `company_name` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `generic_name` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `medicine_type` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `medicine_price` double(8,2) NOT NULL,
  `description` text COLLATE utf8mb4_unicode_ci NOT NULL,
  `image` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `shop_id` bigint(20) UNSIGNED NOT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

--
-- Dumping data for table `medicines`
--

INSERT INTO `medicines` (`id`, `medicine_id`, `medicine_name`, `company_name`, `generic_name`, `medicine_type`, `medicine_price`, `description`, `image`, `shop_id`, `created_at`, `updated_at`) VALUES
(1, 'L-293847', 'Ace Plus', 'Square Pharmaceuticals Ltd.', 'Paracetamol + Caffeine', 'Tablet', 1.00, 'Indications\r\nThe indications of Paracetamol & Caffeine are Headache, Migraine, Toothache, \r\nNeuralgia, Feverishness, Period pain, Sore throat, Backache, Helps reduce temperature,\r\n Aches and pain of colds and flu.\r\n\r\nDosage & Administration\r\nAdult dose: 1-2 tablets every 4-6 hours. Maximum dose: 8 tablets daily.\r\nChild dose: Not recommended for children below 12 years.', '/shops/Lazz Pharma/medicine/1572284391.jpg', 1, '2019-10-28 11:39:51', '2019-10-28 11:39:51'),
(2, 'L-29345', 'Acifix', 'Beximco Pharmaceuticals Ltd.', 'Rabeprazole Sodium', 'Tablet', 7.00, 'Indications\r\nShort-term treatment in healing and symptomatic relief of duodenal ulcers and erosive or ulcerative Gastroesophageal Reflux Disease (GERD).\r\n\r\nMaintaining healing and reducing relapse rates of heartburn symptoms in patients with GERD.\r\n\r\nTreatment of daytime and night time heartburn and other symptoms associated with GERD.\r\n\r\nLong-term treatment of pathological hypersecretory conditions, including Zollinger Ellison Syndrome.\r\n\r\nIn combination with Amoxicillin and Clarithromycin to eradicate Helicobacter pylori.\r\n\r\nDosage & Administration\r\nHealing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD): 20 mg to be taken once daily for 4 to 8 weeks. For those patients who have not healed after 8 weeks of treatment, an additional 8 week course may be considered.\r\n\r\nMaintenance of Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD Maintenance): The recommended adult oral dose is 20 mg once daily.\r\n\r\nTreatment of Symptomatic Gastroesophageal Reflux Disease (GERD):The recommended adult oral dose is 20 mg once daily for 4 weeks. If symptoms do not resolve completely after 4 weeks, an additional course of treatment may be considered.\r\n\r\nHealing of Duodenal Ulcers:The recommended adult oral dose is 20 mg once daily after the morning meal for a period up to four weeks. Most patients with duodenal ulcer heal within four weeks. A few patients may require additional therapy to achieve healing.\r\n\r\nHelicobacter pylori Eradication: To Reduce the Risk of Duodenal Ulcer Recurrence-\r\n*Rabeprazole Sodium 20 mg Twice Daily for 7 Days\r\n*Amoxicillin 1000 mg Twice Daily for 7 Days\r\n*Clarithromycin 500 mg Twice Daily for 7 Days\r\nAll three medications should be taken twice daily with the morning and evening meals. It is important that patients comply with the full 7-day regimen.\r\n\r\nTreatment of Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome: The dosage of Rabeprazole Sodium in patients with pathologic hypersecretory conditions varies with the individual patient. The recommended adult oral starting dose is 60 mg once a day. Doses should be adjusted to individual patient needs and should continue for as long as clinically indicated. Some patients may require divided doses. Doses up to 100 mg QD and 60 mg BID have been administered. Some patients with Zollinger-Ellision syndrome have been treated continuously with Rabeprazole Sodium for up to one year.', '/shops/Lazz Pharma/medicine/1572284737.jpg', 1, '2019-10-28 11:45:37', '2019-10-28 11:45:37'),
(3, 'L-2934523', 'Hyprosol', 'Beximco Pharmaceuticals Ltd.', 'Hydroxypropyl Methyl Cellulose', 'Eye Drop', 65.00, 'Indications\r\nHydroxypropyl Methyl Cellulose gel is indicated as a surgical aid during surgical procedures involving the anterior chamber of the eye, including extraction of the lens, and insertion of intraocular lenses. It maintains the depth of the anterior chamber during the whole surgical procedure and permits greater operative precision without the risk of damaging the endothelium of the cornea or other intraocular tissues.\r\n\r\nHydroxypropyl Methyl Cellulose eye drop is used to treat dry eye conditions where not enough tears are produced to keep the eye lubricated and clean\r\n\r\nDosage & Administration\r\nEye Drop-\r\nFor Dry Eyes: \r\n*Adults and Children: Use 1 drop three or four times a day. This drug does not cause different side effects or problems in children than it does in adults.\r\n\r\nEye Gel-\r\nEach pre-filled glass syringe is for single intraocular use only. The quantity injected into the anterior chamber of the eye must be adjusted according to the volume of the aqueous humour and the anatomical structure to be protected.', '/shops/Lazz Pharma/medicine/1572341627.jpg', 1, '2019-10-29 03:33:47', '2019-10-29 03:33:47'),
(4, 'L-239487', 'Napa', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol', 'Tablet', 1.00, 'Indications\r\nParacetamol is indicated in:\r\n*Fever,common cold and influenza.\r\n*Headache,toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains.\r\n*Pain of colic, back pain, post-operative pain, postpartum pain, chronic pain of cancer,\r\n inflammatory pain, and post-vaccination pain and fever of children.\r\n*Rheumatism and osteoarthritic pain & stiffness of joints in fingers, \r\nhips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.\r\n\r\n\r\nDosage & Administration\r\nTablet:\r\n*Adult: 1-2 tablets every 4 to 6 hours up to a maximum of 4 gm (8 tablets) daily.\r\n*Children (6-12 years): ½ to 1 tablet 3 to 4 times daily. For long term treatment\r\n it is wise not to exceed the dose beyond 2.6 gm/day.\r\nExtended Release Tablet:\r\n*Adults & Children over 12 years: Two tablets, swallowed whole, every 6 to 8 hours \r\n(maximum of 6 tablets in any 24 hours).The tablet must not be crushed.\r\nSyrup/Suspension:\r\n*Children under 3 months: 10 mg/kg body weight (reduce to 5 mg/kg if jaundiced) 3 to 4 times daily.\r\n*3 months to below 1 year: ½ to 1 teaspoonful 3 to 4 times daily.\r\n*1-5 years: 1 -2 teaspoonful 3 to 4 times daily.\r\n*6-12 years: 2-A teaspoonful 3 to 4 times daily.\r\n*Adults: 4-8 teaspoonful 3 to 4 times daily.\r\nSuppository:\r\n*Children 3-12 months: 60-120 mg,4 times daily.\r\n*Children 1-5 years: 125-250 mg 4 times daily.\r\n*Children 6-12 years: 250-500 mg 4 times daily.\r\n*Adults & children over 12 years: 0.5-1 gm 4 times daily.\r\nPaediatric Drop:\r\nChildren Upto 3 months: 0.5 ml (40 mg)\r\n*4 to 11 months: 1.0 ml (80 mg)\r\n*7 to 2 years: 1.5 ml (120 mg). Do not exceed more than 5 dose daily for a maximum of 5 days.', '/shops/Lazz Pharma/medicine/1572341755.jpg', 1, '2019-10-29 03:35:55', '2019-10-29 03:35:55'),
(5, 'L-1298376', 'Orsaline-N', 'Bristol Pharmaceuticals Ltd.', 'Oral Rehydration Salt (Powder)', 'Orsaline', 3.00, 'Composition\r\nReduced osmolarity oral saline:\r\n\r\n1/2 liter formula (10.25 gm): Per sachet contains- \r\nSodium chloride 1.30gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 6.75 gm\r\nHigher osmolarity oral saline:\r\n\r\n1/2 liter formula (13.95 gm): Per sachet contains-\r\nSodium chloride 1.75 gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 10 gm\r\n1 liter formula (27.50 gm): Per sachet contains-\r\nSodium chloride 3.5 gm\r\nSodium biocarbonate 2.5 gm\r\nPotassium chloride 1.5 gm\r\nGlucose anhydrous 20 gm\r\nIndications\r\nOral Rehydration Salt is indicated in Diarrhea (treatment) and Electrolyte depletion (prophylaxis and treatment)\r\n\r\n\r\nDosage & Administration\r\nChildren less than 2 years: After each loose stool or vomiting 10 to 20 spoonful (50-100 ml).\r\n\r\nChildren 2 to 10 years: After each loose stool or vomiting 100-200 ml of prepared oral saline.\r\n\r\nAdult and children above 10 years: After each loose stool or vomiting 200-400 ml of prepared saline.', '/shops/Lazz Pharma/medicine/1572341894.jpg', 1, '2019-10-29 03:38:14', '2019-10-29 03:38:14'),
(6, 'L-934647382', 'Neoceptin', 'Beximco Pharmaceuticals Ltd.', 'Ranitidine', 'Injection', 10.00, 'Indications\r\n*Ranitidine is indicated in:\r\n*Treatment of active duodenal ulcer\r\n*Benign gastric ulcer\r\n*Treatment & prevention of ulcer associated with non-steroidal anti-inflammatory agent\r\n*Post operative stress ulcer.\r\n*Zollinger-Ellison Syndrome.\r\n*Gastroesophageal reflux disease (GERD).\r\n*Gastro-intestinal haemorrhage from stress ulcer in seriously ill patient.\r\n*Recurrent haemorrhage in patients with bleeding peptic ulcer.\r\n*Before general anesthesia in patient considered to be at risk of acid aspiration particulary obstetric patients.\r\n\r\n\r\nDosage & Administration\r\nRanitidine Tablet & Syrup:\r\nDuodenal and gastric ulcer: The usual dosage is 150 mg twice daily taken in the morning and evening or 300 mg as a single daily dose at night for 4 to 8 weeks.\r\n\r\nReflux oesophagitis: 150 mg twice daily or 300 mg at bed time for up to 8 weeks.\r\n\r\nZollinger Ellison syndrome: 150 mg 3 times daily and increased if necessary up to 6 g daily in divided doses. Dosage should be continued as long as clinically indicated.\r\n\r\nEpisodic dyspepsia: 150 mg twice daily or 300 mg at bed time for up to 6 weeks.\r\n\r\nMaintenance: 150 mg at night for preventing recurrences.\r\n\r\nChild (peptic ulcer): 2-4 mg/kg twice daily, maximum 300 mg daily.\r\n\r\n\r\nRanitidine IV injection & IV Infusion:\r\nRanitidine injection may be given either as a slow (over a period of at least two minutes) intravenous injection of 50 mg, after dilution to a volume of 20 ml per 50 mg dose, which may be repeated every six to eight hours; or as an intermittent intravenous infusion at a rate of 25 mg per hour for two hours; the infusion may be repeated at six to eight hour intervals; or as an intramuscular injection of 50 mg (2 ml) every six to eight hours. In the prophylaxis of haemorrhage from stress ulceration in seriously ill patients or the prophylaxis of recurrent haemorrhage in patients bleeding from peptic ulceration, parenteral administration may be continued until oral feeding commences.\r\n\r\nIn the prophylaxis of upper gastrointestinal haemorrhage from stress ulceration in seriously ill patient sapriming dose of 50 mg as low as intravenous injection followed by a continuous intravenous infusion of 0.125-0.250 mg/kg/hour may be preferred. In patients considered to be at risk of developing aspiration syndrome Ranitidine injection 50 mg may be given intramuscularly or by slow intravenous injection 45 to 60 minutes before induction of general anaesthesia.\r\n\r\nChildren: The recommended oral dose for the treatment of peptic ulcer in children is 2 mg/kg to 4 mg/kg twice daily to a maximum of 300 mg ranitidine per day. Safety and effectiveness of Ranitidine injection have not been established in case of children.', '/shops/Lazz Pharma/medicine/1572342023.jpg', 1, '2019-10-29 03:40:23', '2019-10-29 03:40:23'),
(7, 'L-234567', 'Entacyd Plus', 'Square Pharmaceuticals Ltd.', 'Aluminium Hydroxide + Magnesium Hydroxide + Simethicone', 'Tablet', 2.00, 'Composition\r\nEach tablet contains-\r\nAluminium Hydroxide 200 mg\r\nMagnesium Hydroxide 400 mg or 200 mg\r\nSimethicone 30 mg \r\nEach 5 ml Suspension contains-\r\nAluminium Oxide 200 mg\r\nMagnesium Hydroxide 400 mg\r\nSimethicone 30 mg\r\nIndications\r\nThis is indicated for dyspepsia, hyperacidity, gastric and duodenal ulcer, \r\ngastritis; also indicated for the relief of flatulence, abdominal distention and windy colic.\r\n\r\n\r\nDosage & Administration\r\nTablet: 1-2 tablets 1-3 hours after meal and at bed time or as directed by the physician.\r\n\r\nSuspension: 1-2 teaspoonful 1-3 hours after meal and at bedtime or as directed by the physician.', '/shops/Lazz Pharma/medicine/1572342123.jpg', 1, '2019-10-29 03:42:03', '2019-10-29 03:42:03'),
(8, 'L-987656', 'Tusca Plus', 'Square Pharmaceuticals Ltd.', 'Guaifenesin + Levomenthol + Diphenhydramine', 'Syrup', 80.00, 'Indications\r\nThis is indicated for the symptomatic relief of upper respiratory tract disorders accompanied by productive cough.\r\n\r\n\r\nDosage & Administration\r\n12 years and above: 10 ml 4 times a day.', '/shops/Lazz Pharma/medicine/1572342265.jpg', 1, '2019-10-29 03:44:25', '2019-10-29 03:44:25'),
(9, 'L-29356789', 'Flumetanol', 'Aristopharma Ltd.', 'Clioquinol + Flumetasone Pivalate', 'Ear Drop', 100.00, 'Indications\r\nThis combination is indicated for the treatment of external ear inflammation and infections (otitis externa) and fungal infections of the outer ear (otomycosis).\r\n\r\nDosage & Administration\r\nFor adults and children (aged 2 years and over): The recommended dose is 2 to 3 drops twice daily for the prescribed period of time (usually not longer than 10 days). Before you apply the medication, you should warm the ear drops to body temperature by holding the bottle in the palm of your hands. Do not heat it above body temperature.', '/shops/Lazz Pharma/medicine/1572342358.jpg', 1, '2019-10-29 03:45:58', '2019-10-29 03:45:58'),
(10, 'L-248732', 'Osmosol', 'Beximco Pharmaceuticals Ltd.', 'Mannitol', 'IV Infusion', 155.00, 'Indications\r\nMannitol is principally used by IV infusion as an osmotic diuretic to preserve renal function in acute renal failure and to reduce raised intracranial and intraocular pressure. Mannitol is also used as an irrigating solution to prevent hemolysis and hemoglobin buildup during transurethral prostatic resection. It is useful in the management of acute drug poisoning where a route of elimination is through kidney. Besides these, it is also used in symptomatic relief of edema, reperfusion injury, termination of pregnancy, and bowel preparation. So, Mannitol is indicated in-\r\n\r\nRenal insufficiency, Reperfusion injury, Raised intracranial pressure, Bladder irrigation, Raised intraocular presure, Bowel preparation, Edematous status, As a prophylactic in renal failure, Management of poisoning, Termination of Pregnancy\r\n\r\n\r\n\r\nDosage & Administration\r\nThe adult dose of Mannitol ranges from 50 to 100 gm by IV infusion. The rate of administration is usually adjusted to maintain a urine flow of at least 30 to 50 ml/hr. Total dosage, concentration and the rate of administration depends on fluid requirement, urinary output and the severity of the condition being treated\r\n\r\nRenal insufficiency-\r\nAdults: 50 to 100 g of Mannitol administered at a rate adjusted to maintain a urine flow of at least 30 to 50 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area administered over a period of 2 to 6 hrs.\r\nCerebral edema, elevated intracranial pressure, elevated intraocular pressure, Glaucoma-\r\nAdults: 1.5 to 2 gm/kg administered over a period of 30 to 60 minutes.\r\nChildren: 1 to 2 gm/kg body wt. or 30 to 60 gm/m2 of body surface area administered over a period of 30 to 60 mins.\r\nAdjunctive therapy for removal of toxic substances-\r\nAdults: 50 to 200 g of Mannitol administered at a rate adjust to maintain a urine flow of at least 100 to 500 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area\r\nFor termination of pregnancy 50 gm of Mannitol (250 ml of Mannitol) is instilled into the amniotic cavity which induces abortion in a high proportion of pregnancies.', '/shops/Lazz Pharma/medicine/1572342493.jpg', 1, '2019-10-29 03:48:13', '2019-10-29 03:48:13'),
(11, 'L-8754', 'Prudex', 'Beximco Pharmaceuticals Ltd.', 'Dextromethorphan + Pseudoephedrine + Triprolidine', 'Syrup', 70.00, 'Composition\r\nEach 5 ml syrup contains-\r\nDextromethorphan Hydrobromide 10 mg\r\nPseudoephedrine Hydrochloride 30 mg\r\nTriprolidine Hydrochloride 1.25 mg\r\n\r\n\r\nIndications\r\nThis is indicated for the symptomatic relief of upper respiratory tract disorders accompanied by non-productive cough which benefits from the administration of a nasal decongestant, a histamine H1 receptor antagonist and an antitussive combination.\r\n\r\n\r\n\r\nDosage & Administration\r\nAdults: 2 tea-spoon three times daily\r\n\r\nChildren:\r\nOver 12 years: 2 tea-spoon three times daily.\r\n6 to 12 years: 1 tea-spoon three times daily.\r\n2 to 5 years: 1/2 tea-spoon three times daily.\r\n6 months to 2 years: 1/4 tea-spoon three times daily or on advice of a physician only.', '/shops/Lazz Pharma/medicine/1572342566.jpg', 1, '2019-10-29 03:49:26', '2019-10-29 03:49:26'),
(12, 'L-293874', 'Napa', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol', 'Tablet', 1.00, 'Indications\r\nParacetamol is indicated in:\r\n*Fever,common cold and influenza.\r\n*Headache,toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains.\r\n*Pain of colic, back pain, post-operative pain, postpartum pain, chronic pain of cancer,\r\n inflammatory pain, and post-vaccination pain and fever of children.\r\n*Rheumatism and osteoarthritic pain & stiffness of joints in fingers, \r\nhips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.\r\n\r\n\r\nDosage & Administration\r\nTablet:\r\n*Adult: 1-2 tablets every 4 to 6 hours up to a maximum of 4 gm (8 tablets) daily.\r\n*Children (6-12 years): ½ to 1 tablet 3 to 4 times daily. For long term treatment\r\n it is wise not to exceed the dose beyond 2.6 gm/day.\r\nExtended Release Tablet:\r\n*Adults & Children over 12 years: Two tablets, swallowed whole, every 6 to 8 hours \r\n(maximum of 6 tablets in any 24 hours).The tablet must not be crushed.\r\nSyrup/Suspension:\r\n*Children under 3 months: 10 mg/kg body weight (reduce to 5 mg/kg if jaundiced) 3 to 4 times daily.\r\n*3 months to below 1 year: ½ to 1 teaspoonful 3 to 4 times daily.\r\n*1-5 years: 1 -2 teaspoonful 3 to 4 times daily.\r\n*6-12 years: 2-A teaspoonful 3 to 4 times daily.\r\n*Adults: 4-8 teaspoonful 3 to 4 times daily.\r\nSuppository:\r\n*Children 3-12 months: 60-120 mg,4 times daily.\r\n*Children 1-5 years: 125-250 mg 4 times daily.\r\n*Children 6-12 years: 250-500 mg 4 times daily.\r\n*Adults & children over 12 years: 0.5-1 gm 4 times daily.\r\nPaediatric Drop:\r\nChildren Upto 3 months: 0.5 ml (40 mg)\r\n*4 to 11 months: 1.0 ml (80 mg)\r\n*7 to 2 years: 1.5 ml (120 mg). Do not exceed more than 5 dose daily for a maximum of 5 days.', '/shops/Lazz Pharma/medicine/1572342779.jpg', 2, '2019-10-29 03:52:59', '2019-10-29 03:52:59'),
(13, 'L-2948', 'Ace Plus', 'Square Pharmaceuticals Ltd.', 'Paracetamol + Caffeine', 'Tablet', 3.00, 'Indications\r\nThe indications of Paracetamol & Caffeine are Headache, Migraine, Toothache, \r\nNeuralgia, Feverishness, Period pain, Sore throat, Backache, Helps reduce temperature,\r\n Aches and pain of colds and flu.\r\n\r\nDosage & Administration\r\nAdult dose: 1-2 tablets every 4-6 hours. Maximum dose: 8 tablets daily.\r\nChild dose: Not recommended for children below 12 years.', '/shops/Lazz Pharma/medicine/1572342871.jpg', 2, '2019-10-29 03:54:31', '2019-10-29 03:54:31'),
(14, 'L-09765', 'Tearon', 'Beximco Pharmaceuticals Ltd.', 'Polyethylene Glycol + Propylene Glycol', 'Eye Drop', 175.00, 'Indications\r\nThis combination eye drop is indicated for the temporary relief of burning and irritation due to dryness of the eye.\r\n\r\nDosage & Administration\r\nThe frequency of instillation of drops and the duration of treatment will vary depending upon the severity of the underlying condition and the response to treatment. Usually instill 1 or 2 drops in the affected eyes.', '/shops/Lazz Pharma/medicine/1572342951.jpg', 2, '2019-10-29 03:55:51', '2019-10-29 03:55:51'),
(15, 'L-95483', 'Napa IV Infusion', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol (IV Infusion)', 'IV Infusion', 149.00, 'Indications\r\nParacetamol IV is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, the reduction of fever.\r\n\r\nDosage & Administration\r\nAdults and adolescents weighing 50 kg and over: the recommended dosage of Paracetamol IV is 1000 mg every 6 hours or 650 mg every 4 hours, with a maximum single dose of Paracetamol IV of 1000 mg, a minimum dosing interval of 4 hours, and a maximum daily dose of Paracetamol of 4000 mg per day.\r\n\r\nAdults and adolescents weighing under 50 kg: the recommended dosage of Paracetamol IV is 15 mg/kg every 6 hours or 12.5 mg/kg every 4 hours, with a maximum single dose of Paracetamol IV of 15 mg/kg, a minimum dosing interval of 4 hours, and a maximum daily dose of Paracetamol of 75 mg/kg per day.\r\n\r\nChildren >2 to 12 years of age: the recommended dosage of Paracetamol IV is 15 mg/kg every 6 hours or 12.5 mg/kg every 4 hours, with a maximum single dose of Paracetamol IV of 15 mg/kg, a minimum dosing interval of 4 hours, and a maximum daily dose of Paracetamol of 75 mg/kg per day.', '/shops/Lazz Pharma/medicine/1572343089.jpg', 2, '2019-10-29 03:58:09', '2019-10-29 03:58:09'),
(16, 'L-083245', 'Nystat Oral Suspension', 'Acme Laboratories Limited.', 'Nystatin (Oral)', 'Oral Suspension', 22.00, 'Indications\r\nNystatin is an antifungal antibiotic active against a wide range of yeasts and yeast like fungi including Candida albicans. It is used for the prevention and treatment of Candida infections of oral cavity, esophagus and intestinal tract. It provides effective prophylaxis against oral candidiasis in those born of mothers with vaginal candidiasis. It is used for the prophylaxis of Candida overgrowth during courses of broadspectrum antibiotics\r\n\r\n\r\nDosage & Administration\r\nChildren:\r\nIn intestinal and oral candidiasis (thrush): 1,00,000 units (1 ml) should be dropped into the mouth four times daily.The longer the suspension is kept in contact with the affected area in the mouth, before swallowing, the greater will be its effect.\r\nFor prophylaxis in the newborn: The suggested dose is 1,00,000 units (1 ml) once daily or as prescribed by the physician.\r\nAdult:\r\nFor the treatment of intestinal or esophageal candidiasis: 5,00,000 units (5 ml) by mouth 3 or 4 times daily. The dose may be doubled, if required.\r\nFor prophylaxis of intestinal candidiasis in adults: 10,00,000 units (10 ml) daily.\r\nFor prophylaxis to suppress the over growth of Candida albicans in patients receiving broad spectrum antibiotic therapy: 10,00,000 units (10 ml) daily.\r\nFor the treatment of dental sores and oral infection: 1,00,000 units (1 ml) suspension should be dropped into the mouth four times daily.\r\nElderly: Older people with intestinal candidiasis who are unable to swallow tablets should be given 5,00,000 units (5 ml) suspension four times daily.', '/shops/Lazz Pharma/medicine/1572343227.jpg', 2, '2019-10-29 04:00:27', '2019-10-29 04:00:27'),
(17, 'L-87654', 'Orsaline-N', 'Bristol Pharmaceuticals Ltd.', 'Oral Rehydration Salt (Powder)', 'Orsaline', 3.00, 'Composition\r\nReduced osmolarity oral saline:\r\n\r\n1/2 liter formula (10.25 gm): Per sachet contains- \r\nSodium chloride 1.30gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 6.75 gm\r\nHigher osmolarity oral saline:\r\n\r\n1/2 liter formula (13.95 gm): Per sachet contains-\r\nSodium chloride 1.75 gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 10 gm\r\n1 liter formula (27.50 gm): Per sachet contains-\r\nSodium chloride 3.5 gm\r\nSodium biocarbonate 2.5 gm\r\nPotassium chloride 1.5 gm\r\nGlucose anhydrous 20 gm\r\nIndications\r\nOral Rehydration Salt is indicated in Diarrhea (treatment) and Electrolyte depletion (prophylaxis and treatment)\r\n\r\n\r\nDosage & Administration\r\nChildren less than 2 years: After each loose stool or vomiting 10 to 20 spoonful (50-100 ml).\r\n\r\nChildren 2 to 10 years: After each loose stool or vomiting 100-200 ml of prepared oral saline.\r\n\r\nAdult and children above 10 years: After each loose stool or vomiting 200-400 ml of prepared saline.', '/shops/Lazz Pharma/medicine/1572343287.jpg', 2, '2019-10-29 04:01:27', '2019-10-29 04:01:27'),
(18, 'L-34567', 'Esloric', 'Square Pharmaceuticals Ltd.', 'Allopurinol', 'Tablet', 4.00, 'Indications\r\nAallopurinol reduces serum and urinary uric acid concentrations. \r\nIts use should be individualized for each patient and requires an \r\nunderstanding of its mode of action and \r\npharma-cokinetics.Allopurinol is indicated in:\r\n*The management of patients with signs and symptoms of primary or secondary gout \r\n(acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy).\r\nTThe management of patients with leukemia, lymphoma and malignancies who are receiving \r\ncancer therapy which causes elevations of serum and urinary uric acid levels. \r\nTreatment with Allopurinol should be discontinued when the potential for overproduction \r\nof uric acid is no longer present.\r\n*The management of patients with recurrent calcium oxalate calculi whose daily\r\n uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients. \r\nTherapy in such patients should be carefully assessed initially and reassessed periodically \r\nto determine in each case that treatment is beneficial and that the benefits outweigh the risks.\r\n\r\nDosage & Administration\r\nAdults:\r\n*Mild gout: 200 to 300 mg/day.\r\n*Moderately severe tophaceous gout: 400 to 600 mg/day.\r\n The minimal effective dosage is 100 to 200 mg daily and the maximal \r\nrecommended dosage is 800 mg daily. To reduce the possibility of flare-up of\r\n acute gouty attacks, it is recommended that the patient start with a low dose \r\nof Allopurinol  (100 mg daily) and increase at weekly intervals by 100 mg until\r\n a serum uric acid level of 6 mg/day or less is attained but without exceeding \r\nthe maximal recommended dosage.\r\n*Recurrent calcium oxalate stones: 200 to 300 mg/day.\r\nChildren:\r\n*Age 6-10 years: In secondary hyperuricemia associated \r\nwith malignancies may be given 300 mg Allopurinol daily.\r\n*Age under 6 years: generally given 150 mg daily.', '/shops/Lazz Pharma/medicine/1572343434.jpg', 2, '2019-10-29 04:03:54', '2019-10-29 04:03:54'),
(19, 'L-2467', 'Ocof', 'Square Pharmaceuticals Ltd.', 'Dextromethorphan + Phenylephrine + Triprolidine', 'Syrup', 100.00, 'Indications\r\nThis preparation is indicated for the symptomatic relief of upper respiratory tract disorders accompanied by non-productive cough which benefits from the administration of a nasal decongestant, a histamine H1-receptor antagonist and an antitussive combination.\r\n\r\nDosage\r\nAdults & Children over 12 years: 1 teaspoonful 4 times a day.\r\n6-12 years: 1/2 teaspoonful 4 times a day.\r\n\r\nA physician\'s advice should be obtained before administering this combination to children less than 6 years.\r\nAdministration\r\nTake with or without food. Take with food if it causes an upset stomach. Measure liquid doses carefully. Use the measuring device that comes with this medicine.', '/shops/Lazz Pharma/medicine/1572343520.jpg', 2, '2019-10-29 04:05:20', '2019-10-29 04:05:20'),
(20, 'L-29234', 'Beuflox-D', 'Incepta Pharmaceuticals Limited', 'Ciprofloxacin + Dexamethasone', 'Eye/Ear Drop', 75.00, 'Indications\r\nEye: This combination eye drop is indicated for the treatment of steroid responsive inflammatory ocular conditions where bacterial infections or risk of bacterial infections co-exist. The use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where is an expectation that potentially dangerous numbers of bacteria will be present in the eye. The combination can also be used for post-operative inflammation and any other ocular inflammation associated with infection.\r\n\r\nEar: It is indicated for the treatment of ear infections accompanied by inflammation such as otitis externa, otitis media and chronic suppurative otitis media etc. The combination can also be used for post-operative inflammation of ear.\r\n\r\n\r\n\r\nDosage & Administration\r\nFor Eye: 1 drop to be instilled into conjunctival sac(s) every four to six hours. During the initial 24 to 48 hours, the dosage may be increased to 1 drop every two hours.\r\n\r\nFor Ear:\r\nAcute otitis media in pediatric patients with typanastomy tube: 4 drops instilled into the affected ear 2 times daily for 7 days.\r\nAcute otitis externa: 4 drops instilled into the affected ear 2 times daily for 7 days.\r\nFrequency should be decreased gradually or warranted in clinical signs. Care should be taken not to discontinue therapy prematurely.', '/shops/Lazz Pharma/medicine/1572343616.jpg', 2, '2019-10-29 04:06:56', '2019-10-29 04:06:56'),
(21, 'L-5432', 'Omenix', 'Incepta Pharmaceuticals Limited', 'Omeprazole', 'Capsule', 8.00, 'Indications\r\nOmeprazole offers significant therapeutic gains in the treatment of acid related diseases. Healing rates are high in duodenal ulcer, gastric ulcer and erosive reflux oesophagitis; acid production is controlled effectively in Zollinger-Ellison Syndrome and symptom relief is prompt and sustained in all indications. Less clear-cut indications where benefit might be expected but where data are limited include:\r\nPrevention of stress ulceration\r\nPrevention of the acid aspiration syndrome\r\nTreatment of upper gastro-intestinal bleeding\r\nNOTE: In comparative studies, Omeprazole has been found to produce faster symptom relief and higher healing rates in a greater percentage of patients than either Cimetidine or Ranitidine, confirming the ‘therapeutic gains’ achievable with Omeprazole over existing therapies.\r\n\r\nDosage\r\nOral-\r\nDuodenal Ulcer: 20 mg once daily for 4 weeks. In severe cases, 40 mg once daily for 4 weeks.\r\n\r\nGastric Ulcer: 20 mg once daily for 8 weeks. In severe cases, 40 mg once daily for 8 weeks.\r\n\r\nErosive Reflux Oesophagitis: 20 mg once daily for 4 weeks. For those not fully healed, to be continued for 4 more weeks. Refractory Reflux Oesophagitis: 40 mg once daily for 8 weeks. Zollinger-Ellison Syndrome: 60 mg once daily, adjusted individually and continued as long as necessary.\r\n\r\nMost patients will be effectively controlled with 20-120 mg daily. Dosage above 80 mg should be divided and given twice daily. Long-term maintenance treatment with Omeprazole is not recommended.\r\n\r\nImpaired Renal or Hepatic Function: Adjustment is not required. Patients with severe liver disease should not require more than 20 mg Omeprazole daily\r\n\r\n\r\nIV Injection-\r\nProphylaxis of acid aspiration: Omeprazole 40 mg to be given slowly (over a period of 5 minutes) as an intravenous injection, one hour before surgery.\r\n\r\nDuodenal ulcer, gastric ulcer or reflux oesophagitis: In patients with duodenal ulcer, gastric ulcer or reflux oesophagitis where oral medication is inappropriate, Omeprazole IV 40 mg once daily is recommended.\r\n\r\nZollinger- Ellison syndrome (ZES): In patients with Zollinger-Ellison Syndrome the recommended initial dose of Omeprazole given intravenously is 60 mg daily. Higher daily doses may be required and the dose should be adjusted individually. When doses exceed 60 mg daily, the dose should be divided & given twice daily.', '/shops/Lazz Pharma/medicine/1572344366.jpg', 2, '2019-10-29 04:19:26', '2019-10-29 04:19:26'),
(22, 'L-76543', 'Emonium', 'Beximco Pharmaceuticals Ltd.', 'Tiemonium Methylsulphate', 'IM/IV Injection', 15.00, 'Indications\r\nTiemonium Methylsulphate is an antispasmodic drug. It reduces muscle spasms of the intestine, biliary system, uterus & urinary bladder. It is indicated for the pain in gastrointestinal, biliary, urinary and gynecological disease such as gastroenteritis, diarrhea, dysentery, biliary colic, enterocolitis, cholecystytis, colonopathies, mild cystitis, & spasmodic dysmenorrhoea.\r\n\r\n\r\nDosage & Administration\r\nTablet: Recommended oral dose of Tiemonium Methylsulphate tablet is 2-6 tablets (100-300 mg) daily in divided dose.\r\n\r\nInjection: Recommended injectable dose is 1 Tiemonium Methylsulphate Injection 3 times daily, through Intravenous route slowly or Intramuscular route.\r\n\r\nSyrup:\r\nChildren: 3 mg to 6 mg/kg/day or 1.5 ml to 3 ml/kg/day in 3 divided doses.\r\nAdult: 30 mg to 90 mg or 15 ml to 45 ml 3 times daily or as directed by physician.\r\nSuppository: Recommended dose is 20 mg Tiemonium Methylsulphate suppository two or three times daily, through rectal route.', '/shops/Lazz Pharma/medicine/1572344514.jpg', 2, '2019-10-29 04:21:54', '2019-10-29 04:21:54'),
(23, 'L-6876543', 'Osmosol', 'Beximco Pharmaceuticals Ltd.', 'Mannitol', 'IV Infusion', 150.00, 'Indications\r\nMannitol is principally used by IV infusion as an osmotic diuretic to preserve renal function in acute renal failure and to reduce raised intracranial and intraocular pressure. Mannitol is also used as an irrigating solution to prevent hemolysis and hemoglobin buildup during transurethral prostatic resection. It is useful in the management of acute drug poisoning where a route of elimination is through kidney. Besides these, it is also used in symptomatic relief of edema, reperfusion injury, termination of pregnancy, and bowel preparation. So, Mannitol is indicated in-\r\n\r\nRenal insufficiency, Reperfusion injury, Raised intracranial pressure, Bladder irrigation, Raised intraocular presure, Bowel preparation, Edematous status, As a prophylactic in renal failure, Management of poisoning, Termination of Pregnancy\r\n\r\n\r\n\r\nDosage & Administration\r\nThe adult dose of Mannitol ranges from 50 to 100 gm by IV infusion. The rate of administration is usually adjusted to maintain a urine flow of at least 30 to 50 ml/hr. Total dosage, concentration and the rate of administration depends on fluid requirement, urinary output and the severity of the condition being treated\r\n\r\nRenal insufficiency-\r\nAdults: 50 to 100 g of Mannitol administered at a rate adjusted to maintain a urine flow of at least 30 to 50 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area administered over a period of 2 to 6 hrs.\r\nCerebral edema, elevated intracranial pressure, elevated intraocular pressure, Glaucoma-\r\nAdults: 1.5 to 2 gm/kg administered over a period of 30 to 60 minutes.\r\nChildren: 1 to 2 gm/kg body wt. or 30 to 60 gm/m2 of body surface area administered over a period of 30 to 60 mins.\r\nAdjunctive therapy for removal of toxic substances-\r\nAdults: 50 to 200 g of Mannitol administered at a rate adjust to maintain a urine flow of at least 100 to 500 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area\r\nFor termination of pregnancy 50 gm of Mannitol (250 ml of Mannitol) is instilled into the amniotic cavity which induces abortion in a high proportion of pregnancies.', '/shops/Lazz Pharma/medicine/1572344593.jpg', 2, '2019-10-29 04:23:13', '2019-10-29 04:23:13'),
(24, 'L-207678', 'Orsaline-N', 'Bristol Pharmaceuticals Ltd.', 'Oral Rehydration Salt (Powder)', 'Orsaline', 3.00, 'Composition\r\nReduced osmolarity oral saline:\r\n\r\n1/2 liter formula (10.25 gm): Per sachet contains- \r\nSodium chloride 1.30gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 6.75 gm\r\nHigher osmolarity oral saline:\r\n\r\n1/2 liter formula (13.95 gm): Per sachet contains-\r\nSodium chloride 1.75 gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 10 gm\r\n1 liter formula (27.50 gm): Per sachet contains-\r\nSodium chloride 3.5 gm\r\nSodium biocarbonate 2.5 gm\r\nPotassium chloride 1.5 gm\r\nGlucose anhydrous 20 gm\r\nIndications\r\nOral Rehydration Salt is indicated in Diarrhea (treatment) and Electrolyte depletion (prophylaxis and treatment)\r\n\r\n\r\nDosage & Administration\r\nChildren less than 2 years: After each loose stool or vomiting 10 to 20 spoonful (50-100 ml).\r\n\r\nChildren 2 to 10 years: After each loose stool or vomiting 100-200 ml of prepared oral saline.\r\n\r\nAdult and children above 10 years: After each loose stool or vomiting 200-400 ml of prepared saline.', '/shops/Lazz Pharma Limited/medicine/1572345008.jpg', 3, '2019-10-29 04:30:08', '2019-10-29 04:30:08'),
(25, 'L-2543', 'Ace Plus', 'Square Pharmaceuticals Ltd.', 'Paracetamol + Caffeine', 'Tablet', 2.00, 'Indications\r\nThe indications of Paracetamol & Caffeine are Headache, Migraine, Toothache, \r\nNeuralgia, Feverishness, Period pain, Sore throat, Backache, Helps reduce temperature,\r\n Aches and pain of colds and flu.\r\n\r\nDosage & Administration\r\nAdult dose: 1-2 tablets every 4-6 hours. Maximum dose: 8 tablets daily.\r\nChild dose: Not recommended for children below 12 years.', '/shops/Lazz Pharma Limited/medicine/1572345068.jpg', 3, '2019-10-29 04:31:08', '2019-10-29 04:31:08'),
(26, 'L-4543234', 'Losectil', 'Eskayef Bangladesh Ltd.', 'Omeprazole', 'Capsule', 5.00, 'Indications\r\nOmeprazole offers significant therapeutic gains in the treatment of acid related diseases.\r\n Healing rates are high in duodenal ulcer, gastric ulcer and erosive reflux oesophagitis;\r\n acid production is controlled effectively in Zollinger-Ellison Syndrome and symptom relief \r\nis prompt and sustained in all indications. Less clear-cut indications where benefit might be \r\nexpected but where data are limited include:\r\n*Prevention of stress ulceration\r\n*Prevention of the acid aspiration syndrome\r\n*Treatment of upper gastro-intestinal bleeding\r\nNOTE: In comparative studies, Omeprazole has been found to produce faster symptom relief and \r\nhigher healing rates in a greater percentage of patients than either Cimetidine or Ranitidine,\r\n confirming the ‘therapeutic gains’ achievable with Omeprazole over existing therapies.\r\n\r\nDosage\r\nOral-\r\nDuodenal Ulcer: 20 mg once daily for 4 weeks. In severe cases, 40 mg once daily for 4 weeks.\r\n\r\nGastric Ulcer: 20 mg once daily for 8 weeks. In severe cases, 40 mg once daily for 8 weeks.\r\n\r\nErosive Reflux Oesophagitis: 20 mg once daily for 4 weeks. For those not fully healed, to be continued for 4 more weeks. Refractory Reflux Oesophagitis: 40 mg once daily for 8 weeks. Zollinger-Ellison Syndrome: 60 mg once daily, adjusted individually and continued as long as necessary.\r\n\r\nMost patients will be effectively controlled with 20-120 mg daily. Dosage above 80 mg should be divided and given twice daily. Long-term maintenance treatment with Omeprazole is not recommended.\r\n\r\nImpaired Renal or Hepatic Function: Adjustment is not required. Patients with severe liver disease should not require more than 20 mg Omeprazole daily\r\n\r\n\r\nIV Injection-\r\nProphylaxis of acid aspiration: Omeprazole 40 mg to be given slowly (over a period of 5 minutes) as an intravenous injection, one hour before surgery.\r\n\r\nDuodenal ulcer, gastric ulcer or reflux oesophagitis: In patients with duodenal ulcer, gastric ulcer or reflux oesophagitis where oral medication is inappropriate, Omeprazole IV 40 mg once daily is recommended.\r\n\r\nZollinger- Ellison syndrome (ZES): In patients with Zollinger-Ellison Syndrome the recommended initial dose of Omeprazole given intravenously is 60 mg daily. Higher daily doses may be required and the dose should be adjusted individually. When doses exceed 60 mg daily, the dose should be divided & given twice daily.', '/shops/Lazz Pharma Limited/medicine/1572345150.jpg', 3, '2019-10-29 04:32:30', '2019-10-29 04:32:30'),
(27, 'L-7654398', 'Entacyd Plus', 'Square Pharmaceuticals Ltd.', 'Aluminium Hydroxide + Magnesium Hydroxide + Simethicone', 'Tablet', 3.00, 'Composition\r\nEach tablet contains-\r\nAluminium Hydroxide 200 mg\r\nMagnesium Hydroxide 400 mg or 200 mg\r\nSimethicone 30 mg \r\nEach 5 ml Suspension contains-\r\nAluminium Oxide 200 mg\r\nMagnesium Hydroxide 400 mg\r\nSimethicone 30 mg\r\nIndications\r\nThis is indicated for dyspepsia, hyperacidity, gastric and duodenal ulcer, \r\ngastritis; also indicated for the relief of flatulence, abdominal distention and windy colic.\r\n\r\n\r\nDosage & Administration\r\nTablet: 1-2 tablets 1-3 hours after meal and at bed time or as directed by the physician.\r\n\r\nSuspension: 1-2 teaspoonful 1-3 hours after meal and at bedtime or as directed by the physician.', '/shops/Lazz Pharma Limited/medicine/1572345221.jpg', 3, '2019-10-29 04:33:41', '2019-10-29 04:33:41'),
(28, 'L-8765434567874', 'Napa', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol', 'Tablet', 2.00, 'Indications\r\nParacetamol is indicated in:\r\n*Fever,common cold and influenza.\r\n*Headache,toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains.\r\n*Pain of colic, back pain, post-operative pain, postpartum pain, chronic pain of cancer,\r\n inflammatory pain, and post-vaccination pain and fever of children.\r\n*Rheumatism and osteoarthritic pain & stiffness of joints in fingers, \r\nhips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.\r\n\r\n\r\nDosage & Administration\r\nTablet:\r\n*Adult: 1-2 tablets every 4 to 6 hours up to a maximum of 4 gm (8 tablets) daily.\r\n*Children (6-12 years): ½ to 1 tablet 3 to 4 times daily. For long term treatment\r\n it is wise not to exceed the dose beyond 2.6 gm/day.\r\nExtended Release Tablet:\r\n*Adults & Children over 12 years: Two tablets, swallowed whole, every 6 to 8 hours \r\n(maximum of 6 tablets in any 24 hours).The tablet must not be crushed.\r\nSyrup/Suspension:\r\n*Children under 3 months: 10 mg/kg body weight (reduce to 5 mg/kg if jaundiced) 3 to 4 times daily.\r\n*3 months to below 1 year: ½ to 1 teaspoonful 3 to 4 times daily.\r\n*1-5 years: 1 -2 teaspoonful 3 to 4 times daily.\r\n*6-12 years: 2-A teaspoonful 3 to 4 times daily.\r\n*Adults: 4-8 teaspoonful 3 to 4 times daily.\r\nSuppository:\r\n*Children 3-12 months: 60-120 mg,4 times daily.\r\n*Children 1-5 years: 125-250 mg 4 times daily.\r\n*Children 6-12 years: 250-500 mg 4 times daily.\r\n*Adults & children over 12 years: 0.5-1 gm 4 times daily.\r\nPaediatric Drop:\r\nChildren Upto 3 months: 0.5 ml (40 mg)\r\n*4 to 11 months: 1.0 ml (80 mg)\r\n*7 to 2 years: 1.5 ml (120 mg). Do not exceed more than 5 dose daily for a maximum of 5 days.', '/shops/Lazz Pharma Limited/medicine/1572345268.jpg', 3, '2019-10-29 04:34:28', '2019-10-29 04:34:28'),
(29, 'L-654321', 'Tusca Plus', 'Square Pharmaceuticals Ltd.', 'Guaifenesin + Levomenthol + Diphenhydramine', 'Syrup', 90.00, 'Indications\r\nThis is indicated for the symptomatic relief of upper respiratory tract disorders accompanied by productive cough.\r\n\r\n\r\nDosage & Administration\r\n12 years and above: 10 ml 4 times a day.', '/shops/Lazz Pharma Limited/medicine/1572345347.jpg', 3, '2019-10-29 04:35:47', '2019-10-29 04:35:47'),
(30, 'L-7654321', 'Zesup', 'Square Pharmaceuticals Ltd.', 'Zinc Sulphate Monohydrate', 'Syrup', 40.00, 'Indications\r\nZinc Sulphate is indicated for Recurrent Respiratory Tract Infections; Diarrhoea; \r\nLoss of appetite; Severe growth retardation; Deformed bone formation; Impaired immunological response;\r\n Acrodermatitis enteropathica; Parakeratatic skin lesions; \r\nDefective and delayed wound healing; Anaemia; Night blindness; Mental disturbances\r\nDescription\r\nZinc Sulfate Monohydrate is a source of Zinc which is an essential trace element and involved in a number of body enzyme systems. Symptoms of less severe Zinc deficiency include distorted or absent perceptions of taste and smell and poor wound healing. \r\nSevere Zinc deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections \r\nand failure to thrive in children.\r\n\r\nDosage\r\nSyrup-\r\nChildren under 10 kg: One teaspoonful 2 times daily.\r\nChildren within 10 to 30 kg: Two teaspoonful 1-3 times daily.\r\nAdults and children over 30 kg body weight: Four teaspoonful 1-3 times daily.\r\nTablet-\r\nIn the treatment of Diarrhoea Zinc should be given as soon as diarrhoea starts:\r\nFor infants between 2 to 6 months of age: 10 mg Zinc once daily for 10-14 days.\r\nFor children between 6 months to 5 years of age: 20 mg Zinc once daily for 10-14 days.\r\nFor other indications:\r\nThe recommended dose for children: 2 to 2.5 mg/kg/day.\r\nChildren under 10 kg: 10 mg Zinc 2 times daily.\r\nChildren within 10 to 30 kg: 20 mg Zinc 1-3 times daily.\r\nAdults and children over 30 kg body weight: 40 mg Zinc 1-3 times daily.', '/shops/Lazz Pharma Limited/medicine/1572345413.jpg', 3, '2019-10-29 04:36:53', '2019-10-29 04:36:53');
INSERT INTO `medicines` (`id`, `medicine_id`, `medicine_name`, `company_name`, `generic_name`, `medicine_type`, `medicine_price`, `description`, `image`, `shop_id`, `created_at`, `updated_at`) VALUES
(31, 'L-87544321', 'Amodis Oral', 'Square Pharmaceuticals Ltd.', 'Metronidazole', 'Oral Suspension', 32.00, 'Indications\r\nMetronidazole is indicated in:\r\n*All forms of amoebiasis (intestinal and extra-intestinal disease including liver abscess and that of symptomless cyst passers)\r\n*Trichomoniasis\r\n*Giardiasis\r\n*Bacterial vaginosis\r\n*Acute ulcerative gingivitis\r\n*Anaerobic infections including septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis etc.\r\n*Anaerobically-infected leg ulcers and pressure sores\r\n*Acute dental infections (e.g. acute pericoronitis and acute apical infections)\r\n*Surgical prophylaxis (prevention of postoperative infections due to anaerobic bacteria, particularly species of bacteroides and anaerobic streptococci\r\n*Chronic symptomatic peptic ulcer disease (as an agent of triple therapy to eradicate H. pylori-the most important aetiological factor of peptic ulcer)\r\n\r\n\r\n\r\nDosage & Administration\r\nTablet and Suspension:\r\nAmoebic dysentery: Duration 5-10 Days; \r\nFor Tablet: Adults- 750 mg t.i.d. Children- (7-10 years) 500 mg t.i.d. (3-7 years) 250 mg q.i.d. (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 800 mg t.i.d. Children- (7-10 years) 500 mg t.i.d. (3-7 years) 200 mg q.i.d. (1-3 years) 200 mg t.i.d.\r\nAsymptomatic amoebiasis: Duration 5-10 Days;\r\nFor Tablet: Adults- 500-750 mg t.i.d. Children- (7-10 years) 250-500 mg t.i.d. (3-7 years) 250 mg q.i.d. (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 500-800 mg t.i.d. Children- (7-10 years) 200-500 mg t.i.d.; (3-7 years) 200 mg q.i.d.; (1-3 years) 200 mg t.i.d.\r\nHepatic extraintestinal amoebiasis : Duration 5-10 Days (or 2days); \r\nFor Tablet: Adults- 500-750 mg t.i.d.; Children- (7-10 years) 250-500 mg t.i.d.; (3-7 years) 250 mg q.i.d.; (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 500-800 mg t.i.d.; Children- (7-10 years) 200-500 mg t.i.d.; (3-7 years) 200 mg q.i.d.; (1-3 years) 200 mg t.i.d.\r\nGiardiasis: Duration 3 Days;\r\nFor Tablet: Adults- 2 g once daily; Children-(7-10 years) 1g once daily; (3-7 years) 750 mg once daily; (1-3 years) 500 mg once daily.\r\nFor suspension: Adults- 2 g once daily; Children-(7-10 years) 1g once daily; (3-7 years) 800 mg once daily; (1-3 years) 500 mg once daily.\r\nTrichomoniasis: Duration 7 Days;\r\nFor Tablet: Adults- 250 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nTrichomoniasis: Duration 1 Day;\r\nFor Tablet: Adults- 2 g single dose; \r\nFor Suspension: Adults- 2 g single dose; \r\nVincent\'s infection (Ulceration of mucous membrane of respiratory tract & mouth): Duration 3 Days;\r\nFor Tablet: Adults- 250 mg t.i.d. or 500 mg b.i.d; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d. or 500 mg b.i.d; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nPeriodontal infection: Duration 3 Days;\r\nFor Tablet: Adults- 250 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nSevere dental infection: Duration 3 Days;\r\nFor Tablet: Adults- 500 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nAnaerobic infection: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d.; Children- 7.5 mg/kg body weight t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d.; Children- 7.5 mg/kg body weight t.i.d.\r\nPostoperative anaerobic infection (specially in operation abdominal or gynecological surgery): Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d. before and after operation; Children- 7.5 mg/kg body weight t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d. before and after operation; Children- 7.5 mg/kg body weight t.i.d.\r\nBacterial vaginitis: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d. \r\nFor Suspension: Adults- 500 mg b.i.d.\r\nLeg ulcers: Duration 1 Day;\r\nFor Tablet: Adults- 2 g as a single dose \r\nFor Suspension: Adults- 2 g as a single dose\r\nPressure sores: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d. \r\nFor Suspension: Adults- 500 mg t.i.d.\r\nH. pylori infection: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d \r\nFor Suspension: Adults-500 mg b.i.d\r\nAntibiotic Associated Pseudomembranus colitis: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d \r\nFor Suspension: Adults- 500 mg b.i.d\r\n\r\nVaginal Gel:\r\nThe recommended dose is one applicator full of Metronidazole GEL (approximately 5 grams containing approximately 37.5 mg of Metronidazole) intravaginally once or twice a day for 5 days. For once a day dosing, Metronidazole GEL should be administered at bedtime.\r\n\r\n\r\nSuppository:\r\nAnaerobic infections:\r\nAdult: 1 g 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nChild: 5-10 yr 500 mg. All doses to be given 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nProphylaxis of postoperative anaerobic bacterial infections:\r\nAdult: 1 g 2 hr before surgery, repeated 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nChild: 5-10 yr 500 mg 2 hr before surgery, repeated 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\n\r\nIV Infusion:\r\nMetronidazole injection should be infused intravenously at an approximate rate of 5 ml/min. Oral medication should be substituted as soon as feasible. Treatment for 7 days should be satisfactory for most patients, but the physician might decide to prolong treatment.\r\nFor bacterial infections: Adults: 500 mg (100 ml) 8 hourly. Children: 7.5 mg/kg (1.5 ml/kg) 8 hourly. \r\nFor treatment before and during surgery: Adults: 500 mg (100 ml) shortly before operation, repeated 8', '/shops/Lazz Pharma Limited/medicine/1572345541.jpg', 3, '2019-10-29 04:39:01', '2019-10-29 04:39:01'),
(32, 'L-4326718', 'Mannitol', 'Opso Saline Ltd.', 'Mannitol', 'IV Infusion', 155.00, 'Indications\r\nMannitol is principally used by IV infusion as an osmotic diuretic to preserve renal function in acute renal failure and to reduce raised intracranial and intraocular pressure. Mannitol is also used as an irrigating solution to prevent hemolysis and hemoglobin buildup during transurethral prostatic resection. It is useful in the management of acute drug poisoning where a route of elimination is through kidney. Besides these, it is also used in symptomatic relief of edema, reperfusion injury, termination of pregnancy, and bowel preparation. So, Mannitol is indicated in-\r\n\r\nRenal insufficiency, Reperfusion injury, Raised intracranial pressure, Bladder irrigation, Raised intraocular presure, Bowel preparation, Edematous status, As a prophylactic in renal failure, Management of poisoning, Termination of Pregnancy\r\n\r\nDosage & Administration\r\nThe adult dose of Mannitol ranges from 50 to 100 gm by IV infusion. The rate of administration is usually adjusted to maintain a urine flow of at least 30 to 50 ml/hr. Total dosage, concentration and the rate of administration depends on fluid requirement, urinary output and the severity of the condition being treated\r\n\r\nRenal insufficiency-\r\nAdults: 50 to 100 g of Mannitol administered at a rate adjusted to maintain a urine flow of at least 30 to 50 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area administered over a period of 2 to 6 hrs.\r\nCerebral edema, elevated intracranial pressure, elevated intraocular pressure, Glaucoma-\r\nAdults: 1.5 to 2 gm/kg administered over a period of 30 to 60 minutes.\r\nChildren: 1 to 2 gm/kg body wt. or 30 to 60 gm/m2 of body surface area administered over a period of 30 to 60 mins.\r\nAdjunctive therapy for removal of toxic substances-\r\nAdults: 50 to 200 g of Mannitol administered at a rate adjust to maintain a urine flow of at least 100 to 500 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area\r\nFor termination of pregnancy 50 gm of Mannitol (250 ml of Mannitol) is instilled into the amniotic cavity which induces abortion in a high proportion of pregnancies.', '/shops/Lazz Pharma Limited/medicine/1572345629.jpg', 3, '2019-10-29 04:40:29', '2019-10-29 04:40:29'),
(33, 'L-8765432', 'Omastin IV', 'Beximco Pharmaceuticals Ltd.', 'Fluconazole', 'IV Infusion', 200.00, 'Indications\r\nFluconazole is indicated in\r\n*Superficial candidal infections such as oral or vaginal thrush\r\n*Esophagitis caused by Candida or other susceptible species\r\n*Maintenance therapy of cryptococcal meningitis\r\n*Disseminated candidiasis\r\n*Prophylaxis for fungal infection in neutropenic cancer patients\r\n*Acute treatment of other systemic fungal infections\r\n*Dermatophyte and Candida skin infections\r\n*Fungal UTIs\r\n\r\nDosage\r\nOral-\r\nAdults: \r\nOropharyngeal Candidiasis: 200 mg on the first day, followed by 100 mg once daily for 7-14 days.\r\nEsophageal Candidiasis: 200 mg on the first day, followed by 100 mg once daily for 2-3 weeks.\r\nSystemic Candidiasis and Cryptococcal Meningitis: 400 mg daily followed by 200 mg once daily. The recommended duration of treatment for initial therapy of cryptococcal meningitis is 10 to 12 weeks.\r\nAcute or recurrent vaginal candidiasis: Single dose of 150 mg.\r\nUrinary Tract Infections and Peritonitis: 50 to 200 mg once daily. Prophylaxis in Patients Undergoing Bone Marrow Transplantation: 400 mg once daily.\r\nChildren:\r\nOropharyngeal Candidiasis: 6 mg/kg on the first day, followed by 3 mg/kg once daily. Treatment should be administered for at least 2 weeks to decrease the likelihood of relapse.\r\nEsophageal Candidiasis: 6 mg/kg on the first day, followed by 3 mg/kg once daily.\r\nCryptococcal meningitis: Initial therapy should be started with 6 to 12 mg/kg daily. Doses up to 12 mg/kg/day may be used for three weeks and treatment for initial therapy of cryptococcal meningitis is 10 to 12 weeks.\r\n\r\nIntravenous-\r\nAdult & child: Invasive candidal infections including candidaemia and disseminated candidiasis and cryptococcal infections including meningitis, by IV, 400 mg initially then 200 mg daily, increased if necessary to 400 mg daily, treatment continued according to response (at least 6-8 weeks for cryptococcal meningitis); Child 6-12 mg/kg daily (every 72 hours in neonate up to 2 weeks old, every 48 hours in neonate 2-4 weeks old); maximum 400 mg daily.\r\n\r\nPrevention of relapse of cryptococcal meningitis, by IV, 100-200 mg daily.', '/shops/Lazz Pharma Limited/medicine/1572345689.jpg', 3, '2019-10-29 04:41:29', '2019-10-29 04:41:29'),
(34, 'L-4323456', 'Citicol', 'Beximco Pharmaceuticals Ltd.', 'Citicoline Sodium', 'Injection', 145.00, 'Indications\r\nUse for the improvement of thinking, learning and memory in people suffering from Alzheimer\'s disease, \r\ndementia, head trauma, Parkinson\'s disease and glaucoma. Also used in loss of consciousness due to brain damage, head injury or brain surgery and cerebral infarction, age-related memory problems and stroke.\r\n\r\n\r\nDosage & Administration\r\nDisturbance of Consciousness: Due to Head Injury or Brain Surgery: 100-500 mg 1-2 times daily.\r\n\r\nPsychologic or Neurologic Disorders: Disturbance of Consciousness in the Acute Stage of Cerebral Infarction: 1000 mg once daily for 2 consecutive weeks or as prescribed by the physician.', '/shops/Lazz Pharma Limited/medicine/1572345768.jpg', 3, '2019-10-29 04:42:48', '2019-10-29 04:42:48'),
(35, 'L-345257', 'Odycin Eye Drop', 'Beximco Pharmaceuticals Ltd.', 'Moxifloxacin Hydrochloride (Eye)', 'Eye Drop', 140.00, 'Indications\r\nThe ophthalmic solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:\r\n*Aerobic Gram-positive microorganisms: Corynebacterium species, Micrococcus luteus, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus warneri, Streptococcus pneumoniae, Streptococcus viridans group\r\n*Aerobic Gram-negative microorganisms: Acinetobacterlwoffii, Haemophilusinfluenzae, Haemophilusparainfluenzae\r\n*Other microorganisms: Chlamydia trachomatis.\r\n\r\nDosage & Administration\r\nFor Eye Drops:\r\n*Moxifloxacin 0.5%: One drop in the affected eye 3 times per day for 7 days.\r\n*Moxifloxacin 0.5% (Enriched with Xanthan Gum 0.4%): One drop in the affected eye(s) 2 times daily for 7 days.\r\nFor Eye Ointment: It should be applied thinly and evenly to the affected eye three times a day for the first two days and for the next five days apply two times a day or as advised by the registered physician.', '/shops/Lazz Pharma Limited/medicine/1572345935.jpg', 3, '2019-10-29 04:45:35', '2019-10-29 04:45:35'),
(36, 'L-4567890987', 'Flumetanol Ear Drop', 'Aristopharma Ltd.', 'Clioquinol + Flumetasone Pivalate', 'Ear Drop', 104.00, 'Indications\r\nThis combination is indicated for the treatment of external ear inflammation and infections (otitis externa) and fungal infections of the outer ear (otomycosis).\r\n\r\nDosage & Administration\r\nFor adults and children (aged 2 years and over): The recommended dose is 2 to 3 drops twice daily for the prescribed period of time (usually not longer than 10 days). Before you apply the medication, you should warm the ear drops to body temperature by holding the bottle in the palm of your hands. Do not heat it above body temperature.', '/shops/Lazz Pharma Limited/medicine/1572346024.jpg', 3, '2019-10-29 04:47:04', '2019-10-29 04:47:04'),
(37, 'N-398476', 'Napa', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol', 'Tablet', 1.00, 'Indications\r\nParacetamol is indicated in:\r\n*Fever,common cold and influenza.\r\n*Headache,toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains.\r\n*Pain of colic, back pain, post-operative pain, postpartum pain, chronic pain of cancer,\r\n inflammatory pain, and post-vaccination pain and fever of children.\r\n*Rheumatism and osteoarthritic pain & stiffness of joints in fingers, \r\nhips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.\r\n\r\n\r\nDosage & Administration\r\nTablet:\r\n*Adult: 1-2 tablets every 4 to 6 hours up to a maximum of 4 gm (8 tablets) daily.\r\n*Children (6-12 years): ½ to 1 tablet 3 to 4 times daily. For long term treatment\r\n it is wise not to exceed the dose beyond 2.6 gm/day.\r\nExtended Release Tablet:\r\n*Adults & Children over 12 years: Two tablets, swallowed whole, every 6 to 8 hours \r\n(maximum of 6 tablets in any 24 hours).The tablet must not be crushed.\r\nSyrup/Suspension:\r\n*Children under 3 months: 10 mg/kg body weight (reduce to 5 mg/kg if jaundiced) 3 to 4 times daily.\r\n*3 months to below 1 year: ½ to 1 teaspoonful 3 to 4 times daily.\r\n*1-5 years: 1 -2 teaspoonful 3 to 4 times daily.\r\n*6-12 years: 2-A teaspoonful 3 to 4 times daily.\r\n*Adults: 4-8 teaspoonful 3 to 4 times daily.\r\nSuppository:\r\n*Children 3-12 months: 60-120 mg,4 times daily.\r\n*Children 1-5 years: 125-250 mg 4 times daily.\r\n*Children 6-12 years: 250-500 mg 4 times daily.\r\n*Adults & children over 12 years: 0.5-1 gm 4 times daily.\r\nPaediatric Drop:\r\nChildren Upto 3 months: 0.5 ml (40 mg)\r\n*4 to 11 months: 1.0 ml (80 mg)\r\n*7 to 2 years: 1.5 ml (120 mg). Do not exceed more than 5 dose daily for a maximum of 5 days.', '/shops/Nilu Pharmacy/medicine/1572348412.jpg', 7, '2019-10-29 05:26:52', '2019-10-29 05:26:52'),
(38, 'N-9765433', 'Entacyd Plus', 'Square Pharmaceuticals Ltd.', 'Aluminium Hydroxide + Magnesium Hydroxide + Simethicone', 'Tablet', 3.00, 'Composition\r\nEach tablet contains-\r\nAluminium Hydroxide 200 mg\r\nMagnesium Hydroxide 400 mg or 200 mg\r\nSimethicone 30 mg \r\nEach 5 ml Suspension contains-\r\nAluminium Oxide 200 mg\r\nMagnesium Hydroxide 400 mg\r\nSimethicone 30 mg\r\nIndications\r\nThis is indicated for dyspepsia, hyperacidity, gastric and duodenal ulcer, \r\ngastritis; also indicated for the relief of flatulence, abdominal distention and windy colic.\r\n\r\n\r\nDosage & Administration\r\nTablet: 1-2 tablets 1-3 hours after meal and at bed time or as directed by the physician.\r\n\r\nSuspension: 1-2 teaspoonful 1-3 hours after meal and at bedtime or as directed by the physician.', '/shops/Nilu Pharmacy/medicine/1572348508.jpg', 7, '2019-10-29 05:28:28', '2019-10-29 05:28:28'),
(39, 'N-82345678', 'Alatrol', 'Square Pharmaceuticals Ltd.', 'Cetirizine Dihydrochloride', 'Tablet', 2.00, 'Indications\r\nCetirizine is indicated for the treatment of seasonal\r\n allergic rhinitis and conjunctivitis, perennial allergic rhinitis,\r\n pruritus and urticaria. It is also used in allergen induced asthma.\r\n\r\nDosage & Administration\r\nTablet:\r\nAdults and children over 6 years: 1 tablet (10 mg) once daily or ½ tablet twice daily. \r\nChildren 2-6 years: ½ tablet once daily.\r\nSyrup:\r\nAdults and children over 6 years: 2 teaspoonful (10 mg) once daily or 1 teaspoon (5 mg) twice daily. \r\nChildren 2-6 years: 1 teaspoonful once daily or ½ teaspoon twice daily.', '/shops/Nilu Pharmacy/medicine/1572348579.jpg', 7, '2019-10-29 05:29:39', '2019-10-29 05:29:39'),
(40, 'N-873', 'Orsaline-N', 'Bristol Pharmaceuticals Ltd.', 'Oral Rehydration Salt (Powder)', 'Orsaline', 2.00, 'Composition\r\nReduced osmolarity oral saline:\r\n\r\n1/2 liter formula (10.25 gm): Per sachet contains- \r\nSodium chloride 1.30gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 6.75 gm\r\nHigher osmolarity oral saline:\r\n\r\n1/2 liter formula (13.95 gm): Per sachet contains-\r\nSodium chloride 1.75 gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 10 gm\r\n1 liter formula (27.50 gm): Per sachet contains-\r\nSodium chloride 3.5 gm\r\nSodium biocarbonate 2.5 gm\r\nPotassium chloride 1.5 gm\r\nGlucose anhydrous 20 gm\r\nIndications\r\nOral Rehydration Salt is indicated in Diarrhea (treatment) and Electrolyte depletion (prophylaxis and treatment)\r\n\r\n\r\nDosage & Administration\r\nChildren less than 2 years: After each loose stool or vomiting 10 to 20 spoonful (50-100 ml).\r\n\r\nChildren 2 to 10 years: After each loose stool or vomiting 100-200 ml of prepared oral saline.\r\n\r\nAdult and children above 10 years: After each loose stool or vomiting 200-400 ml of prepared saline.', '/shops/Nilu Pharmacy/medicine/1572348667.jpg', 7, '2019-10-29 05:31:07', '2019-10-29 05:31:07'),
(41, 'N-234567', 'Ocof', 'Square Pharmaceuticals Ltd.', 'Dextromethorphan + Phenylephrine + Triprolidine', 'Syrup', 105.00, 'Indications\r\nThis preparation is indicated for the symptomatic relief of upper respiratory tract disorders accompanied by non-productive cough which benefits from the administration of a nasal decongestant, a histamine H1-receptor antagonist and an antitussive combination.\r\n\r\nDosage\r\nAdults & Children over 12 years: 1 teaspoonful 4 times a day.\r\n6-12 years: 1/2 teaspoonful 4 times a day.\r\n\r\nA physician\'s advice should be obtained before administering this combination to children less than 6 years.\r\nAdministration\r\nTake with or without food. Take with food if it causes an upset stomach. Measure liquid doses carefully. Use the measuring device that comes with this medicine.', '/shops/Nilu Pharmacy/medicine/1572348740.jpg', 7, '2019-10-29 05:32:20', '2019-10-29 05:32:20'),
(42, 'N-654326', 'Prudex', 'Beximco Pharmaceuticals Ltd.', 'Dextromethorphan + Pseudoephedrine + Triprolidine', 'Syrup', 75.00, 'Composition\r\nEach 5 ml syrup contains-\r\nDextromethorphan Hydrobromide 10 mg\r\nPseudoephedrine Hydrochloride 30 mg\r\nTriprolidine Hydrochloride 1.25 mg\r\n\r\n\r\nIndications\r\nThis is indicated for the symptomatic relief of upper respiratory tract disorders accompanied by non-productive cough which benefits from the administration of a nasal decongestant, a histamine H1 receptor antagonist and an antitussive combination.\r\n\r\n\r\n\r\nDosage & Administration\r\nAdults: 2 tea-spoon three times daily\r\n\r\nChildren:\r\nOver 12 years: 2 tea-spoon three times daily.\r\n6 to 12 years: 1 tea-spoon three times daily.\r\n2 to 5 years: 1/2 tea-spoon three times daily.\r\n6 months to 2 years: 1/4 tea-spoon three times daily or on advice of a physician only.', '/shops/Nilu Pharmacy/medicine/1572348805.jpg', 7, '2019-10-29 05:33:25', '2019-10-29 05:33:25'),
(43, 'N-98765432', 'Fungistin', 'Beximco Pharmaceuticals Ltd.', 'Nystatin (Oral)', 'Oral Suspension', 25.00, 'Indications\r\nNystatin is an antifungal antibiotic active against a wide range of yeasts and yeast like fungi including Candida albicans. It is used for the prevention and treatment of Candida infections of oral cavity, esophagus and intestinal tract. It provides effective prophylaxis against oral candidiasis in those born of mothers with vaginal candidiasis. It is used for the prophylaxis of Candida overgrowth during courses of broadspectrum antibiotics\r\n\r\n\r\n\r\nDosage & Administration\r\nChildren:\r\nIn intestinal and oral candidiasis (thrush): 1,00,000 units (1 ml) should be dropped into the mouth four times daily.The longer the suspension is kept in contact with the affected area in the mouth, before swallowing, the greater will be its effect.\r\nFor prophylaxis in the newborn: The suggested dose is 1,00,000 units (1 ml) once daily or as prescribed by the physician.\r\nAdult:\r\nFor the treatment of intestinal or esophageal candidiasis: 5,00,000 units (5 ml) by mouth 3 or 4 times daily. The dose may be doubled, if required.\r\nFor prophylaxis of intestinal candidiasis in adults: 10,00,000 units (10 ml) daily.\r\nFor prophylaxis to suppress the over growth of Candida albicans in patients receiving broad spectrum antibiotic therapy: 10,00,000 units (10 ml) daily.\r\nFor the treatment of dental sores and oral infection: 1,00,000 units (1 ml) suspension should be dropped into the mouth four times daily.\r\nElderly: Older people with intestinal candidiasis who are unable to swallow tablets should be given 5,00,000 units (5 ml) suspension four times daily.', '/shops/Nilu Pharmacy/medicine/1572348893.jpg', 7, '2019-10-29 05:34:53', '2019-10-29 05:34:53'),
(44, 'N-5433456', 'Neoceptin R', 'Beximco Pharmaceuticals Ltd.', 'Ranitidine', 'Injection', 11.00, 'Indications\r\n*Ranitidine is indicated in:\r\n*Treatment of active duodenal ulcer\r\n*Benign gastric ulcer\r\n*Treatment & prevention of ulcer associated with non-steroidal anti-inflammatory agent\r\n*Post operative stress ulcer.\r\n*Zollinger-Ellison Syndrome.\r\n*Gastroesophageal reflux disease (GERD).\r\n*Gastro-intestinal haemorrhage from stress ulcer in seriously ill patient.\r\n*Recurrent haemorrhage in patients with bleeding peptic ulcer.\r\n*Before general anesthesia in patient considered to be at risk of acid aspiration particulary obstetric patients.\r\n\r\n\r\nDosage & Administration\r\nRanitidine Tablet & Syrup:\r\nDuodenal and gastric ulcer: The usual dosage is 150 mg twice daily taken in the morning and evening or 300 mg as a single daily dose at night for 4 to 8 weeks.\r\n\r\nReflux oesophagitis: 150 mg twice daily or 300 mg at bed time for up to 8 weeks.\r\n\r\nZollinger Ellison syndrome: 150 mg 3 times daily and increased if necessary up to 6 g daily in divided doses. Dosage should be continued as long as clinically indicated.\r\n\r\nEpisodic dyspepsia: 150 mg twice daily or 300 mg at bed time for up to 6 weeks.\r\n\r\nMaintenance: 150 mg at night for preventing recurrences.\r\n\r\nChild (peptic ulcer): 2-4 mg/kg twice daily, maximum 300 mg daily.\r\n\r\n\r\nRanitidine IV injection & IV Infusion:\r\nRanitidine injection may be given either as a slow (over a period of at least two minutes) intravenous injection of 50 mg, after dilution to a volume of 20 ml per 50 mg dose, which may be repeated every six to eight hours; or as an intermittent intravenous infusion at a rate of 25 mg per hour for two hours; the infusion may be repeated at six to eight hour intervals; or as an intramuscular injection of 50 mg (2 ml) every six to eight hours. In the prophylaxis of haemorrhage from stress ulceration in seriously ill patients or the prophylaxis of recurrent haemorrhage in patients bleeding from peptic ulceration, parenteral administration may be continued until oral feeding commences.\r\n\r\nIn the prophylaxis of upper gastrointestinal haemorrhage from stress ulceration in seriously ill patient sapriming dose of 50 mg as low as intravenous injection followed by a continuous intravenous infusion of 0.125-0.250 mg/kg/hour may be preferred. In patients considered to be at risk of developing aspiration syndrome Ranitidine injection 50 mg may be given intramuscularly or by slow intravenous injection 45 to 60 minutes before induction of general anaesthesia.\r\n\r\nChildren: The recommended oral dose for the treatment of peptic ulcer in children is 2 mg/kg to 4 mg/kg twice daily to a maximum of 300 mg ranitidine per day. Safety and effectiveness of Ranitidine injection have not been established in case of children.', '/shops/Nilu Pharmacy/medicine/1572348990.jpg', 7, '2019-10-29 05:36:30', '2019-10-29 05:36:30'),
(45, 'N-36512883', 'Osmosol IV', 'Beximco Pharmaceuticals Ltd.', 'Mannitol', 'IV Infusion', 160.00, 'Indications\r\nMannitol is principally used by IV infusion as an osmotic diuretic to preserve renal function in acute renal failure and to reduce raised intracranial and intraocular pressure. Mannitol is also used as an irrigating solution to prevent hemolysis and hemoglobin buildup during transurethral prostatic resection. It is useful in the management of acute drug poisoning where a route of elimination is through kidney. Besides these, it is also used in symptomatic relief of edema, reperfusion injury, termination of pregnancy, and bowel preparation. So, Mannitol is indicated in-\r\n\r\nRenal insufficiency, Reperfusion injury, Raised intracranial pressure, Bladder irrigation, Raised intraocular presure, Bowel preparation, Edematous status, As a prophylactic in renal failure, Management of poisoning, Termination of Pregnancy\r\n\r\n\r\n\r\nDosage & Administration\r\nThe adult dose of Mannitol ranges from 50 to 100 gm by IV infusion. The rate of administration is usually adjusted to maintain a urine flow of at least 30 to 50 ml/hr. Total dosage, concentration and the rate of administration depends on fluid requirement, urinary output and the severity of the condition being treated\r\n\r\nRenal insufficiency-\r\nAdults: 50 to 100 g of Mannitol administered at a rate adjusted to maintain a urine flow of at least 30 to 50 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area administered over a period of 2 to 6 hrs.\r\nCerebral edema, elevated intracranial pressure, elevated intraocular pressure, Glaucoma-\r\nAdults: 1.5 to 2 gm/kg administered over a period of 30 to 60 minutes.\r\nChildren: 1 to 2 gm/kg body wt. or 30 to 60 gm/m2 of body surface area administered over a period of 30 to 60 mins.\r\nAdjunctive therapy for removal of toxic substances-\r\nAdults: 50 to 200 g of Mannitol administered at a rate adjust to maintain a urine flow of at least 100 to 500 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area\r\nFor termination of pregnancy 50 gm of Mannitol (250 ml of Mannitol) is instilled into the amniotic cavity which induces abortion in a high proportion of pregnancies.', '/shops/Nilu Pharmacy/medicine/1572349153.jpg', 7, '2019-10-29 05:39:13', '2019-10-29 05:39:13'),
(46, 'N-349892883', 'Beuflox-D', 'Incepta Pharmaceuticals Limited', 'Ciprofloxacin + Dexamethasone', 'Eye/Ear Drop', 80.00, 'Indications\r\nEye: This combination eye drop is indicated for the treatment of steroid responsive inflammatory ocular conditions where bacterial infections or risk of bacterial infections co-exist. The use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where is an expectation that potentially dangerous numbers of bacteria will be present in the eye. The combination can also be used for post-operative inflammation and any other ocular inflammation associated with infection.\r\n\r\nEar: It is indicated for the treatment of ear infections accompanied by inflammation such as otitis externa, otitis media and chronic suppurative otitis media etc. The combination can also be used for post-operative inflammation of ear.\r\n\r\n\r\n\r\nDosage & Administration\r\nFor Eye: 1 drop to be instilled into conjunctival sac(s) every four to six hours. During the initial 24 to 48 hours, the dosage may be increased to 1 drop every two hours.\r\n\r\nFor Ear:\r\nAcute otitis media in pediatric patients with typanastomy tube: 4 drops instilled into the affected ear 2 times daily for 7 days.\r\nAcute otitis externa: 4 drops instilled into the affected ear 2 times daily for 7 days.\r\nFrequency should be decreased gradually or warranted in clinical signs. Care should be taken not to discontinue therapy prematurely.', '/shops/Nilu Pharmacy/medicine/1572349253.jpg', 7, '2019-10-29 05:40:53', '2019-10-29 05:40:53'),
(47, 'N-76654323', 'Hyprosol', 'Beximco Pharmaceuticals Ltd.', 'Hydroxypropyl Methyl Cellulose', 'Eye Drop', 70.00, 'Indications\r\nHydroxypropyl Methyl Cellulose gel is indicated as a surgical aid during surgical procedures involving the anterior chamber of the eye, including extraction of the lens, and insertion of intraocular lenses. It maintains the depth of the anterior chamber during the whole surgical procedure and permits greater operative precision without the risk of damaging the endothelium of the cornea or other intraocular tissues.\r\n\r\nHydroxypropyl Methyl Cellulose eye drop is used to treat dry eye conditions where not enough tears are produced to keep the eye lubricated and clean\r\n\r\nDosage & Administration\r\nEye Drop-\r\nFor Dry Eyes: \r\n*Adults and Children: Use 1 drop three or four times a day. This drug does not cause different side effects or problems in children than it does in adults.\r\n\r\nEye Gel-\r\nEach pre-filled glass syringe is for single intraocular use only. The quantity injected into the anterior chamber of the eye must be adjusted according to the volume of the aqueous humour and the anatomical structure to be protected.', '/shops/Nilu Pharmacy/medicine/1572349336.jpg', 7, '2019-10-29 05:42:16', '2019-10-29 05:42:16'),
(48, 'N-1234878', 'Losectil', 'Eskayef Bangladesh Ltd.', 'Omeprazole', 'Capsule', 6.00, 'Indications\r\nOmeprazole offers significant therapeutic gains in the treatment of acid related diseases.\r\n Healing rates are high in duodenal ulcer, gastric ulcer and erosive reflux oesophagitis;\r\n acid production is controlled effectively in Zollinger-Ellison Syndrome and symptom relief \r\nis prompt and sustained in all indications. Less clear-cut indications where benefit might be \r\nexpected but where data are limited include:\r\n*Prevention of stress ulceration\r\n*Prevention of the acid aspiration syndrome\r\n*Treatment of upper gastro-intestinal bleeding\r\nNOTE: In comparative studies, Omeprazole has been found to produce faster symptom relief and \r\nhigher healing rates in a greater percentage of patients than either Cimetidine or Ranitidine,\r\n confirming the ‘therapeutic gains’ achievable with Omeprazole over existing therapies.\r\n\r\nDosage\r\nOral-\r\nDuodenal Ulcer: 20 mg once daily for 4 weeks. In severe cases, 40 mg once daily for 4 weeks.\r\n\r\nGastric Ulcer: 20 mg once daily for 8 weeks. In severe cases, 40 mg once daily for 8 weeks.\r\n\r\nErosive Reflux Oesophagitis: 20 mg once daily for 4 weeks. For those not fully healed, to be continued for 4 more weeks. Refractory Reflux Oesophagitis: 40 mg once daily for 8 weeks. Zollinger-Ellison Syndrome: 60 mg once daily, adjusted individually and continued as long as necessary.\r\n\r\nMost patients will be effectively controlled with 20-120 mg daily. Dosage above 80 mg should be divided and given twice daily. Long-term maintenance treatment with Omeprazole is not recommended.\r\n\r\nImpaired Renal or Hepatic Function: Adjustment is not required. Patients with severe liver disease should not require more than 20 mg Omeprazole daily\r\n\r\n\r\nIV Injection-\r\nProphylaxis of acid aspiration: Omeprazole 40 mg to be given slowly (over a period of 5 minutes) as an intravenous injection, one hour before surgery.\r\n\r\nDuodenal ulcer, gastric ulcer or reflux oesophagitis: In patients with duodenal ulcer, gastric ulcer or reflux oesophagitis where oral medication is inappropriate, Omeprazole IV 40 mg once daily is recommended.\r\n\r\nZollinger- Ellison syndrome (ZES): In patients with Zollinger-Ellison Syndrome the recommended initial dose of Omeprazole given intravenously is 60 mg daily. Higher daily doses may be required and the dose should be adjusted individually. When doses exceed 60 mg daily, the dose should be divided & given twice daily.', '/shops/Nilu Pharmacy/medicine/1572349413.jpg', 7, '2019-10-29 05:43:33', '2019-10-29 05:43:33'),
(49, 'm-65237', 'Napa Extra', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol + Caffeine', 'Tablet', 3.00, 'Indications\r\nThe indications of Paracetamol & Caffeine are Headache, Migraine, Toothache, \r\nNeuralgia, Feverishness, Period pain, Sore throat, Backache, Helps reduce temperature, \r\nAches and pain of colds and flu.\r\n\r\nDosage & Administration\r\nAdult dose: 1-2 tablets every 4-6 hours. Maximum dose: 8 tablets daily.\r\nChild dose: Not recommended for children below 12 years.', '/shops/Maa Pharmacy/medicine/1572349764.jpg', 4, '2019-10-29 05:49:24', '2019-10-29 05:49:24'),
(50, 'm-37847', 'Acifix', 'Beximco Pharmaceuticals Ltd.', 'Rabeprazole Sodium', 'Tablet', 8.00, 'Indications\r\nShort-term treatment in healing and symptomatic relief of duodenal ulcers and erosive or ulcerative Gastroesophageal Reflux Disease (GERD).\r\n\r\nMaintaining healing and reducing relapse rates of heartburn symptoms in patients with GERD.\r\n\r\nTreatment of daytime and night time heartburn and other symptoms associated with GERD.\r\n\r\nLong-term treatment of pathological hypersecretory conditions, including Zollinger Ellison Syndrome.\r\n\r\nIn combination with Amoxicillin and Clarithromycin to eradicate Helicobacter pylori.\r\n\r\nDosage & Administration\r\nHealing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD): 20 mg to be taken once daily for 4 to 8 weeks. For those patients who have not healed after 8 weeks of treatment, an additional 8 week course may be considered.\r\n\r\nMaintenance of Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD Maintenance): The recommended adult oral dose is 20 mg once daily.\r\n\r\nTreatment of Symptomatic Gastroesophageal Reflux Disease (GERD):The recommended adult oral dose is 20 mg once daily for 4 weeks. If symptoms do not resolve completely after 4 weeks, an additional course of treatment may be considered.\r\n\r\nHealing of Duodenal Ulcers:The recommended adult oral dose is 20 mg once daily after the morning meal for a period up to four weeks. Most patients with duodenal ulcer heal within four weeks. A few patients may require additional therapy to achieve healing.\r\n\r\nHelicobacter pylori Eradication: To Reduce the Risk of Duodenal Ulcer Recurrence-\r\n*Rabeprazole Sodium 20 mg Twice Daily for 7 Days\r\n*Amoxicillin 1000 mg Twice Daily for 7 Days\r\n*Clarithromycin 500 mg Twice Daily for 7 Days\r\nAll three medications should be taken twice daily with the morning and evening meals. It is important that patients comply with the full 7-day regimen.\r\n\r\nTreatment of Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome: The dosage of Rabeprazole Sodium in patients with pathologic hypersecretory conditions varies with the individual patient. The recommended adult oral starting dose is 60 mg once a day. Doses should be adjusted to individual patient needs and should continue for as long as clinically indicated. Some patients may require divided doses. Doses up to 100 mg QD and 60 mg BID have been administered. Some patients with Zollinger-Ellision syndrome have been treated continuously with Rabeprazole Sodium for up to one year.', '/shops/Maa Pharmacy/medicine/1572349842.jpg', 4, '2019-10-29 05:50:42', '2019-10-29 05:50:42'),
(51, 'm-13456', 'Napa', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol', 'Tablet', 2.00, 'Indications\r\nParacetamol is indicated in:\r\n*Fever,common cold and influenza.\r\n*Headache,toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains.\r\n*Pain of colic, back pain, post-operative pain, postpartum pain, chronic pain of cancer,\r\n inflammatory pain, and post-vaccination pain and fever of children.\r\n*Rheumatism and osteoarthritic pain & stiffness of joints in fingers, \r\nhips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.\r\n\r\n\r\nDosage & Administration\r\nTablet:\r\n*Adult: 1-2 tablets every 4 to 6 hours up to a maximum of 4 gm (8 tablets) daily.\r\n*Children (6-12 years): ½ to 1 tablet 3 to 4 times daily. For long term treatment\r\n it is wise not to exceed the dose beyond 2.6 gm/day.\r\nExtended Release Tablet:\r\n*Adults & Children over 12 years: Two tablets, swallowed whole, every 6 to 8 hours \r\n(maximum of 6 tablets in any 24 hours).The tablet must not be crushed.\r\nSyrup/Suspension:\r\n*Children under 3 months: 10 mg/kg body weight (reduce to 5 mg/kg if jaundiced) 3 to 4 times daily.\r\n*3 months to below 1 year: ½ to 1 teaspoonful 3 to 4 times daily.\r\n*1-5 years: 1 -2 teaspoonful 3 to 4 times daily.\r\n*6-12 years: 2-A teaspoonful 3 to 4 times daily.\r\n*Adults: 4-8 teaspoonful 3 to 4 times daily.\r\nSuppository:\r\n*Children 3-12 months: 60-120 mg,4 times daily.\r\n*Children 1-5 years: 125-250 mg 4 times daily.\r\n*Children 6-12 years: 250-500 mg 4 times daily.\r\n*Adults & children over 12 years: 0.5-1 gm 4 times daily.\r\nPaediatric Drop:\r\nChildren Upto 3 months: 0.5 ml (40 mg)\r\n*4 to 11 months: 1.0 ml (80 mg)\r\n*7 to 2 years: 1.5 ml (120 mg). Do not exceed more than 5 dose daily for a maximum of 5 days.', '/shops/Maa Pharmacy/medicine/1572349915.jpg', 4, '2019-10-29 05:51:55', '2019-10-29 05:51:55'),
(52, 'm-25677ww', 'Ace Plus', 'Square Pharmaceuticals Ltd.', 'Paracetamol + Caffeine', 'Tablet', 4.00, 'Indications\r\nThe indications of Paracetamol & Caffeine are Headache, Migraine, Toothache, \r\nNeuralgia, Feverishness, Period pain, Sore throat, Backache, Helps reduce temperature,\r\n Aches and pain of colds and flu.\r\n\r\nDosage & Administration\r\nAdult dose: 1-2 tablets every 4-6 hours. Maximum dose: 8 tablets daily.\r\nChild dose: Not recommended for children below 12 years.', '/shops/Maa Pharmacy/medicine/1572349998.jpg', 4, '2019-10-29 05:53:18', '2019-10-29 05:53:18'),
(53, 'm-3768', 'Orsaline-N', 'Bristol Pharmaceuticals Ltd.', 'Oral Rehydration Salt (Powder)', 'Orsaline', 4.00, 'Composition\r\nReduced osmolarity oral saline:\r\n\r\n1/2 liter formula (10.25 gm): Per sachet contains- \r\nSodium chloride 1.30gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 6.75 gm\r\nHigher osmolarity oral saline:\r\n\r\n1/2 liter formula (13.95 gm): Per sachet contains-\r\nSodium chloride 1.75 gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 10 gm\r\n1 liter formula (27.50 gm): Per sachet contains-\r\nSodium chloride 3.5 gm\r\nSodium biocarbonate 2.5 gm\r\nPotassium chloride 1.5 gm\r\nGlucose anhydrous 20 gm\r\nIndications\r\nOral Rehydration Salt is indicated in Diarrhea (treatment) and Electrolyte depletion (prophylaxis and treatment)\r\n\r\n\r\nDosage & Administration\r\nChildren less than 2 years: After each loose stool or vomiting 10 to 20 spoonful (50-100 ml).\r\n\r\nChildren 2 to 10 years: After each loose stool or vomiting 100-200 ml of prepared oral saline.\r\n\r\nAdult and children above 10 years: After each loose stool or vomiting 200-400 ml of prepared saline.', '/shops/Maa Pharmacy/medicine/1572350068.jpg', 4, '2019-10-29 05:54:28', '2019-10-29 05:54:28'),
(54, 'm-54346', 'Tusca Plus', 'Square Pharmaceuticals Ltd.', 'Syrup', 'Guaifenesin + Levomenthol + Diphenhydramine', 85.00, 'Indications\r\nThis is indicated for the symptomatic relief of upper respiratory tract disorders accompanied by productive cough.\r\n\r\n\r\nDosage & Administration\r\n12 years and above: 10 ml 4 times a day.', '/shops/Maa Pharmacy/medicine/1572350163.jpg', 4, '2019-10-29 05:56:03', '2019-10-29 05:56:03'),
(55, 'm-7643', 'Brofex', 'Square Pharmaceuticals Ltd.', 'Dextromethorphan Hydrobromide', 'Syrup', 42.00, 'Indications\r\nDextromethorphan is indicated in Chronic dry cough or unproductive cough; Acute dry cough which is interfering with normal function or sleep.\r\n\r\n\r\nDosage & Administration\r\nAdults and Children over 12 years: 15 to 30 mg three to four times per day. However, 60 mg doses up to four times per day have been used without increased side effects.\r\n\r\nChildren between 6 and 12 years: 5-15 mg up to four times per day.\r\n\r\nChildren between 2 and 6 years: 2.5-5 mg up to four times per day', '/shops/Maa Pharmacy/medicine/1572350254.jpg', 4, '2019-10-29 05:57:34', '2019-10-29 05:57:34'),
(56, 'm-73467', 'Nystat Oral', 'Acme Laboratories Limited.', 'Nystatin (Oral)', 'Oral Suspension', 25.00, 'Indications\r\nNystatin is an antifungal antibiotic active against a wide range of yeasts and yeast like fungi including Candida albicans. It is used for the prevention and treatment of Candida infections of oral cavity, esophagus and intestinal tract. It provides effective prophylaxis against oral candidiasis in those born of mothers with vaginal candidiasis. It is used for the prophylaxis of Candida overgrowth during courses of broadspectrum antibiotics\r\n\r\n\r\nDosage & Administration\r\nChildren:\r\nIn intestinal and oral candidiasis (thrush): 1,00,000 units (1 ml) should be dropped into the mouth four times daily.The longer the suspension is kept in contact with the affected area in the mouth, before swallowing, the greater will be its effect.\r\nFor prophylaxis in the newborn: The suggested dose is 1,00,000 units (1 ml) once daily or as prescribed by the physician.\r\nAdult:\r\nFor the treatment of intestinal or esophageal candidiasis: 5,00,000 units (5 ml) by mouth 3 or 4 times daily. The dose may be doubled, if required.\r\nFor prophylaxis of intestinal candidiasis in adults: 10,00,000 units (10 ml) daily.\r\nFor prophylaxis to suppress the over growth of Candida albicans in patients receiving broad spectrum antibiotic therapy: 10,00,000 units (10 ml) daily.\r\nFor the treatment of dental sores and oral infection: 1,00,000 units (1 ml) suspension should be dropped into the mouth four times daily.\r\nElderly: Older people with intestinal candidiasis who are unable to swallow tablets should be given 5,00,000 units (5 ml) suspension four times daily.', '/shops/Maa Pharmacy/medicine/1572350335.jpg', 4, '2019-10-29 05:58:55', '2019-10-29 05:58:55'),
(57, 'm-5432325', 'Napa IV', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol (IV Infusion)', 'IV Infusion', 155.00, 'Indications\r\nParacetamol IV is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, the reduction of fever.\r\n\r\nDosage & Administration\r\nAdults and adolescents weighing 50 kg and over: the recommended dosage of Paracetamol IV is 1000 mg every 6 hours or 650 mg every 4 hours, with a maximum single dose of Paracetamol IV of 1000 mg, a minimum dosing interval of 4 hours, and a maximum daily dose of Paracetamol of 4000 mg per day.\r\n\r\nAdults and adolescents weighing under 50 kg: the recommended dosage of Paracetamol IV is 15 mg/kg every 6 hours or 12.5 mg/kg every 4 hours, with a maximum single dose of Paracetamol IV of 15 mg/kg, a minimum dosing interval of 4 hours, and a maximum daily dose of Paracetamol of 75 mg/kg per day.\r\n\r\nChildren >2 to 12 years of age: the recommended dosage of Paracetamol IV is 15 mg/kg every 6 hours or 12.5 mg/kg every 4 hours, with a maximum single dose of Paracetamol IV of 15 mg/kg, a minimum dosing interval of 4 hours, and a maximum daily dose of Paracetamol of 75 mg/kg per day.', '/shops/Maa Pharmacy/medicine/1572350404.jpg', 4, '2019-10-29 06:00:04', '2019-10-29 06:00:04'),
(58, 'm-32668', 'Veniron IV', 'Beximco Pharmaceuticals Ltd.', 'Iron Sucrose Injection (Elemental Iron)', 'IV Injection', 300.00, 'Indications\r\nThis is indicated for the treatment of Iron deficiency in the following indications:\r\n*Where there is a clinical need for a rapid Iron supply\r\n*In patients who can not tolerate oral Iron therapy or who are non-compliant\r\n*In active inflammatory bowel disease where oral Iron preparations are ineffective\r\n*Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients receiving an erythropoietin\r\n*Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients not receiving an erythropoietin\r\n*Hemodialysis dependent-chronic kidney disease (HDD-CKD) patients receiving an erythropoietin\r\n*Peritoneal dialysis dependent-chronic kidney disease (PDD-CKD) patients receiving an erythropoietin\r\nIt is also indicated in the treatment of Iron deficiency anaemia in patients undergoing surgical procedures, patients donating blood, postpartum patients.\r\n\r\n\r\n\r\nDosage & Administration\r\nAdults and Elderly: 5-10 ml (100-200 mg Iron) once to three times a week depending on the hemoglobin level.\r\n\r\nIron Sucrose has exclusively to be administered intravenously by slow injection or by drip infusion or directly into the venous limb of the dialyzer. Iron Sucrose must not be used for intramuscular injection.\r\n\r\nChildren: There is limited data on children under study conditions. If there is a clinical need, it is recommended not to exceed 0.15 ml (3 mg Iron) per kg body weight once to three times per week depending on the haemoglobin level.\r\n\r\nAs injection: Iron Sucrose can also be administered undiluted by slow IV injection at a rate of 1 ml Iron Sucrose (20 mg Iron) in at least 1 minute a maximum of 10 ml Iron Sucrose (200 mg Iron) can be administered per injection in at least 10 minutes.\r\n\r\nAs infusion: Iron Sucrose should preferably be administered by drip infusion ( in order to reduce hypotensive episodes) in a dilution of 1 ml Iron Sucrose in maximum 20 ml 0.9% NaCl etc up to 25 ml Iron Sucrose in maximum 500 ml 0.9% NaCl. Dilution must take place immediately prior to infusion and solution must be administered as follows: 100 mg Iron in at least 15 minutes; 200 mg Iron in at least 30 minutes ete. Normal posology is to use 5-10 ml Iron Sucrose 1-3 times a week depending on the Hemoglobin level. For the administration of the maximum tolerable dose of 7 mg Iron/kg body weight an infusion time of at least 3.5 hours has to be respected, independently of the total dose.', '/shops/Maa Pharmacy/medicine/1572350489.jpg', 4, '2019-10-29 06:01:29', '2019-10-29 06:01:29'),
(59, 'm-32689', 'Odycin', 'Beximco Pharmaceuticals Ltd.', 'Moxifloxacin Hydrochloride (Eye)', 'Eye Drop', 150.00, 'Indications\r\nThe ophthalmic solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:\r\n*Aerobic Gram-positive microorganisms: Corynebacterium species, Micrococcus luteus, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus warneri, Streptococcus pneumoniae, Streptococcus viridans group\r\n*Aerobic Gram-negative microorganisms: Acinetobacterlwoffii, Haemophilusinfluenzae, Haemophilusparainfluenzae\r\n*Other microorganisms: Chlamydia trachomatis.\r\n\r\nDosage & Administration\r\nFor Eye Drops:\r\n*Moxifloxacin 0.5%: One drop in the affected eye 3 times per day for 7 days.\r\n*Moxifloxacin 0.5% (Enriched with Xanthan Gum 0.4%): One drop in the affected eye(s) 2 times daily for 7 days.\r\nFor Eye Ointment: It should be applied thinly and evenly to the affected eye three times a day for the first two days and for the next five days apply two times a day or as advised by the registered physician.', '/shops/Maa Pharmacy/medicine/1572350601.jpg', 4, '2019-10-29 06:03:21', '2019-10-29 06:03:21'),
(60, 'm-6494', 'Flumetanol', 'Aristopharma Ltd.', 'Clioquinol + Flumetasone Pivalate', 'Ear Drop', 100.00, 'Indications\r\nThis combination is indicated for the treatment of external ear inflammation and infections (otitis externa) and fungal infections of the outer ear (otomycosis).\r\n\r\nDosage & Administration\r\nFor adults and children (aged 2 years and over): The recommended dose is 2 to 3 drops twice daily for the prescribed period of time (usually not longer than 10 days). Before you apply the medication, you should warm the ear drops to body temperature by holding the bottle in the palm of your hands. Do not heat it above body temperature.', '/shops/Maa Pharmacy/medicine/1572350677.jpg', 4, '2019-10-29 06:04:37', '2019-10-29 06:04:37');
INSERT INTO `medicines` (`id`, `medicine_id`, `medicine_name`, `company_name`, `generic_name`, `medicine_type`, `medicine_price`, `description`, `image`, `shop_id`, `created_at`, `updated_at`) VALUES
(61, 'm-5278', 'Omenix', 'Incepta Pharmaceuticals Limited', 'Omeprazole', 'Capsule', 9.00, 'Indications\r\nOmeprazole offers significant therapeutic gains in the treatment of acid related diseases. Healing rates are high in duodenal ulcer, gastric ulcer and erosive reflux oesophagitis; acid production is controlled effectively in Zollinger-Ellison Syndrome and symptom relief is prompt and sustained in all indications. Less clear-cut indications where benefit might be expected but where data are limited include:\r\nPrevention of stress ulceration\r\nPrevention of the acid aspiration syndrome\r\nTreatment of upper gastro-intestinal bleeding\r\nNOTE: In comparative studies, Omeprazole has been found to produce faster symptom relief and higher healing rates in a greater percentage of patients than either Cimetidine or Ranitidine, confirming the ‘therapeutic gains’ achievable with Omeprazole over existing therapies.\r\n\r\nDosage\r\nOral-\r\nDuodenal Ulcer: 20 mg once daily for 4 weeks. In severe cases, 40 mg once daily for 4 weeks.\r\n\r\nGastric Ulcer: 20 mg once daily for 8 weeks. In severe cases, 40 mg once daily for 8 weeks.\r\n\r\nErosive Reflux Oesophagitis: 20 mg once daily for 4 weeks. For those not fully healed, to be continued for 4 more weeks. Refractory Reflux Oesophagitis: 40 mg once daily for 8 weeks. Zollinger-Ellison Syndrome: 60 mg once daily, adjusted individually and continued as long as necessary.\r\n\r\nMost patients will be effectively controlled with 20-120 mg daily. Dosage above 80 mg should be divided and given twice daily. Long-term maintenance treatment with Omeprazole is not recommended.\r\n\r\nImpaired Renal or Hepatic Function: Adjustment is not required. Patients with severe liver disease should not require more than 20 mg Omeprazole daily\r\n\r\n\r\nIV Injection-\r\nProphylaxis of acid aspiration: Omeprazole 40 mg to be given slowly (over a period of 5 minutes) as an intravenous injection, one hour before surgery.\r\n\r\nDuodenal ulcer, gastric ulcer or reflux oesophagitis: In patients with duodenal ulcer, gastric ulcer or reflux oesophagitis where oral medication is inappropriate, Omeprazole IV 40 mg once daily is recommended.\r\n\r\nZollinger- Ellison syndrome (ZES): In patients with Zollinger-Ellison Syndrome the recommended initial dose of Omeprazole given intravenously is 60 mg daily. Higher daily doses may be required and the dose should be adjusted individually. When doses exceed 60 mg daily, the dose should be divided & given twice daily.', '/shops/Maa Pharmacy/medicine/1572350744.jpg', 4, '2019-10-29 06:05:44', '2019-10-29 06:05:44'),
(62, 'r-3852', 'Seclo', 'Square Pharmaceuticals Ltd.', 'Omeprazole', 'Capsule', 9.00, 'Indications\r\nOmeprazole offers significant therapeutic gains in the treatment of acid related diseases. Healing rates are high in duodenal ulcer, gastric ulcer and erosive reflux oesophagitis; acid production is controlled effectively in Zollinger-Ellison Syndrome and symptom relief is prompt and sustained in all indications. Less clear-cut indications where benefit might be expected but where data are limited include:\r\n*Prevention of stress ulceration\r\n*Prevention of the acid aspiration syndrome\r\n*Treatment of upper gastro-intestinal bleeding\r\nNOTE: In comparative studies, Omeprazole has been found to produce faster symptom relief and higher healing rates in a greater percentage of patients than either Cimetidine or Ranitidine, confirming the ‘therapeutic gains’ achievable with Omeprazole over existing therapies.\r\n\r\nDosage\r\nOral-\r\nDuodenal Ulcer: 20 mg once daily for 4 weeks. In severe cases, 40 mg once daily for 4 weeks.\r\n\r\nGastric Ulcer: 20 mg once daily for 8 weeks. In severe cases, 40 mg once daily for 8 weeks.\r\n\r\nErosive Reflux Oesophagitis: 20 mg once daily for 4 weeks. For those not fully healed, to be continued for 4 more weeks. Refractory Reflux Oesophagitis: 40 mg once daily for 8 weeks. Zollinger-Ellison Syndrome: 60 mg once daily, adjusted individually and continued as long as necessary.\r\n\r\nMost patients will be effectively controlled with 20-120 mg daily. Dosage above 80 mg should be divided and given twice daily. Long-term maintenance treatment with Omeprazole is not recommended.\r\n\r\nImpaired Renal or Hepatic Function: Adjustment is not required. Patients with severe liver disease should not require more than 20 mg Omeprazole daily\r\n\r\n\r\nIV Injection-\r\nProphylaxis of acid aspiration: Omeprazole 40 mg to be given slowly (over a period of 5 minutes) as an intravenous injection, one hour before surgery.\r\n\r\nDuodenal ulcer, gastric ulcer or reflux oesophagitis: In patients with duodenal ulcer, gastric ulcer or reflux oesophagitis where oral medication is inappropriate, Omeprazole IV 40 mg once daily is recommended.\r\n\r\nZollinger- Ellison syndrome (ZES): In patients with Zollinger-Ellison Syndrome the recommended initial dose of Omeprazole given intravenously is 60 mg daily. Higher daily doses may be required and the dose should be adjusted individually. When doses exceed 60 mg daily, the dose should be divided & given twice daily.', '/shops/Reshma Pharmacy/medicine/1572351888.jpg', 5, '2019-10-29 06:24:48', '2019-10-29 06:24:48'),
(63, 'r-548w43', 'Hyprosol', 'Beximco Pharmaceuticals Ltd.', 'Hydroxypropyl Methyl Cellulose', 'Eye Drop', 70.00, 'Indications\r\nHydroxypropyl Methyl Cellulose gel is indicated as a surgical aid during surgical procedures involving the anterior chamber of the eye, including extraction of the lens, and insertion of intraocular lenses. It maintains the depth of the anterior chamber during the whole surgical procedure and permits greater operative precision without the risk of damaging the endothelium of the cornea or other intraocular tissues.\r\n\r\nHydroxypropyl Methyl Cellulose eye drop is used to treat dry eye conditions where not enough tears are produced to keep the eye lubricated and clean\r\n\r\nDosage & Administration\r\nEye Drop-\r\nFor Dry Eyes: \r\n*Adults and Children: Use 1 drop three or four times a day. This drug does not cause different side effects or problems in children than it does in adults.\r\n\r\nEye Gel-\r\nEach pre-filled glass syringe is for single intraocular use only. The quantity injected into the anterior chamber of the eye must be adjusted according to the volume of the aqueous humour and the anatomical structure to be protected.', '/shops/Reshma Pharmacy/medicine/1572351976.jpg', 5, '2019-10-29 06:26:16', '2019-10-29 06:26:16'),
(64, 'r-58400', 'Beuflox-D', 'Incepta Pharmaceuticals Limited', 'Ciprofloxacin + Dexamethasone', 'Eye/Ear Drop', 80.00, 'Indications\r\nEye: This combination eye drop is indicated for the treatment of steroid responsive inflammatory ocular conditions where bacterial infections or risk of bacterial infections co-exist. The use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where is an expectation that potentially dangerous numbers of bacteria will be present in the eye. The combination can also be used for post-operative inflammation and any other ocular inflammation associated with infection.\r\n\r\nEar: It is indicated for the treatment of ear infections accompanied by inflammation such as otitis externa, otitis media and chronic suppurative otitis media etc. The combination can also be used for post-operative inflammation of ear.\r\n\r\n\r\n\r\nDosage & Administration\r\nFor Eye: 1 drop to be instilled into conjunctival sac(s) every four to six hours. During the initial 24 to 48 hours, the dosage may be increased to 1 drop every two hours.\r\n\r\nFor Ear:\r\nAcute otitis media in pediatric patients with typanastomy tube: 4 drops instilled into the affected ear 2 times daily for 7 days.\r\nAcute otitis externa: 4 drops instilled into the affected ear 2 times daily for 7 days.\r\nFrequency should be decreased gradually or warranted in clinical signs. Care should be taken not to discontinue therapy prematurely.', '/shops/Reshma Pharmacy/medicine/1572352058.jpg', 5, '2019-10-29 06:27:38', '2019-10-29 06:27:38'),
(65, 'r-42378', 'Mannitol', 'Opso Saline Ltd.', 'Mannitol', 'IV Infusion', 158.00, 'Indications\r\nMannitol is principally used by IV infusion as an osmotic diuretic to preserve renal function in acute renal failure and to reduce raised intracranial and intraocular pressure. Mannitol is also used as an irrigating solution to prevent hemolysis and hemoglobin buildup during transurethral prostatic resection. It is useful in the management of acute drug poisoning where a route of elimination is through kidney. Besides these, it is also used in symptomatic relief of edema, reperfusion injury, termination of pregnancy, and bowel preparation. So, Mannitol is indicated in-\r\n\r\nRenal insufficiency, Reperfusion injury, Raised intracranial pressure, Bladder irrigation, Raised intraocular presure, Bowel preparation, Edematous status, As a prophylactic in renal failure, Management of poisoning, Termination of Pregnancy\r\n\r\nDosage & Administration\r\nThe adult dose of Mannitol ranges from 50 to 100 gm by IV infusion. The rate of administration is usually adjusted to maintain a urine flow of at least 30 to 50 ml/hr. Total dosage, concentration and the rate of administration depends on fluid requirement, urinary output and the severity of the condition being treated\r\n\r\nRenal insufficiency-\r\nAdults: 50 to 100 g of Mannitol administered at a rate adjusted to maintain a urine flow of at least 30 to 50 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area administered over a period of 2 to 6 hrs.\r\nCerebral edema, elevated intracranial pressure, elevated intraocular pressure, Glaucoma-\r\nAdults: 1.5 to 2 gm/kg administered over a period of 30 to 60 minutes.\r\nChildren: 1 to 2 gm/kg body wt. or 30 to 60 gm/m2 of body surface area administered over a period of 30 to 60 mins.\r\nAdjunctive therapy for removal of toxic substances-\r\nAdults: 50 to 200 g of Mannitol administered at a rate adjust to maintain a urine flow of at least 100 to 500 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area\r\nFor termination of pregnancy 50 gm of Mannitol (250 ml of Mannitol) is instilled into the amniotic cavity which induces abortion in a high proportion of pregnancies.', '/shops/Reshma Pharmacy/medicine/1572352144.jpg', 5, '2019-10-29 06:29:04', '2019-10-29 06:29:04'),
(66, 'r-8753434', 'Omastin', 'Beximco Pharmaceuticals Ltd.', 'Fluconazole', 'IV Infusion', 210.00, 'Indications\r\nFluconazole is indicated in\r\n*Superficial candidal infections such as oral or vaginal thrush\r\n*Esophagitis caused by Candida or other susceptible species\r\n*Maintenance therapy of cryptococcal meningitis\r\n*Disseminated candidiasis\r\n*Prophylaxis for fungal infection in neutropenic cancer patients\r\n*Acute treatment of other systemic fungal infections\r\n*Dermatophyte and Candida skin infections\r\n*Fungal UTIs\r\n\r\nDosage\r\nOral-\r\nAdults: \r\nOropharyngeal Candidiasis: 200 mg on the first day, followed by 100 mg once daily for 7-14 days.\r\nEsophageal Candidiasis: 200 mg on the first day, followed by 100 mg once daily for 2-3 weeks.\r\nSystemic Candidiasis and Cryptococcal Meningitis: 400 mg daily followed by 200 mg once daily. The recommended duration of treatment for initial therapy of cryptococcal meningitis is 10 to 12 weeks.\r\nAcute or recurrent vaginal candidiasis: Single dose of 150 mg.\r\nUrinary Tract Infections and Peritonitis: 50 to 200 mg once daily. Prophylaxis in Patients Undergoing Bone Marrow Transplantation: 400 mg once daily.\r\nChildren:\r\nOropharyngeal Candidiasis: 6 mg/kg on the first day, followed by 3 mg/kg once daily. Treatment should be administered for at least 2 weeks to decrease the likelihood of relapse.\r\nEsophageal Candidiasis: 6 mg/kg on the first day, followed by 3 mg/kg once daily.\r\nCryptococcal meningitis: Initial therapy should be started with 6 to 12 mg/kg daily. Doses up to 12 mg/kg/day may be used for three weeks and treatment for initial therapy of cryptococcal meningitis is 10 to 12 weeks.\r\n\r\nIntravenous-\r\nAdult & child: Invasive candidal infections including candidaemia and disseminated candidiasis and cryptococcal infections including meningitis, by IV, 400 mg initially then 200 mg daily, increased if necessary to 400 mg daily, treatment continued according to response (at least 6-8 weeks for cryptococcal meningitis); Child 6-12 mg/kg daily (every 72 hours in neonate up to 2 weeks old, every 48 hours in neonate 2-4 weeks old); maximum 400 mg daily.\r\n\r\nPrevention of relapse of cryptococcal meningitis, by IV, 100-200 mg daily.', '/shops/Reshma Pharmacy/medicine/1572352391.jpg', 5, '2019-10-29 06:33:11', '2019-10-29 06:33:11'),
(67, 'r-33572e8', 'Neoceptin R', 'Beximco Pharmaceuticals Ltd.', 'Ranitidine', 'Injection', 11.00, 'Indications\r\n*Ranitidine is indicated in:\r\n*Treatment of active duodenal ulcer\r\n*Benign gastric ulcer\r\n*Treatment & prevention of ulcer associated with non-steroidal anti-inflammatory agent\r\n*Post operative stress ulcer.\r\n*Zollinger-Ellison Syndrome.\r\n*Gastroesophageal reflux disease (GERD).\r\n*Gastro-intestinal haemorrhage from stress ulcer in seriously ill patient.\r\n*Recurrent haemorrhage in patients with bleeding peptic ulcer.\r\n*Before general anesthesia in patient considered to be at risk of acid aspiration particulary obstetric patients.\r\n\r\n\r\nDosage & Administration\r\nRanitidine Tablet & Syrup:\r\nDuodenal and gastric ulcer: The usual dosage is 150 mg twice daily taken in the morning and evening or 300 mg as a single daily dose at night for 4 to 8 weeks.\r\n\r\nReflux oesophagitis: 150 mg twice daily or 300 mg at bed time for up to 8 weeks.\r\n\r\nZollinger Ellison syndrome: 150 mg 3 times daily and increased if necessary up to 6 g daily in divided doses. Dosage should be continued as long as clinically indicated.\r\n\r\nEpisodic dyspepsia: 150 mg twice daily or 300 mg at bed time for up to 6 weeks.\r\n\r\nMaintenance: 150 mg at night for preventing recurrences.\r\n\r\nChild (peptic ulcer): 2-4 mg/kg twice daily, maximum 300 mg daily.\r\n\r\n\r\nRanitidine IV injection & IV Infusion:\r\nRanitidine injection may be given either as a slow (over a period of at least two minutes) intravenous injection of 50 mg, after dilution to a volume of 20 ml per 50 mg dose, which may be repeated every six to eight hours; or as an intermittent intravenous infusion at a rate of 25 mg per hour for two hours; the infusion may be repeated at six to eight hour intervals; or as an intramuscular injection of 50 mg (2 ml) every six to eight hours. In the prophylaxis of haemorrhage from stress ulceration in seriously ill patients or the prophylaxis of recurrent haemorrhage in patients bleeding from peptic ulceration, parenteral administration may be continued until oral feeding commences.\r\n\r\nIn the prophylaxis of upper gastrointestinal haemorrhage from stress ulceration in seriously ill patient sapriming dose of 50 mg as low as intravenous injection followed by a continuous intravenous infusion of 0.125-0.250 mg/kg/hour may be preferred. In patients considered to be at risk of developing aspiration syndrome Ranitidine injection 50 mg may be given intramuscularly or by slow intravenous injection 45 to 60 minutes before induction of general anaesthesia.\r\n\r\nChildren: The recommended oral dose for the treatment of peptic ulcer in children is 2 mg/kg to 4 mg/kg twice daily to a maximum of 300 mg ranitidine per day. Safety and effectiveness of Ranitidine injection have not been established in case of children.', '/shops/Reshma Pharmacy/medicine/1572352475.jpg', 5, '2019-10-29 06:34:35', '2019-10-29 06:34:35'),
(68, 'r-9348', 'Amodis', 'Square Pharmaceuticals Ltd.', 'Metronidazole', 'Oral Suspension', 32.00, 'Indications\r\nMetronidazole is indicated in:\r\n*All forms of amoebiasis (intestinal and extra-intestinal disease including liver abscess and that of symptomless cyst passers)\r\n*Trichomoniasis\r\n*Giardiasis\r\n*Bacterial vaginosis\r\n*Acute ulcerative gingivitis\r\n*Anaerobic infections including septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis etc.\r\n*Anaerobically-infected leg ulcers and pressure sores\r\n*Acute dental infections (e.g. acute pericoronitis and acute apical infections)\r\n*Surgical prophylaxis (prevention of postoperative infections due to anaerobic bacteria, particularly species of bacteroides and anaerobic streptococci\r\n*Chronic symptomatic peptic ulcer disease (as an agent of triple therapy to eradicate H. pylori-the most important aetiological factor of peptic ulcer)\r\n\r\n\r\n\r\nDosage & Administration\r\nTablet and Suspension:\r\nAmoebic dysentery: Duration 5-10 Days; \r\nFor Tablet: Adults- 750 mg t.i.d. Children- (7-10 years) 500 mg t.i.d. (3-7 years) 250 mg q.i.d. (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 800 mg t.i.d. Children- (7-10 years) 500 mg t.i.d. (3-7 years) 200 mg q.i.d. (1-3 years) 200 mg t.i.d.\r\nAsymptomatic amoebiasis: Duration 5-10 Days;\r\nFor Tablet: Adults- 500-750 mg t.i.d. Children- (7-10 years) 250-500 mg t.i.d. (3-7 years) 250 mg q.i.d. (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 500-800 mg t.i.d. Children- (7-10 years) 200-500 mg t.i.d.; (3-7 years) 200 mg q.i.d.; (1-3 years) 200 mg t.i.d.\r\nHepatic extraintestinal amoebiasis : Duration 5-10 Days (or 2days); \r\nFor Tablet: Adults- 500-750 mg t.i.d.; Children- (7-10 years) 250-500 mg t.i.d.; (3-7 years) 250 mg q.i.d.; (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 500-800 mg t.i.d.; Children- (7-10 years) 200-500 mg t.i.d.; (3-7 years) 200 mg q.i.d.; (1-3 years) 200 mg t.i.d.\r\nGiardiasis: Duration 3 Days;\r\nFor Tablet: Adults- 2 g once daily; Children-(7-10 years) 1g once daily; (3-7 years) 750 mg once daily; (1-3 years) 500 mg once daily.\r\nFor suspension: Adults- 2 g once daily; Children-(7-10 years) 1g once daily; (3-7 years) 800 mg once daily; (1-3 years) 500 mg once daily.\r\nTrichomoniasis: Duration 7 Days;\r\nFor Tablet: Adults- 250 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nTrichomoniasis: Duration 1 Day;\r\nFor Tablet: Adults- 2 g single dose; \r\nFor Suspension: Adults- 2 g single dose; \r\nVincent\'s infection (Ulceration of mucous membrane of respiratory tract & mouth): Duration 3 Days;\r\nFor Tablet: Adults- 250 mg t.i.d. or 500 mg b.i.d; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d. or 500 mg b.i.d; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nPeriodontal infection: Duration 3 Days;\r\nFor Tablet: Adults- 250 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nSevere dental infection: Duration 3 Days;\r\nFor Tablet: Adults- 500 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nAnaerobic infection: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d.; Children- 7.5 mg/kg body weight t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d.; Children- 7.5 mg/kg body weight t.i.d.\r\nPostoperative anaerobic infection (specially in operation abdominal or gynecological surgery): Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d. before and after operation; Children- 7.5 mg/kg body weight t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d. before and after operation; Children- 7.5 mg/kg body weight t.i.d.\r\nBacterial vaginitis: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d. \r\nFor Suspension: Adults- 500 mg b.i.d.\r\nLeg ulcers: Duration 1 Day;\r\nFor Tablet: Adults- 2 g as a single dose \r\nFor Suspension: Adults- 2 g as a single dose\r\nPressure sores: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d. \r\nFor Suspension: Adults- 500 mg t.i.d.\r\nH. pylori infection: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d \r\nFor Suspension: Adults-500 mg b.i.d\r\nAntibiotic Associated Pseudomembranus colitis: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d \r\nFor Suspension: Adults- 500 mg b.i.d\r\n\r\nVaginal Gel:\r\nThe recommended dose is one applicator full of Metronidazole GEL (approximately 5 grams containing approximately 37.5 mg of Metronidazole) intravaginally once or twice a day for 5 days. For once a day dosing, Metronidazole GEL should be administered at bedtime.\r\n\r\n\r\nSuppository:\r\nAnaerobic infections:\r\nAdult: 1 g 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nChild: 5-10 yr 500 mg. All doses to be given 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nProphylaxis of postoperative anaerobic bacterial infections:\r\nAdult: 1 g 2 hr before surgery, repeated 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nChild: 5-10 yr 500 mg 2 hr before surgery, repeated 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\n\r\nIV Infusion:\r\nMetronidazole injection should be infused intravenously at an approximate rate of 5 ml/min. Oral medication should be substituted as soon as feasible. Treatment for 7 days should be satisfactory for most patients, but the physician might decide to prolong treatment.\r\nFor bacterial infections: Adults: 500 mg (100 ml) 8 hourly. Children: 7.5 mg/kg (1.5 ml/kg) 8 hourly. \r\nFor treatment before and during surgery: Adults: 500 mg (100 ml) shortly before operation, repeated 8 hourly. Children: 7.5 mg/kg (1.5 ml/kg) 8 hourly', '/shops/Reshma Pharmacy/medicine/1572352583.jpg', 5, '2019-10-29 06:36:23', '2019-10-29 06:36:23'),
(69, 'r-05499', 'Ocof', 'Square Pharmaceuticals Ltd.', 'Dextromethorphan + Phenylephrine + Triprolidine', 'Syrup', 110.00, 'Indications\r\nThis preparation is indicated for the symptomatic relief of upper respiratory tract disorders accompanied by non-productive cough which benefits from the administration of a nasal decongestant, a histamine H1-receptor antagonist and an antitussive combination.\r\n\r\nDosage\r\nAdults & Children over 12 years: 1 teaspoonful 4 times a day.\r\n6-12 years: 1/2 teaspoonful 4 times a day.\r\n\r\nA physician\'s advice should be obtained before administering this combination to children less than 6 years.\r\nAdministration\r\nTake with or without food. Take with food if it causes an upset stomach. Measure liquid doses carefully. Use the measuring device that comes with this medicine.', '/shops/Reshma Pharmacy/medicine/1572352688.jpg', 5, '2019-10-29 06:38:08', '2019-10-29 06:38:08'),
(70, 'r-654236', 'Zesup', 'Square Pharmaceuticals Ltd.', 'Zinc Sulphate Monohydrate', 'Syrup', 45.00, 'Indications\r\nZinc Sulphate is indicated for Recurrent Respiratory Tract Infections; Diarrhoea; \r\nLoss of appetite; Severe growth retardation; Deformed bone formation; Impaired immunological response;\r\n Acrodermatitis enteropathica; Parakeratatic skin lesions; \r\nDefective and delayed wound healing; Anaemia; Night blindness; Mental disturbances\r\nDescription\r\nZinc Sulfate Monohydrate is a source of Zinc which is an essential trace element and involved in a number of body enzyme systems. Symptoms of less severe Zinc deficiency include distorted or absent perceptions of taste and smell and poor wound healing. \r\nSevere Zinc deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections \r\nand failure to thrive in children.\r\n\r\nDosage\r\nSyrup-\r\nChildren under 10 kg: One teaspoonful 2 times daily.\r\nChildren within 10 to 30 kg: Two teaspoonful 1-3 times daily.\r\nAdults and children over 30 kg body weight: Four teaspoonful 1-3 times daily.\r\nTablet-\r\nIn the treatment of Diarrhoea Zinc should be given as soon as diarrhoea starts:\r\nFor infants between 2 to 6 months of age: 10 mg Zinc once daily for 10-14 days.\r\nFor children between 6 months to 5 years of age: 20 mg Zinc once daily for 10-14 days.\r\nFor other indications:\r\nThe recommended dose for children: 2 to 2.5 mg/kg/day.\r\nChildren under 10 kg: 10 mg Zinc 2 times daily.\r\nChildren within 10 to 30 kg: 20 mg Zinc 1-3 times daily.\r\nAdults and children over 30 kg body weight: 40 mg Zinc 1-3 times daily.', '/shops/Reshma Pharmacy/medicine/1572352781.jpg', 5, '2019-10-29 06:39:41', '2019-10-29 06:39:41'),
(71, 'r-1143686', 'Napa', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol', 'Tablet', 1.00, 'Indications\r\nParacetamol is indicated in:\r\n*Fever,common cold and influenza.\r\n*Headache,toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains.\r\n*Pain of colic, back pain, post-operative pain, postpartum pain, chronic pain of cancer,\r\n inflammatory pain, and post-vaccination pain and fever of children.\r\n*Rheumatism and osteoarthritic pain & stiffness of joints in fingers, \r\nhips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.\r\n\r\n\r\nDosage & Administration\r\nTablet:\r\n*Adult: 1-2 tablets every 4 to 6 hours up to a maximum of 4 gm (8 tablets) daily.\r\n*Children (6-12 years): ½ to 1 tablet 3 to 4 times daily. For long term treatment\r\n it is wise not to exceed the dose beyond 2.6 gm/day.\r\nExtended Release Tablet:\r\n*Adults & Children over 12 years: Two tablets, swallowed whole, every 6 to 8 hours \r\n(maximum of 6 tablets in any 24 hours).The tablet must not be crushed.\r\nSyrup/Suspension:\r\n*Children under 3 months: 10 mg/kg body weight (reduce to 5 mg/kg if jaundiced) 3 to 4 times daily.\r\n*3 months to below 1 year: ½ to 1 teaspoonful 3 to 4 times daily.\r\n*1-5 years: 1 -2 teaspoonful 3 to 4 times daily.\r\n*6-12 years: 2-A teaspoonful 3 to 4 times daily.\r\n*Adults: 4-8 teaspoonful 3 to 4 times daily.\r\nSuppository:\r\n*Children 3-12 months: 60-120 mg,4 times daily.\r\n*Children 1-5 years: 125-250 mg 4 times daily.\r\n*Children 6-12 years: 250-500 mg 4 times daily.\r\n*Adults & children over 12 years: 0.5-1 gm 4 times daily.\r\nPaediatric Drop:\r\nChildren Upto 3 months: 0.5 ml (40 mg)\r\n*4 to 11 months: 1.0 ml (80 mg)\r\n*7 to 2 years: 1.5 ml (120 mg). Do not exceed more than 5 dose daily for a maximum of 5 days.', '/shops/Reshma Pharmacy/medicine/1572352855.jpg', 5, '2019-10-29 06:40:55', '2019-10-29 06:40:55'),
(72, 'r-11433638', 'Napa Extra', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol + Caffeine', 'Tablet', 4.00, 'Indications\r\nThe indications of Paracetamol & Caffeine are Headache, Migraine, Toothache, \r\nNeuralgia, Feverishness, Period pain, Sore throat, Backache, Helps reduce temperature, \r\nAches and pain of colds and flu.\r\n\r\nDosage & Administration\r\nAdult dose: 1-2 tablets every 4-6 hours. Maximum dose: 8 tablets daily.\r\nChild dose: Not recommended for children below 12 years.', '/shops/Reshma Pharmacy/medicine/1572352909.jpg', 5, '2019-10-29 06:41:49', '2019-10-29 06:41:49'),
(73, 'r-11145783', 'Entacyd Plus', 'Square Pharmaceuticals Ltd.', 'Aluminium Hydroxide + Magnesium Hydroxide + Simethicone', 'Tablet', 3.00, 'Composition\r\nEach tablet contains-\r\nAluminium Hydroxide 200 mg\r\nMagnesium Hydroxide 400 mg or 200 mg\r\nSimethicone 30 mg \r\nEach 5 ml Suspension contains-\r\nAluminium Oxide 200 mg\r\nMagnesium Hydroxide 400 mg\r\nSimethicone 30 mg\r\nIndications\r\nThis is indicated for dyspepsia, hyperacidity, gastric and duodenal ulcer, \r\ngastritis; also indicated for the relief of flatulence, abdominal distention and windy colic.\r\n\r\n\r\nDosage & Administration\r\nTablet: 1-2 tablets 1-3 hours after meal and at bed time or as directed by the physician.\r\n\r\nSuspension: 1-2 teaspoonful 1-3 hours after meal and at bedtime or as directed by the physician.', '/shops/Reshma Pharmacy/medicine/1572352981.jpg', 5, '2019-10-29 06:43:01', '2019-10-29 06:43:01'),
(74, 'R-2567246', 'Geston', 'Square Pharmaceuticals Ltd.', 'Geston', 'Tablet', 10.00, 'Indications\r\nAllystrenol is indicated in:\r\nIntra Uterine Growth Retardation (IUGR)\r\nThreatened abortion\r\nHabitual abortion\r\nThreatened premature delivery\r\n\r\nDosage & Administration\r\nIntra Uterine Growth Retardation: 1 tablet three times a day at least two months. Dose to be reduced if symptoms improve.\r\n\r\nThreatened abortion: 1 tablet three times daily until symptoms disappear.\r\n\r\nHabitual abortion: 1-2 tablets daily as soon as pregnancy is diagnosed. The administration should be continued for at least one month after the end of the critical period.\r\n\r\nThreatened premature delivery: Dosage must be determined individually. High dosages (up to 40 mg daily) have been used.\r\n\r\nIn case of a missed dose, it should be taken as soon as the patient remembers & she should continue the regular dosing schedule. A double dose is not recommended.', '/shops/Reshma Pharmacy/medicine/1572353058.jpg', 5, '2019-10-29 06:44:18', '2019-10-29 06:44:18'),
(75, 'r-254887', 'Orsaline-N', 'Bristol Pharmaceuticals Ltd.', 'Oral Rehydration Salt (Powder)', 'Orsaline', 3.00, 'Composition\r\nReduced osmolarity oral saline:\r\n\r\n1/2 liter formula (10.25 gm): Per sachet contains- \r\nSodium chloride 1.30gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 6.75 gm\r\nHigher osmolarity oral saline:\r\n\r\n1/2 liter formula (13.95 gm): Per sachet contains-\r\nSodium chloride 1.75 gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 10 gm\r\n1 liter formula (27.50 gm): Per sachet contains-\r\nSodium chloride 3.5 gm\r\nSodium biocarbonate 2.5 gm\r\nPotassium chloride 1.5 gm\r\nGlucose anhydrous 20 gm\r\nIndications\r\nOral Rehydration Salt is indicated in Diarrhea (treatment) and Electrolyte depletion (prophylaxis and treatment)\r\n\r\n\r\nDosage & Administration\r\nChildren less than 2 years: After each loose stool or vomiting 10 to 20 spoonful (50-100 ml).\r\n\r\nChildren 2 to 10 years: After each loose stool or vomiting 100-200 ml of prepared oral saline.\r\n\r\nAdult and children above 10 years: After each loose stool or vomiting 200-400 ml of prepared saline.', '/shops/Reshma Pharmacy/medicine/1572353141.jpg', 5, '2019-10-29 06:45:41', '2019-10-29 06:45:41'),
(76, 'i-48135', 'Napa', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol', 'Tablet', 2.00, 'Indications\r\nParacetamol is indicated in:\r\n*Fever,common cold and influenza.\r\n*Headache,toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains.\r\n*Pain of colic, back pain, post-operative pain, postpartum pain, chronic pain of cancer,\r\n inflammatory pain, and post-vaccination pain and fever of children.\r\n*Rheumatism and osteoarthritic pain & stiffness of joints in fingers, \r\nhips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.\r\n\r\n\r\nDosage & Administration\r\nTablet:\r\n*Adult: 1-2 tablets every 4 to 6 hours up to a maximum of 4 gm (8 tablets) daily.\r\n*Children (6-12 years): ½ to 1 tablet 3 to 4 times daily. For long term treatment\r\n it is wise not to exceed the dose beyond 2.6 gm/day.\r\nExtended Release Tablet:\r\n*Adults & Children over 12 years: Two tablets, swallowed whole, every 6 to 8 hours \r\n(maximum of 6 tablets in any 24 hours).The tablet must not be crushed.\r\nSyrup/Suspension:\r\n*Children under 3 months: 10 mg/kg body weight (reduce to 5 mg/kg if jaundiced) 3 to 4 times daily.\r\n*3 months to below 1 year: ½ to 1 teaspoonful 3 to 4 times daily.\r\n*1-5 years: 1 -2 teaspoonful 3 to 4 times daily.\r\n*6-12 years: 2-A teaspoonful 3 to 4 times daily.\r\n*Adults: 4-8 teaspoonful 3 to 4 times daily.\r\nSuppository:\r\n*Children 3-12 months: 60-120 mg,4 times daily.\r\n*Children 1-5 years: 125-250 mg 4 times daily.\r\n*Children 6-12 years: 250-500 mg 4 times daily.\r\n*Adults & children over 12 years: 0.5-1 gm 4 times daily.\r\nPaediatric Drop:\r\nChildren Upto 3 months: 0.5 ml (40 mg)\r\n*4 to 11 months: 1.0 ml (80 mg)\r\n*7 to 2 years: 1.5 ml (120 mg). Do not exceed more than 5 dose daily for a maximum of 5 days.', '/shops/Ibn Sina Pharmacy/medicine/1572364266.jpg', 6, '2019-10-29 09:51:06', '2019-10-29 09:51:06'),
(77, 'i-1427846', 'Ace Plus', 'Square Pharmaceuticals Ltd.', 'Paracetamol + Caffeine', 'Tablet', 3.00, 'Indications\r\nThe indications of Paracetamol & Caffeine are Headache, Migraine, Toothache, \r\nNeuralgia, Feverishness, Period pain, Sore throat, Backache, Helps reduce temperature,\r\n Aches and pain of colds and flu.\r\n\r\nDosage & Administration\r\nAdult dose: 1-2 tablets every 4-6 hours. Maximum dose: 8 tablets daily.\r\nChild dose: Not recommended for children below 12 years.', '/shops/Ibn Sina Pharmacy/medicine/1572364321.jpg', 6, '2019-10-29 09:52:01', '2019-10-29 09:52:01'),
(78, 'i-8467143', 'Flexi', 'Square Pharmaceuticals Ltd.', 'Aceclofenac', 'Tablet', 5.00, 'Indications\r\nAceclofenac is indicated for the relief of pain and inflammation in osteoarthritis,\r\n rheumatoid arthritis and ankylosing spondylitis.\r\n\r\nDosage & Administration\r\nAdults: 100 mg twice daily, one in the morning & one in the evening or 200 mg (one SR tablet) once daily.\r\nChildren: Not recommended.\r\n\r\nReduce the dosage to 100 mg daily initially in patients with hepatic dysfunction. There is no evidence that the dosage of aceclofenac needs to be modified in patients with mild renal impairment,\r\n but as with other NSAIDs caution should be exercised.', '/shops/Ibn Sina Pharmacy/medicine/1572364416.jpg', 6, '2019-10-29 09:53:36', '2019-10-29 09:53:36'),
(79, 'i-3948577', 'Entacyd Plus', 'Square Pharmaceuticals Ltd.', 'Aluminium Hydroxide + Magnesium Hydroxide + Simethicone', 'Tablet', 3.00, 'Composition\r\nEach tablet contains-\r\nAluminium Hydroxide 200 mg\r\nMagnesium Hydroxide 400 mg or 200 mg\r\nSimethicone 30 mg \r\nEach 5 ml Suspension contains-\r\nAluminium Oxide 200 mg\r\nMagnesium Hydroxide 400 mg\r\nSimethicone 30 mg\r\nIndications\r\nThis is indicated for dyspepsia, hyperacidity, gastric and duodenal ulcer, \r\ngastritis; also indicated for the relief of flatulence, abdominal distention and windy colic.\r\n\r\n\r\nDosage & Administration\r\nTablet: 1-2 tablets 1-3 hours after meal and at bed time or as directed by the physician.\r\n\r\nSuspension: 1-2 teaspoonful 1-3 hours after meal and at bedtime or as directed by the physician.', '/shops/Ibn Sina Pharmacy/medicine/1572364537.jpg', 6, '2019-10-29 09:55:37', '2019-10-29 09:55:37'),
(80, 'i-293847', 'Ocof', 'Square Pharmaceuticals Ltd.', 'Dextromethorphan + Phenylephrine + Triprolidine', 'Syrup', 105.00, 'Indications\r\nThis preparation is indicated for the symptomatic relief of upper respiratory tract disorders accompanied by non-productive cough which benefits from the administration of a nasal decongestant, a histamine H1-receptor antagonist and an antitussive combination.\r\n\r\nDosage\r\nAdults & Children over 12 years: 1 teaspoonful 4 times a day.\r\n6-12 years: 1/2 teaspoonful 4 times a day.\r\n\r\nA physician\'s advice should be obtained before administering this combination to children less than 6 years.\r\nAdministration\r\nTake with or without food. Take with food if it causes an upset stomach. Measure liquid doses carefully. Use the measuring device that comes with this medicine.', '/shops/Ibn Sina Pharmacy/medicine/1572364709.jpg', 6, '2019-10-29 09:58:29', '2019-10-29 09:58:29'),
(81, 'i-577687', 'Prudex', 'Beximco Pharmaceuticals Ltd.', 'Dextromethorphan + Pseudoephedrine + Triprolidine', 'Syrup', 75.00, 'Composition\r\nEach 5 ml syrup contains-\r\nDextromethorphan Hydrobromide 10 mg\r\nPseudoephedrine Hydrochloride 30 mg\r\nTriprolidine Hydrochloride 1.25 mg\r\n\r\n\r\nIndications\r\nThis is indicated for the symptomatic relief of upper respiratory tract disorders accompanied by non-productive cough which benefits from the administration of a nasal decongestant, a histamine H1 receptor antagonist and an antitussive combination.\r\n\r\n\r\n\r\nDosage & Administration\r\nAdults: 2 tea-spoon three times daily\r\n\r\nChildren:\r\nOver 12 years: 2 tea-spoon three times daily.\r\n6 to 12 years: 1 tea-spoon three times daily.\r\n2 to 5 years: 1/2 tea-spoon three times daily.\r\n6 months to 2 years: 1/4 tea-spoon three times daily or on advice of a physician only.', '/shops/Ibn Sina Pharmacy/medicine/1572364789.jpg', 6, '2019-10-29 09:59:49', '2019-10-29 09:59:49'),
(82, 'i-68734357', 'Amodis', 'Square Pharmaceuticals Ltd.', 'Metronidazole', 'Oral Suspension', 32.00, 'Indications\r\nMetronidazole is indicated in:\r\n*All forms of amoebiasis (intestinal and extra-intestinal disease including liver abscess and that of symptomless cyst passers)\r\n*Trichomoniasis\r\n*Giardiasis\r\n*Bacterial vaginosis\r\n*Acute ulcerative gingivitis\r\n*Anaerobic infections including septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis etc.\r\n*Anaerobically-infected leg ulcers and pressure sores\r\n*Acute dental infections (e.g. acute pericoronitis and acute apical infections)\r\n*Surgical prophylaxis (prevention of postoperative infections due to anaerobic bacteria, particularly species of bacteroides and anaerobic streptococci\r\n*Chronic symptomatic peptic ulcer disease (as an agent of triple therapy to eradicate H. pylori-the most important aetiological factor of peptic ulcer)\r\n\r\n\r\n\r\nDosage & Administration\r\nTablet and Suspension:\r\nAmoebic dysentery: Duration 5-10 Days; \r\nFor Tablet: Adults- 750 mg t.i.d. Children- (7-10 years) 500 mg t.i.d. (3-7 years) 250 mg q.i.d. (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 800 mg t.i.d. Children- (7-10 years) 500 mg t.i.d. (3-7 years) 200 mg q.i.d. (1-3 years) 200 mg t.i.d.\r\nAsymptomatic amoebiasis: Duration 5-10 Days;\r\nFor Tablet: Adults- 500-750 mg t.i.d. Children- (7-10 years) 250-500 mg t.i.d. (3-7 years) 250 mg q.i.d. (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 500-800 mg t.i.d. Children- (7-10 years) 200-500 mg t.i.d.; (3-7 years) 200 mg q.i.d.; (1-3 years) 200 mg t.i.d.\r\nHepatic extraintestinal amoebiasis : Duration 5-10 Days (or 2days); \r\nFor Tablet: Adults- 500-750 mg t.i.d.; Children- (7-10 years) 250-500 mg t.i.d.; (3-7 years) 250 mg q.i.d.; (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 500-800 mg t.i.d.; Children- (7-10 years) 200-500 mg t.i.d.; (3-7 years) 200 mg q.i.d.; (1-3 years) 200 mg t.i.d.\r\nGiardiasis: Duration 3 Days;\r\nFor Tablet: Adults- 2 g once daily; Children-(7-10 years) 1g once daily; (3-7 years) 750 mg once daily; (1-3 years) 500 mg once daily.\r\nFor suspension: Adults- 2 g once daily; Children-(7-10 years) 1g once daily; (3-7 years) 800 mg once daily; (1-3 years) 500 mg once daily.\r\nTrichomoniasis: Duration 7 Days;\r\nFor Tablet: Adults- 250 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nTrichomoniasis: Duration 1 Day;\r\nFor Tablet: Adults- 2 g single dose; \r\nFor Suspension: Adults- 2 g single dose; \r\nVincent\'s infection (Ulceration of mucous membrane of respiratory tract & mouth): Duration 3 Days;\r\nFor Tablet: Adults- 250 mg t.i.d. or 500 mg b.i.d; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d. or 500 mg b.i.d; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nPeriodontal infection: Duration 3 Days;\r\nFor Tablet: Adults- 250 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nSevere dental infection: Duration 3 Days;\r\nFor Tablet: Adults- 500 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nAnaerobic infection: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d.; Children- 7.5 mg/kg body weight t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d.; Children- 7.5 mg/kg body weight t.i.d.\r\nPostoperative anaerobic infection (specially in operation abdominal or gynecological surgery): Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d. before and after operation; Children- 7.5 mg/kg body weight t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d. before and after operation; Children- 7.5 mg/kg body weight t.i.d.\r\nBacterial vaginitis: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d. \r\nFor Suspension: Adults- 500 mg b.i.d.\r\nLeg ulcers: Duration 1 Day;\r\nFor Tablet: Adults- 2 g as a single dose \r\nFor Suspension: Adults- 2 g as a single dose\r\nPressure sores: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d. \r\nFor Suspension: Adults- 500 mg t.i.d.\r\nH. pylori infection: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d \r\nFor Suspension: Adults-500 mg b.i.d\r\nAntibiotic Associated Pseudomembranus colitis: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d \r\nFor Suspension: Adults- 500 mg b.i.d\r\n\r\nVaginal Gel:\r\nThe recommended dose is one applicator full of Metronidazole GEL (approximately 5 grams containing approximately 37.5 mg of Metronidazole) intravaginally once or twice a day for 5 days. For once a day dosing, Metronidazole GEL should be administered at bedtime.\r\n\r\n\r\nSuppository:\r\nAnaerobic infections:\r\nAdult: 1 g 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nChild: 5-10 yr 500 mg. All doses to be given 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nProphylaxis of postoperative anaerobic bacterial infections:\r\nAdult: 1 g 2 hr before surgery, repeated 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nChild: 5-10 yr 500 mg 2 hr before surgery, repeated 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\n\r\nIV Infusion:\r\nMetronidazole injection should be infused intravenously at an approximate rate of 5 ml/min. Oral medication should be substituted as soon as feasible. Treatment for 7 days should be satisfactory for most patients, but the physician might decide to prolong treatment.\r\nFor bacterial infections: Adults: 500 mg (100 ml) 8 hourly. Children: 7.5 mg/kg (1.5 ml/kg) 8 hourly. \r\nFor treatment before and during surgery: Adults: 500 mg (100 ml) shortly before operation, repeated 8 hourly. Children: 7.5 mg/kg (1.5 ml/kg) 8 hourly', '/shops/Ibn Sina Pharmacy/medicine/1572364888.jpg', 6, '2019-10-29 10:01:28', '2019-10-29 10:01:28'),
(83, 'i-5483697', 'Osmosol', 'Beximco Pharmaceuticals Ltd.', 'Mannitol', 'IV Infusion', 160.00, 'Indications\r\nMannitol is principally used by IV infusion as an osmotic diuretic to preserve renal function in acute renal failure and to reduce raised intracranial and intraocular pressure. Mannitol is also used as an irrigating solution to prevent hemolysis and hemoglobin buildup during transurethral prostatic resection. It is useful in the management of acute drug poisoning where a route of elimination is through kidney. Besides these, it is also used in symptomatic relief of edema, reperfusion injury, termination of pregnancy, and bowel preparation. So, Mannitol is indicated in-\r\n\r\nRenal insufficiency, Reperfusion injury, Raised intracranial pressure, Bladder irrigation, Raised intraocular presure, Bowel preparation, Edematous status, As a prophylactic in renal failure, Management of poisoning, Termination of Pregnancy\r\n\r\n\r\n\r\nDosage & Administration\r\nThe adult dose of Mannitol ranges from 50 to 100 gm by IV infusion. The rate of administration is usually adjusted to maintain a urine flow of at least 30 to 50 ml/hr. Total dosage, concentration and the rate of administration depends on fluid requirement, urinary output and the severity of the condition being treated\r\n\r\nRenal insufficiency-\r\nAdults: 50 to 100 g of Mannitol administered at a rate adjusted to maintain a urine flow of at least 30 to 50 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area administered over a period of 2 to 6 hrs.\r\nCerebral edema, elevated intracranial pressure, elevated intraocular pressure, Glaucoma-\r\nAdults: 1.5 to 2 gm/kg administered over a period of 30 to 60 minutes.\r\nChildren: 1 to 2 gm/kg body wt. or 30 to 60 gm/m2 of body surface area administered over a period of 30 to 60 mins.\r\nAdjunctive therapy for removal of toxic substances-\r\nAdults: 50 to 200 g of Mannitol administered at a rate adjust to maintain a urine flow of at least 100 to 500 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area\r\nFor termination of pregnancy 50 gm of Mannitol (250 ml of Mannitol) is instilled into the amniotic cavity which induces abortion in a high proportion of pregnancies.', '/shops/Ibn Sina Pharmacy/medicine/1572365002.jpg', 6, '2019-10-29 10:03:22', '2019-10-29 10:03:22'),
(84, 'i-28436', 'Napa IV', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol (IV Infusion)', 'IV Infusion', 155.00, 'Indications\r\nParacetamol IV is indicated for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics, the reduction of fever.\r\n\r\nDosage & Administration\r\nAdults and adolescents weighing 50 kg and over: the recommended dosage of Paracetamol IV is 1000 mg every 6 hours or 650 mg every 4 hours, with a maximum single dose of Paracetamol IV of 1000 mg, a minimum dosing interval of 4 hours, and a maximum daily dose of Paracetamol of 4000 mg per day.\r\n\r\nAdults and adolescents weighing under 50 kg: the recommended dosage of Paracetamol IV is 15 mg/kg every 6 hours or 12.5 mg/kg every 4 hours, with a maximum single dose of Paracetamol IV of 15 mg/kg, a minimum dosing interval of 4 hours, and a maximum daily dose of Paracetamol of 75 mg/kg per day.\r\n\r\nChildren >2 to 12 years of age: the recommended dosage of Paracetamol IV is 15 mg/kg every 6 hours or 12.5 mg/kg every 4 hours, with a maximum single dose of Paracetamol IV of 15 mg/kg, a minimum dosing interval of 4 hours, and a maximum daily dose of Paracetamol of 75 mg/kg per day.', '/shops/Ibn Sina Pharmacy/medicine/1572365146.jpg', 6, '2019-10-29 10:05:46', '2019-10-29 10:05:46'),
(85, 'i-4564909', 'Citicol', 'Beximco Pharmaceuticals Ltd.', 'Citicoline Sodium', 'Injection', 145.00, 'Indications\r\nUse for the improvement of thinking, learning and memory in people suffering from Alzheimer\'s disease, \r\ndementia, head trauma, Parkinson\'s disease and glaucoma. Also used in loss of consciousness due to brain damage, head injury or brain surgery and cerebral infarction, age-related memory problems and stroke.\r\n\r\n\r\nDosage & Administration\r\nDisturbance of Consciousness: Due to Head Injury or Brain Surgery: 100-500 mg 1-2 times daily.\r\n\r\nPsychologic or Neurologic Disorders: Disturbance of Consciousness in the Acute Stage of Cerebral Infarction: 1000 mg once daily for 2 consecutive weeks or as prescribed by the physician.', '/shops/Ibn Sina Pharmacy/medicine/1572365218.jpg', 6, '2019-10-29 10:06:58', '2019-10-29 10:06:58'),
(86, 'i-943876', 'Tearon', 'Beximco Pharmaceuticals Ltd.', 'Polyethylene Glycol + Propylene Glycol', 'Eye Drop', 180.00, 'Indications\r\nThis combination eye drop is indicated for the temporary relief of burning and irritation due to dryness of the eye.\r\n\r\nDosage & Administration\r\nThe frequency of instillation of drops and the duration of treatment will vary depending upon the severity of the underlying condition and the response to treatment. Usually instill 1 or 2 drops in the affected eyes.', '/shops/Ibn Sina Pharmacy/medicine/1572365315.jpg', 6, '2019-10-29 10:08:35', '2019-10-29 10:08:35');
INSERT INTO `medicines` (`id`, `medicine_id`, `medicine_name`, `company_name`, `generic_name`, `medicine_type`, `medicine_price`, `description`, `image`, `shop_id`, `created_at`, `updated_at`) VALUES
(87, 'i-32984754', 'Ocutrex', 'Beximco Pharmaceuticals Ltd.', 'Chloramphenicol', 'Eye/Ear Drop', 40.00, 'Indications\r\nChloramphenicol is indicated in Ocular infections, Bacterial meningitis, Anaerobic bacterial infections, Anthrax, Brain abscess, Ehrlichiosis, Gas gangrene, Granuloma inguinale, Infections caused by H. influenzae, Listeriosis,\r\nPlague, Psittacosis, Q fever, Severe gastroenteritis, Severe melioidosis, Severe systemic infections with Camphylobacter fetus, Tularaemia, Whipple\'s disease, Otitis externa\r\n\r\n\r\n\r\nDosage & Administration\r\nFor Eye: Adults, children and infants (all age groups): One or two drops 4 to 6 times a day should be placed in the infected eyes. If necessary the frequency of dose can be increased. Treatment should be continued for approximately 7 days but should not be continued for more than three weeks without re-evaluation by the prescribing physician.\r\n\r\nFor Ear: 2 to 3 drops into ear canal thrice or four times daily.\r\n\r\nOtic/Aural: Otitis externa: Instill 2-3 drops of a 5% solution into the ear bid-tid.\r\n\r\nOral: Bacterial meningitis, Anaerobic bacterial infections, Anthrax, Brain abscess, Ehrlichiosis, Gas gangrene, Granuloma inguinale, Infections caused by H. influenzae, Listeriosis, Plague, Psittacosis, Q fever, Severe gastroenteritis, Severe melioidosis, Severe systemic infections with Camphylobacter fetus, Tularaemia, Whipple\'s disease:\r\nAdult: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections due to moderately resistant organisms. Continue treatment after the patient\'s temperature has normalised for a further 4 days in rickettsial disease and 8-10 days in typhoid fever.\r\nChild: Premature and full-term neonates: 25 mg/kg/day in 4 divided doses. Full-term infants >2 wk: 50 mg/kg/day in 4 divided doses. Children: 50 mg/kg/day in 4 divided doses increased to 100 mg/kg/day for meningitis or severe infections.', '/shops/Ibn Sina Pharmacy/medicine/1572365418.jpg', 6, '2019-10-29 10:10:18', '2019-10-29 10:10:18'),
(88, 'i-948375643721', 'Losectil', 'Eskayef Bangladesh Ltd.', 'Omeprazole', 'Capsule', 6.00, 'Indications\r\nOmeprazole offers significant therapeutic gains in the treatment of acid related diseases.\r\n Healing rates are high in duodenal ulcer, gastric ulcer and erosive reflux oesophagitis;\r\n acid production is controlled effectively in Zollinger-Ellison Syndrome and symptom relief \r\nis prompt and sustained in all indications. Less clear-cut indications where benefit might be \r\nexpected but where data are limited include:\r\n*Prevention of stress ulceration\r\n*Prevention of the acid aspiration syndrome\r\n*Treatment of upper gastro-intestinal bleeding\r\nNOTE: In comparative studies, Omeprazole has been found to produce faster symptom relief and \r\nhigher healing rates in a greater percentage of patients than either Cimetidine or Ranitidine,\r\n confirming the ‘therapeutic gains’ achievable with Omeprazole over existing therapies.\r\n\r\nDosage\r\nOral-\r\nDuodenal Ulcer: 20 mg once daily for 4 weeks. In severe cases, 40 mg once daily for 4 weeks.\r\n\r\nGastric Ulcer: 20 mg once daily for 8 weeks. In severe cases, 40 mg once daily for 8 weeks.\r\n\r\nErosive Reflux Oesophagitis: 20 mg once daily for 4 weeks. For those not fully healed, to be continued for 4 more weeks. Refractory Reflux Oesophagitis: 40 mg once daily for 8 weeks. Zollinger-Ellison Syndrome: 60 mg once daily, adjusted individually and continued as long as necessary.\r\n\r\nMost patients will be effectively controlled with 20-120 mg daily. Dosage above 80 mg should be divided and given twice daily. Long-term maintenance treatment with Omeprazole is not recommended.\r\n\r\nImpaired Renal or Hepatic Function: Adjustment is not required. Patients with severe liver disease should not require more than 20 mg Omeprazole daily\r\n\r\n\r\nIV Injection-\r\nProphylaxis of acid aspiration: Omeprazole 40 mg to be given slowly (over a period of 5 minutes) as an intravenous injection, one hour before surgery.\r\n\r\nDuodenal ulcer, gastric ulcer or reflux oesophagitis: In patients with duodenal ulcer, gastric ulcer or reflux oesophagitis where oral medication is inappropriate, Omeprazole IV 40 mg once daily is recommended.\r\n\r\nZollinger- Ellison syndrome (ZES): In patients with Zollinger-Ellison Syndrome the recommended initial dose of Omeprazole given intravenously is 60 mg daily. Higher daily doses may be required and the dose should be adjusted individually. When doses exceed 60 mg daily, the dose should be divided & given twice daily.', '/shops/Ibn Sina Pharmacy/medicine/1572365520.jpg', 6, '2019-10-29 10:12:00', '2019-10-29 10:12:00'),
(89, 'i-293847454', 'Orsaline-N', 'Bristol Pharmaceuticals Ltd.', 'Oral Rehydration Salt (Powder)', 'Orsaline', 3.00, 'Composition\r\nReduced osmolarity oral saline:\r\n\r\n1/2 liter formula (10.25 gm): Per sachet contains- \r\nSodium chloride 1.30gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 6.75 gm\r\nHigher osmolarity oral saline:\r\n\r\n1/2 liter formula (13.95 gm): Per sachet contains-\r\nSodium chloride 1.75 gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 10 gm\r\n1 liter formula (27.50 gm): Per sachet contains-\r\nSodium chloride 3.5 gm\r\nSodium biocarbonate 2.5 gm\r\nPotassium chloride 1.5 gm\r\nGlucose anhydrous 20 gm\r\nIndications\r\nOral Rehydration Salt is indicated in Diarrhea (treatment) and Electrolyte depletion (prophylaxis and treatment)\r\n\r\n\r\nDosage & Administration\r\nChildren less than 2 years: After each loose stool or vomiting 10 to 20 spoonful (50-100 ml).\r\n\r\nChildren 2 to 10 years: After each loose stool or vomiting 100-200 ml of prepared oral saline.\r\n\r\nAdult and children above 10 years: After each loose stool or vomiting 200-400 ml of prepared saline.', '/shops/Ibn Sina Pharmacy/medicine/1572365588.jpg', 6, '2019-10-29 10:13:08', '2019-10-29 10:13:08'),
(90, 'A-8474643', 'Napa', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol', 'Tablet', 3.00, 'Indications\r\nParacetamol is indicated in:\r\n*Fever,common cold and influenza.\r\n*Headache,toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains.\r\n*Pain of colic, back pain, post-operative pain, postpartum pain, chronic pain of cancer,\r\n inflammatory pain, and post-vaccination pain and fever of children.\r\n*Rheumatism and osteoarthritic pain & stiffness of joints in fingers, \r\nhips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.\r\n\r\n\r\nDosage & Administration\r\nTablet:\r\n*Adult: 1-2 tablets every 4 to 6 hours up to a maximum of 4 gm (8 tablets) daily.\r\n*Children (6-12 years): ½ to 1 tablet 3 to 4 times daily. For long term treatment\r\n it is wise not to exceed the dose beyond 2.6 gm/day.\r\nExtended Release Tablet:\r\n*Adults & Children over 12 years: Two tablets, swallowed whole, every 6 to 8 hours \r\n(maximum of 6 tablets in any 24 hours).The tablet must not be crushed.\r\nSyrup/Suspension:\r\n*Children under 3 months: 10 mg/kg body weight (reduce to 5 mg/kg if jaundiced) 3 to 4 times daily.\r\n*3 months to below 1 year: ½ to 1 teaspoonful 3 to 4 times daily.\r\n*1-5 years: 1 -2 teaspoonful 3 to 4 times daily.\r\n*6-12 years: 2-A teaspoonful 3 to 4 times daily.\r\n*Adults: 4-8 teaspoonful 3 to 4 times daily.\r\nSuppository:\r\n*Children 3-12 months: 60-120 mg,4 times daily.\r\n*Children 1-5 years: 125-250 mg 4 times daily.\r\n*Children 6-12 years: 250-500 mg 4 times daily.\r\n*Adults & children over 12 years: 0.5-1 gm 4 times daily.\r\nPaediatric Drop:\r\nChildren Upto 3 months: 0.5 ml (40 mg)\r\n*4 to 11 months: 1.0 ml (80 mg)\r\n*7 to 2 years: 1.5 ml (120 mg). Do not exceed more than 5 dose daily for a maximum of 5 days.', '/shops/Best Pharma/medicine/1572366688.jpg', 8, '2019-10-29 10:31:28', '2019-10-29 10:31:28'),
(91, 'A-673578', 'Ace Plus', 'Square Pharmaceuticals Ltd.', 'Paracetamol + Caffeine', 'Tablet', 3.00, 'Indications\r\nThe indications of Paracetamol & Caffeine are Headache, Migraine, Toothache, \r\nNeuralgia, Feverishness, Period pain, Sore throat, Backache, Helps reduce temperature,\r\n Aches and pain of colds and flu.\r\n\r\nDosage & Administration\r\nAdult dose: 1-2 tablets every 4-6 hours. Maximum dose: 8 tablets daily.\r\nChild dose: Not recommended for children below 12 years.', '/shops/Best Pharma/medicine/1572366737.jpg', 8, '2019-10-29 10:32:17', '2019-10-29 10:32:17'),
(92, 'A-6846454367834', 'Moxacil', 'Square Pharmaceuticals Ltd.', 'Amoxicillin Trihydrate', 'Tablet', 8.00, 'Indications\r\nAmoxicillin is indicated for the treatment of the following bacterial infections when caused by susceptible organisms:\r\nRespiratory tract, ENT infections: Acute and chronic bronchitis, pneumonia, otitis media, sinusitis, tonsillitis, pharyngitis & laryngitis, lobar & bronchopneumonia, chronic bronchial sepsis.\r\nUrinary tract infections: Pyelonephritis, cystitis and urethritis.\r\nObstetric & gynaecological infections: Bacteriuria in pregnancy, septic abortion, intra-abdominal sepsis and puerperal sepsis.\r\nGastro-intestinal infections: Typhoid and paratyphoid.\r\nSkin & soft tissue infections: Cellulitis, infected wounds and abscesses.\r\nGeneralized infections: Septicemia, bacterial endocarditis, meningitis, peritonitis and osteomyelitis.\r\nVenereal infections: Gonorrhea and syphilis. Amoxicillin may also be used as prophylactic cover for patients at risk of developing endocarditis when undergoing dental surgery.\r\n\r\nDosage\r\nEar/Nose/Throat Infection (Mild to Moderate):\r\nAdult: 500 mg every 12 hours or 250 mg every 8 hours\r\nChildren: 25 mg/kg/day in divided doses every 12 hours or 20 mg/kg/day in divided doses every 8 hours\r\nEar/Nose/Throat Infection (Severe):\r\nAdult: 875 mg every 12 hours or 500 mg every 8 hours\r\nChildren: 45 mg/kg/day in divided doses every 12 hours or 40 mg/kg/day in divided doses every 8 hours\r\nLower respiratory tract Infection (Mild/ Moderate/ Severe): \r\nAdult: 875 mg every 12 hours or 500 mg every 8 hours\r\nChildren: 45 mg/kg/day in divided doses every 12 hours or 40 mg/kg/day in divided doses every 8 hours\r\nSkin/skin structure Infection (Mild/Moderate):\r\nAdult: 500 mg every 12 hours or 250 mg every 8 hours\r\nChildren: 25 mg/kg/day in divided doses every 12 hours or 20 mg/kg/day in divided doses every 8 hours\r\nSkin/skin structure Infection (Severe):\r\nAdult: 875 mg every 12 hours or 500 mg every 8 hours\r\nChildren: 45 mg/kg/day in divided doses every 12 hours or 40 mg/kg/day in divided doses every 8 hours\r\nGenitourinary tract Infection (Mild/ Moderate):\r\nAdult: 500 mg every 12 hours or 250 mg every 8 hours\r\nChildren: 25 mg/kg/day in divided doses every 12 hours or 20 mg/kg/day in divided doses every 8 hours\r\nGenitourinary tract Infection (Severe):\r\nAdult: 875 mg every 12 hours or 500 mg every 8 hours\r\nChildren: 45 mg/kg/day in divided doses every 12 hours or 40 mg/kg/day in divided doses every 8 hours\r\nGonorrhea, Acute, uncomplicated ano-genital, and urethral infections in males and females:\r\nAdult: 3 g as single oral dose\r\nPrepubertal children: 50 mg/Kg/Amoxycillin, combined with 25 mg/kg Probenecid as a single dose. Since Probenecid is contraindicated in children under 2 years, do not use this regimen in these cases.', '/shops/Best Pharma/medicine/1572366831.jpg', 8, '2019-10-29 10:33:51', '2019-10-29 10:33:51'),
(93, 'A-0234856', 'Tusca Plus', 'Square Pharmaceuticals Ltd.', 'Guaifenesin + Levomenthol + Diphenhydramine', 'Syrup', 85.00, 'Indications\r\nThis is indicated for the symptomatic relief of upper respiratory tract disorders accompanied by productive cough.\r\n\r\n\r\nDosage & Administration\r\n12 years and above: 10 ml 4 times a day.', '/shops/Best Pharma/medicine/1572366890.jpg', 8, '2019-10-29 10:34:50', '2019-10-29 10:34:50'),
(94, 'A-356890', 'Ocof', 'Square Pharmaceuticals Ltd.', 'Dextromethorphan + Phenylephrine + Triprolidine', 'Syrup', 105.00, 'Indications\r\nThis preparation is indicated for the symptomatic relief of upper respiratory tract disorders accompanied by non-productive cough which benefits from the administration of a nasal decongestant, a histamine H1-receptor antagonist and an antitussive combination.\r\n\r\nDosage\r\nAdults & Children over 12 years: 1 teaspoonful 4 times a day.\r\n6-12 years: 1/2 teaspoonful 4 times a day.\r\n\r\nA physician\'s advice should be obtained before administering this combination to children less than 6 years.\r\nAdministration\r\nTake with or without food. Take with food if it causes an upset stomach. Measure liquid doses carefully. Use the measuring device that comes with this medicine.', '/shops/Best Pharma/medicine/1572366950.jpg', 8, '2019-10-29 10:35:50', '2019-10-29 10:35:50'),
(95, 'A-204395867', 'Fungistin', 'Beximco Pharmaceuticals Ltd.', 'Nystatin (Oral)', 'Oral Suspension', 25.00, 'Indications\r\nNystatin is an antifungal antibiotic active against a wide range of yeasts and yeast like fungi including Candida albicans. It is used for the prevention and treatment of Candida infections of oral cavity, esophagus and intestinal tract. It provides effective prophylaxis against oral candidiasis in those born of mothers with vaginal candidiasis. It is used for the prophylaxis of Candida overgrowth during courses of broadspectrum antibiotics\r\n\r\n\r\n\r\nDosage & Administration\r\nChildren:\r\nIn intestinal and oral candidiasis (thrush): 1,00,000 units (1 ml) should be dropped into the mouth four times daily.The longer the suspension is kept in contact with the affected area in the mouth, before swallowing, the greater will be its effect.\r\nFor prophylaxis in the newborn: The suggested dose is 1,00,000 units (1 ml) once daily or as prescribed by the physician.\r\nAdult:\r\nFor the treatment of intestinal or esophageal candidiasis: 5,00,000 units (5 ml) by mouth 3 or 4 times daily. The dose may be doubled, if required.\r\nFor prophylaxis of intestinal candidiasis in adults: 10,00,000 units (10 ml) daily.\r\nFor prophylaxis to suppress the over growth of Candida albicans in patients receiving broad spectrum antibiotic therapy: 10,00,000 units (10 ml) daily.\r\nFor the treatment of dental sores and oral infection: 1,00,000 units (1 ml) suspension should be dropped into the mouth four times daily.\r\nElderly: Older people with intestinal candidiasis who are unable to swallow tablets should be given 5,00,000 units (5 ml) suspension four times daily.', '/shops/Best Pharma/medicine/1572367022.jpg', 8, '2019-10-29 10:37:02', '2019-10-29 10:37:02'),
(96, 'A-0726436', 'Osmosol', 'Beximco Pharmaceuticals Ltd.', 'Mannitol', 'IV Infusion', 160.00, 'Indications\r\nMannitol is principally used by IV infusion as an osmotic diuretic to preserve renal function in acute renal failure and to reduce raised intracranial and intraocular pressure. Mannitol is also used as an irrigating solution to prevent hemolysis and hemoglobin buildup during transurethral prostatic resection. It is useful in the management of acute drug poisoning where a route of elimination is through kidney. Besides these, it is also used in symptomatic relief of edema, reperfusion injury, termination of pregnancy, and bowel preparation. So, Mannitol is indicated in-\r\n\r\nRenal insufficiency, Reperfusion injury, Raised intracranial pressure, Bladder irrigation, Raised intraocular presure, Bowel preparation, Edematous status, As a prophylactic in renal failure, Management of poisoning, Termination of Pregnancy\r\n\r\n\r\n\r\nDosage & Administration\r\nThe adult dose of Mannitol ranges from 50 to 100 gm by IV infusion. The rate of administration is usually adjusted to maintain a urine flow of at least 30 to 50 ml/hr. Total dosage, concentration and the rate of administration depends on fluid requirement, urinary output and the severity of the condition being treated\r\n\r\nRenal insufficiency-\r\nAdults: 50 to 100 g of Mannitol administered at a rate adjusted to maintain a urine flow of at least 30 to 50 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area administered over a period of 2 to 6 hrs.\r\nCerebral edema, elevated intracranial pressure, elevated intraocular pressure, Glaucoma-\r\nAdults: 1.5 to 2 gm/kg administered over a period of 30 to 60 minutes.\r\nChildren: 1 to 2 gm/kg body wt. or 30 to 60 gm/m2 of body surface area administered over a period of 30 to 60 mins.\r\nAdjunctive therapy for removal of toxic substances-\r\nAdults: 50 to 200 g of Mannitol administered at a rate adjust to maintain a urine flow of at least 100 to 500 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area\r\nFor termination of pregnancy 50 gm of Mannitol (250 ml of Mannitol) is instilled into the amniotic cavity which induces abortion in a high proportion of pregnancies.', '/shops/Best Pharma/medicine/1572367119.jpg', 8, '2019-10-29 10:38:39', '2019-10-29 10:38:39'),
(97, 'A-387546273', 'Emonium', 'Beximco Pharmaceuticals Ltd.', 'Tiemonium Methylsulphate', 'IM/IV Injection', 20.00, 'Indications\r\nTiemonium Methylsulphate is an antispasmodic drug. It reduces muscle spasms of the intestine, biliary system, uterus & urinary bladder. It is indicated for the pain in gastrointestinal, biliary, urinary and gynecological disease such as gastroenteritis, diarrhea, dysentery, biliary colic, enterocolitis, cholecystytis, colonopathies, mild cystitis, & spasmodic dysmenorrhoea.\r\n\r\n\r\nDosage & Administration\r\nTablet: Recommended oral dose of Tiemonium Methylsulphate tablet is 2-6 tablets (100-300 mg) daily in divided dose.\r\n\r\nInjection: Recommended injectable dose is 1 Tiemonium Methylsulphate Injection 3 times daily, through Intravenous route slowly or Intramuscular route.\r\n\r\nSyrup:\r\nChildren: 3 mg to 6 mg/kg/day or 1.5 ml to 3 ml/kg/day in 3 divided doses.\r\nAdult: 30 mg to 90 mg or 15 ml to 45 ml 3 times daily or as directed by physician.\r\nSuppository: Recommended dose is 20 mg Tiemonium Methylsulphate suppository two or three times daily, through rectal route.', '/shops/Best Pharma/medicine/1572367242.jpg', 8, '2019-10-29 10:40:42', '2019-10-29 10:40:42'),
(98, 'A-04987', 'Neotear', 'Aristopharma Ltd.', 'Carboxymethylcellulose Sodium + Glycerin', 'Eye Drop', 195.00, 'Indications\r\nThis Sterile Eye Drops is indicated for the temporary relief of burning, irritation, and discomfort due to dryness of the eye or exposure to wind or sun.\r\n\r\nDosage & Administration\r\nInstill 1 drop in the affected eyes as needed. It can be used in children.', '/shops/Best Pharma/medicine/1572367355.jpg', 8, '2019-10-29 10:42:35', '2019-10-29 10:42:35'),
(99, 'A-4857672', 'Beuflox-D', 'Incepta Pharmaceuticals Limited', 'Ciprofloxacin + Dexamethasone', 'Eye/Ear Drop', 80.00, 'Indications\r\nEye: This combination eye drop is indicated for the treatment of steroid responsive inflammatory ocular conditions where bacterial infections or risk of bacterial infections co-exist. The use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where is an expectation that potentially dangerous numbers of bacteria will be present in the eye. The combination can also be used for post-operative inflammation and any other ocular inflammation associated with infection.\r\n\r\nEar: It is indicated for the treatment of ear infections accompanied by inflammation such as otitis externa, otitis media and chronic suppurative otitis media etc. The combination can also be used for post-operative inflammation of ear.\r\n\r\n\r\n\r\nDosage & Administration\r\nFor Eye: 1 drop to be instilled into conjunctival sac(s) every four to six hours. During the initial 24 to 48 hours, the dosage may be increased to 1 drop every two hours.\r\n\r\nFor Ear:\r\nAcute otitis media in pediatric patients with typanastomy tube: 4 drops instilled into the affected ear 2 times daily for 7 days.\r\nAcute otitis externa: 4 drops instilled into the affected ear 2 times daily for 7 days.\r\nFrequency should be decreased gradually or warranted in clinical signs. Care should be taken not to discontinue therapy prematurely.', '/shops/Best Pharma/medicine/1572367436.jpg', 8, '2019-10-29 10:43:56', '2019-10-29 10:43:56'),
(100, 'A-498576', 'Omenix', 'Incepta Pharmaceuticals Limited', 'Omeprazole', 'Capsule', 10.00, 'Indications\r\nOmeprazole offers significant therapeutic gains in the treatment of acid related diseases. Healing rates are high in duodenal ulcer, gastric ulcer and erosive reflux oesophagitis; acid production is controlled effectively in Zollinger-Ellison Syndrome and symptom relief is prompt and sustained in all indications. Less clear-cut indications where benefit might be expected but where data are limited include:\r\nPrevention of stress ulceration\r\nPrevention of the acid aspiration syndrome\r\nTreatment of upper gastro-intestinal bleeding\r\nNOTE: In comparative studies, Omeprazole has been found to produce faster symptom relief and higher healing rates in a greater percentage of patients than either Cimetidine or Ranitidine, confirming the ‘therapeutic gains’ achievable with Omeprazole over existing therapies.\r\n\r\nDosage\r\nOral-\r\nDuodenal Ulcer: 20 mg once daily for 4 weeks. In severe cases, 40 mg once daily for 4 weeks.\r\n\r\nGastric Ulcer: 20 mg once daily for 8 weeks. In severe cases, 40 mg once daily for 8 weeks.\r\n\r\nErosive Reflux Oesophagitis: 20 mg once daily for 4 weeks. For those not fully healed, to be continued for 4 more weeks. Refractory Reflux Oesophagitis: 40 mg once daily for 8 weeks. Zollinger-Ellison Syndrome: 60 mg once daily, adjusted individually and continued as long as necessary.\r\n\r\nMost patients will be effectively controlled with 20-120 mg daily. Dosage above 80 mg should be divided and given twice daily. Long-term maintenance treatment with Omeprazole is not recommended.\r\n\r\nImpaired Renal or Hepatic Function: Adjustment is not required. Patients with severe liver disease should not require more than 20 mg Omeprazole daily\r\n\r\n\r\nIV Injection-\r\nProphylaxis of acid aspiration: Omeprazole 40 mg to be given slowly (over a period of 5 minutes) as an intravenous injection, one hour before surgery.\r\n\r\nDuodenal ulcer, gastric ulcer or reflux oesophagitis: In patients with duodenal ulcer, gastric ulcer or reflux oesophagitis where oral medication is inappropriate, Omeprazole IV 40 mg once daily is recommended.\r\n\r\nZollinger- Ellison syndrome (ZES): In patients with Zollinger-Ellison Syndrome the recommended initial dose of Omeprazole given intravenously is 60 mg daily. Higher daily doses may be required and the dose should be adjusted individually. When doses exceed 60 mg daily, the dose should be divided & given twice daily.', '/shops/Best Pharma/medicine/1572367533.jpg', 8, '2019-10-29 10:45:33', '2019-10-29 10:45:33'),
(101, 'T-29847567', 'Seclo', 'Square Pharmaceuticals Ltd.', 'Omeprazole', 'Capsule', 9.00, 'Indications\r\nOmeprazole offers significant therapeutic gains in the treatment of acid related diseases. Healing rates are high in duodenal ulcer, gastric ulcer and erosive reflux oesophagitis; acid production is controlled effectively in Zollinger-Ellison Syndrome and symptom relief is prompt and sustained in all indications. Less clear-cut indications where benefit might be expected but where data are limited include:\r\n*Prevention of stress ulceration\r\n*Prevention of the acid aspiration syndrome\r\n*Treatment of upper gastro-intestinal bleeding\r\nNOTE: In comparative studies, Omeprazole has been found to produce faster symptom relief and higher healing rates in a greater percentage of patients than either Cimetidine or Ranitidine, confirming the ‘therapeutic gains’ achievable with Omeprazole over existing therapies.\r\n\r\nDosage\r\nOral-\r\nDuodenal Ulcer: 20 mg once daily for 4 weeks. In severe cases, 40 mg once daily for 4 weeks.\r\n\r\nGastric Ulcer: 20 mg once daily for 8 weeks. In severe cases, 40 mg once daily for 8 weeks.\r\n\r\nErosive Reflux Oesophagitis: 20 mg once daily for 4 weeks. For those not fully healed, to be continued for 4 more weeks. Refractory Reflux Oesophagitis: 40 mg once daily for 8 weeks. Zollinger-Ellison Syndrome: 60 mg once daily, adjusted individually and continued as long as necessary.\r\n\r\nMost patients will be effectively controlled with 20-120 mg daily. Dosage above 80 mg should be divided and given twice daily. Long-term maintenance treatment with Omeprazole is not recommended.\r\n\r\nImpaired Renal or Hepatic Function: Adjustment is not required. Patients with severe liver disease should not require more than 20 mg Omeprazole daily\r\n\r\n\r\nIV Injection-\r\nProphylaxis of acid aspiration: Omeprazole 40 mg to be given slowly (over a period of 5 minutes) as an intravenous injection, one hour before surgery.\r\n\r\nDuodenal ulcer, gastric ulcer or reflux oesophagitis: In patients with duodenal ulcer, gastric ulcer or reflux oesophagitis where oral medication is inappropriate, Omeprazole IV 40 mg once daily is recommended.\r\n\r\nZollinger- Ellison syndrome (ZES): In patients with Zollinger-Ellison Syndrome the recommended initial dose of Omeprazole given intravenously is 60 mg daily. Higher daily doses may be required and the dose should be adjusted individually. When doses exceed 60 mg daily, the dose should be divided & given twice daily.', '/shops/Tamanna Pharmacy/medicine/1572367988.jpg', 9, '2019-10-29 10:53:08', '2019-10-29 10:53:08'),
(102, 'T-87653456', 'Flumetanol', 'Aristopharma Ltd.', 'Clioquinol + Flumetasone Pivalate', 'Ear Drop', 100.00, 'Indications\r\nThis combination is indicated for the treatment of external ear inflammation and infections (otitis externa) and fungal infections of the outer ear (otomycosis).\r\n\r\nDosage & Administration\r\nFor adults and children (aged 2 years and over): The recommended dose is 2 to 3 drops twice daily for the prescribed period of time (usually not longer than 10 days). Before you apply the medication, you should warm the ear drops to body temperature by holding the bottle in the palm of your hands. Do not heat it above body temperature.', '/shops/Tamanna Pharmacy/medicine/1572368075.jpg', 9, '2019-10-29 10:54:35', '2019-10-29 10:54:35'),
(103, 'T-74653627', 'Hyprosol', 'Beximco Pharmaceuticals Ltd.', 'Hydroxypropyl Methyl Cellulose', 'Eye Drop', 65.00, 'Indications\r\nHydroxypropyl Methyl Cellulose gel is indicated as a surgical aid during surgical procedures involving the anterior chamber of the eye, including extraction of the lens, and insertion of intraocular lenses. It maintains the depth of the anterior chamber during the whole surgical procedure and permits greater operative precision without the risk of damaging the endothelium of the cornea or other intraocular tissues.\r\n\r\nHydroxypropyl Methyl Cellulose eye drop is used to treat dry eye conditions where not enough tears are produced to keep the eye lubricated and clean\r\n\r\nDosage & Administration\r\nEye Drop-\r\nFor Dry Eyes: \r\n*Adults and Children: Use 1 drop three or four times a day. This drug does not cause different side effects or problems in children than it does in adults.\r\n\r\nEye Gel-\r\nEach pre-filled glass syringe is for single intraocular use only. The quantity injected into the anterior chamber of the eye must be adjusted according to the volume of the aqueous humour and the anatomical structure to be protected.', '/shops/Tamanna Pharmacy/medicine/1572368154.jpg', 9, '2019-10-29 10:55:54', '2019-10-29 10:55:54'),
(104, 'T-3843576', 'Mannitol', 'Opso Saline Ltd.', 'Mannitol', 'IV Infusion', 155.00, 'Indications\r\nMannitol is principally used by IV infusion as an osmotic diuretic to preserve renal function in acute renal failure and to reduce raised intracranial and intraocular pressure. Mannitol is also used as an irrigating solution to prevent hemolysis and hemoglobin buildup during transurethral prostatic resection. It is useful in the management of acute drug poisoning where a route of elimination is through kidney. Besides these, it is also used in symptomatic relief of edema, reperfusion injury, termination of pregnancy, and bowel preparation. So, Mannitol is indicated in-\r\n\r\nRenal insufficiency, Reperfusion injury, Raised intracranial pressure, Bladder irrigation, Raised intraocular presure, Bowel preparation, Edematous status, As a prophylactic in renal failure, Management of poisoning, Termination of Pregnancy\r\n\r\nDosage & Administration\r\nThe adult dose of Mannitol ranges from 50 to 100 gm by IV infusion. The rate of administration is usually adjusted to maintain a urine flow of at least 30 to 50 ml/hr. Total dosage, concentration and the rate of administration depends on fluid requirement, urinary output and the severity of the condition being treated\r\n\r\nRenal insufficiency-\r\nAdults: 50 to 100 g of Mannitol administered at a rate adjusted to maintain a urine flow of at least 30 to 50 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area administered over a period of 2 to 6 hrs.\r\nCerebral edema, elevated intracranial pressure, elevated intraocular pressure, Glaucoma-\r\nAdults: 1.5 to 2 gm/kg administered over a period of 30 to 60 minutes.\r\nChildren: 1 to 2 gm/kg body wt. or 30 to 60 gm/m2 of body surface area administered over a period of 30 to 60 mins.\r\nAdjunctive therapy for removal of toxic substances-\r\nAdults: 50 to 200 g of Mannitol administered at a rate adjust to maintain a urine flow of at least 100 to 500 ml/hr.\r\nChildren: 2 gm/kg or 60 gm/m2 of body surface area\r\nFor termination of pregnancy 50 gm of Mannitol (250 ml of Mannitol) is instilled into the amniotic cavity which induces abortion in a high proportion of pregnancies.', '/shops/Tamanna Pharmacy/medicine/1572368255.jpg', 9, '2019-10-29 10:57:35', '2019-10-29 10:57:35'),
(105, 'T-13847653', 'Neoceptin R', 'Beximco Pharmaceuticals Ltd.', 'Ranitidine', 'Injection', 12.00, 'Indications\r\n*Ranitidine is indicated in:\r\n*Treatment of active duodenal ulcer\r\n*Benign gastric ulcer\r\n*Treatment & prevention of ulcer associated with non-steroidal anti-inflammatory agent\r\n*Post operative stress ulcer.\r\n*Zollinger-Ellison Syndrome.\r\n*Gastroesophageal reflux disease (GERD).\r\n*Gastro-intestinal haemorrhage from stress ulcer in seriously ill patient.\r\n*Recurrent haemorrhage in patients with bleeding peptic ulcer.\r\n*Before general anesthesia in patient considered to be at risk of acid aspiration particulary obstetric patients.\r\n\r\n\r\nDosage & Administration\r\nRanitidine Tablet & Syrup:\r\nDuodenal and gastric ulcer: The usual dosage is 150 mg twice daily taken in the morning and evening or 300 mg as a single daily dose at night for 4 to 8 weeks.\r\n\r\nReflux oesophagitis: 150 mg twice daily or 300 mg at bed time for up to 8 weeks.\r\n\r\nZollinger Ellison syndrome: 150 mg 3 times daily and increased if necessary up to 6 g daily in divided doses. Dosage should be continued as long as clinically indicated.\r\n\r\nEpisodic dyspepsia: 150 mg twice daily or 300 mg at bed time for up to 6 weeks.\r\n\r\nMaintenance: 150 mg at night for preventing recurrences.\r\n\r\nChild (peptic ulcer): 2-4 mg/kg twice daily, maximum 300 mg daily.\r\n\r\n\r\nRanitidine IV injection & IV Infusion:\r\nRanitidine injection may be given either as a slow (over a period of at least two minutes) intravenous injection of 50 mg, after dilution to a volume of 20 ml per 50 mg dose, which may be repeated every six to eight hours; or as an intermittent intravenous infusion at a rate of 25 mg per hour for two hours; the infusion may be repeated at six to eight hour intervals; or as an intramuscular injection of 50 mg (2 ml) every six to eight hours. In the prophylaxis of haemorrhage from stress ulceration in seriously ill patients or the prophylaxis of recurrent haemorrhage in patients bleeding from peptic ulceration, parenteral administration may be continued until oral feeding commences.\r\n\r\nIn the prophylaxis of upper gastrointestinal haemorrhage from stress ulceration in seriously ill patient sapriming dose of 50 mg as low as intravenous injection followed by a continuous intravenous infusion of 0.125-0.250 mg/kg/hour may be preferred. In patients considered to be at risk of developing aspiration syndrome Ranitidine injection 50 mg may be given intramuscularly or by slow intravenous injection 45 to 60 minutes before induction of general anaesthesia.\r\n\r\nChildren: The recommended oral dose for the treatment of peptic ulcer in children is 2 mg/kg to 4 mg/kg twice daily to a maximum of 300 mg ranitidine per day. Safety and effectiveness of Ranitidine injection have not been established in case of children.', '/shops/Tamanna Pharmacy/medicine/1572368336.jpg', 9, '2019-10-29 10:58:56', '2019-10-29 10:58:56'),
(106, 'T-3248736534', 'Nystat', 'Acme Laboratories Limited.', 'Nystatin (Oral)', 'Oral Suspension', 25.00, 'Indications\r\nNystatin is an antifungal antibiotic active against a wide range of yeasts and yeast like fungi including Candida albicans. It is used for the prevention and treatment of Candida infections of oral cavity, esophagus and intestinal tract. It provides effective prophylaxis against oral candidiasis in those born of mothers with vaginal candidiasis. It is used for the prophylaxis of Candida overgrowth during courses of broadspectrum antibiotics\r\n\r\n\r\nDosage & Administration\r\nChildren:\r\nIn intestinal and oral candidiasis (thrush): 1,00,000 units (1 ml) should be dropped into the mouth four times daily.The longer the suspension is kept in contact with the affected area in the mouth, before swallowing, the greater will be its effect.\r\nFor prophylaxis in the newborn: The suggested dose is 1,00,000 units (1 ml) once daily or as prescribed by the physician.\r\nAdult:\r\nFor the treatment of intestinal or esophageal candidiasis: 5,00,000 units (5 ml) by mouth 3 or 4 times daily. The dose may be doubled, if required.\r\nFor prophylaxis of intestinal candidiasis in adults: 10,00,000 units (10 ml) daily.\r\nFor prophylaxis to suppress the over growth of Candida albicans in patients receiving broad spectrum antibiotic therapy: 10,00,000 units (10 ml) daily.\r\nFor the treatment of dental sores and oral infection: 1,00,000 units (1 ml) suspension should be dropped into the mouth four times daily.\r\nElderly: Older people with intestinal candidiasis who are unable to swallow tablets should be given 5,00,000 units (5 ml) suspension four times daily.', '/shops/Tamanna Pharmacy/medicine/1572368408.jpg', 9, '2019-10-29 11:00:08', '2019-10-29 11:00:08'),
(107, 'T-9387465', 'Brofex', 'Square Pharmaceuticals Ltd.', 'Dextromethorphan + Phenylephrine + Triprolidine', 'Syrup', 42.00, 'Indications\r\nDextromethorphan is indicated in Chronic dry cough or unproductive cough; Acute dry cough which is interfering with normal function or sleep.\r\n\r\n\r\nDosage & Administration\r\nAdults and Children over 12 years: 15 to 30 mg three to four times per day. However, 60 mg doses up to four times per day have been used without increased side effects.\r\n\r\nChildren between 6 and 12 years: 5-15 mg up to four times per day.\r\n\r\nChildren between 2 and 6 years: 2.5-5 mg up to four times per day.', '/shops/Tamanna Pharmacy/medicine/1572368476.jpg', 9, '2019-10-29 11:01:16', '2019-10-29 11:01:16'),
(108, 'T-94837635', 'Zesup', 'Square Pharmaceuticals Ltd.', 'Zinc Sulphate Monohydrate', 'Syrup', 35.00, 'Indications\r\nZinc Sulphate is indicated for Recurrent Respiratory Tract Infections; Diarrhoea; \r\nLoss of appetite; Severe growth retardation; Deformed bone formation; Impaired immunological response;\r\n Acrodermatitis enteropathica; Parakeratatic skin lesions; \r\nDefective and delayed wound healing; Anaemia; Night blindness; Mental disturbances\r\nDescription\r\nZinc Sulfate Monohydrate is a source of Zinc which is an essential trace element and involved in a number of body enzyme systems. Symptoms of less severe Zinc deficiency include distorted or absent perceptions of taste and smell and poor wound healing. \r\nSevere Zinc deficiency causes skin lesion, alopecia, diarrhoea, increased susceptibility to infections \r\nand failure to thrive in children.\r\n\r\nDosage\r\nSyrup-\r\nChildren under 10 kg: One teaspoonful 2 times daily.\r\nChildren within 10 to 30 kg: Two teaspoonful 1-3 times daily.\r\nAdults and children over 30 kg body weight: Four teaspoonful 1-3 times daily.\r\nTablet-\r\nIn the treatment of Diarrhoea Zinc should be given as soon as diarrhoea starts:\r\nFor infants between 2 to 6 months of age: 10 mg Zinc once daily for 10-14 days.\r\nFor children between 6 months to 5 years of age: 20 mg Zinc once daily for 10-14 days.\r\nFor other indications:\r\nThe recommended dose for children: 2 to 2.5 mg/kg/day.\r\nChildren under 10 kg: 10 mg Zinc 2 times daily.\r\nChildren within 10 to 30 kg: 20 mg Zinc 1-3 times daily.\r\nAdults and children over 30 kg body weight: 40 mg Zinc 1-3 times daily.', '/shops/Tamanna Pharmacy/medicine/1572368571.jpg', 9, '2019-10-29 11:02:51', '2019-10-29 11:02:51'),
(109, 't-4567877655432', 'Napa', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol', 'Tablet', 2.00, 'Indications\r\nParacetamol is indicated in:\r\n*Fever,common cold and influenza.\r\n*Headache,toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains.\r\n*Pain of colic, back pain, post-operative pain, postpartum pain, chronic pain of cancer,\r\n inflammatory pain, and post-vaccination pain and fever of children.\r\n*Rheumatism and osteoarthritic pain & stiffness of joints in fingers, \r\nhips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.\r\n\r\n\r\nDosage & Administration\r\nTablet:\r\n*Adult: 1-2 tablets every 4 to 6 hours up to a maximum of 4 gm (8 tablets) daily.\r\n*Children (6-12 years): ½ to 1 tablet 3 to 4 times daily. For long term treatment\r\n it is wise not to exceed the dose beyond 2.6 gm/day.\r\nExtended Release Tablet:\r\n*Adults & Children over 12 years: Two tablets, swallowed whole, every 6 to 8 hours \r\n(maximum of 6 tablets in any 24 hours).The tablet must not be crushed.\r\nSyrup/Suspension:\r\n*Children under 3 months: 10 mg/kg body weight (reduce to 5 mg/kg if jaundiced) 3 to 4 times daily.\r\n*3 months to below 1 year: ½ to 1 teaspoonful 3 to 4 times daily.\r\n*1-5 years: 1 -2 teaspoonful 3 to 4 times daily.\r\n*6-12 years: 2-A teaspoonful 3 to 4 times daily.\r\n*Adults: 4-8 teaspoonful 3 to 4 times daily.\r\nSuppository:\r\n*Children 3-12 months: 60-120 mg,4 times daily.\r\n*Children 1-5 years: 125-250 mg 4 times daily.\r\n*Children 6-12 years: 250-500 mg 4 times daily.\r\n*Adults & children over 12 years: 0.5-1 gm 4 times daily.\r\nPaediatric Drop:\r\nChildren Upto 3 months: 0.5 ml (40 mg)\r\n*4 to 11 months: 1.0 ml (80 mg)\r\n*7 to 2 years: 1.5 ml (120 mg). Do not exceed more than 5 dose daily for a maximum of 5 days.', '/shops/Tamanna Pharmacy/medicine/1572368644.jpg', 9, '2019-10-29 11:04:04', '2019-10-29 11:04:04'),
(110, 'T-6543234567', 'Napa Extra', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol + Caffeine', 'Tablet', 4.00, 'Indications\r\nThe indications of Paracetamol & Caffeine are Headache, Migraine, Toothache, \r\nNeuralgia, Feverishness, Period pain, Sore throat, Backache, Helps reduce temperature, \r\nAches and pain of colds and flu.\r\n\r\nDosage & Administration\r\nAdult dose: 1-2 tablets every 4-6 hours. Maximum dose: 8 tablets daily.\r\nChild dose: Not recommended for children below 12 years.', '/shops/Tamanna Pharmacy/medicine/1572368707.jpg', 9, '2019-10-29 11:05:07', '2019-10-29 11:05:07'),
(111, 't-6543356789', 'Alatrol', 'Square Pharmaceuticals Ltd.', 'Cetirizine Dihydrochloride', 'Tablet', 4.00, 'Indications\r\nCetirizine is indicated for the treatment of seasonal\r\n allergic rhinitis and conjunctivitis, perennial allergic rhinitis,\r\n pruritus and urticaria. It is also used in allergen induced asthma.\r\n\r\nDosage & Administration\r\nTablet:\r\nAdults and children over 6 years: 1 tablet (10 mg) once daily or ½ tablet twice daily. \r\nChildren 2-6 years: ½ tablet once daily.\r\nSyrup:\r\nAdults and children over 6 years: 2 teaspoonful (10 mg) once daily or 1 teaspoon (5 mg) twice daily. \r\nChildren 2-6 years: 1 teaspoonful once daily or ½ teaspoon twice daily.', '/shops/Tamanna Pharmacy/medicine/1572368775.jpg', 9, '2019-10-29 11:06:15', '2019-10-29 11:06:15'),
(112, 'T-3987465', 'Orsaline-N', 'Bristol Pharmaceuticals Ltd.', 'Oral Rehydration Salt (Powder)', 'Orsaline', 3.00, 'Composition\r\nReduced osmolarity oral saline:\r\n\r\n1/2 liter formula (10.25 gm): Per sachet contains- \r\nSodium chloride 1.30gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 6.75 gm\r\nHigher osmolarity oral saline:\r\n\r\n1/2 liter formula (13.95 gm): Per sachet contains-\r\nSodium chloride 1.75 gm\r\nPotassium chloride 0.75 gm\r\nTri-sodium citrate dihydrate 1.45 gm\r\nGlucose anhydrous 10 gm\r\n1 liter formula (27.50 gm): Per sachet contains-\r\nSodium chloride 3.5 gm\r\nSodium biocarbonate 2.5 gm\r\nPotassium chloride 1.5 gm\r\nGlucose anhydrous 20 gm\r\nIndications\r\nOral Rehydration Salt is indicated in Diarrhea (treatment) and Electrolyte depletion (prophylaxis and treatment)\r\n\r\n\r\nDosage & Administration\r\nChildren less than 2 years: After each loose stool or vomiting 10 to 20 spoonful (50-100 ml).\r\n\r\nChildren 2 to 10 years: After each loose stool or vomiting 100-200 ml of prepared oral saline.\r\n\r\nAdult and children above 10 years: After each loose stool or vomiting 200-400 ml of prepared saline.', '/shops/Tamanna Pharmacy/medicine/1572368858.jpg', 9, '2019-10-29 11:07:38', '2019-10-29 11:07:38'),
(113, 'H-398476578', 'Napa  500 mg', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol', 'Tablet', 2.00, 'Indications\r\nParacetamol is indicated in:\r\n*Fever,common cold and influenza.\r\n*Headache,toothache, earache, bodyache, myalgia, dysmenorrhoea, neuralgia and sprains.\r\n*Pain of colic, back pain, post-operative pain, postpartum pain, chronic pain of cancer,\r\n inflammatory pain, and post-vaccination pain and fever of children.\r\n*Rheumatism and osteoarthritic pain & stiffness of joints in fingers, \r\nhips, knees, wrists, elbows, feet, ankles and top & bottom of the spine.\r\n\r\n\r\nDosage & Administration\r\nTablet:\r\n*Adult: 1-2 tablets every 4 to 6 hours up to a maximum of 4 gm (8 tablets) daily.\r\n*Children (6-12 years): ½ to 1 tablet 3 to 4 times daily. For long term treatment\r\n it is wise not to exceed the dose beyond 2.6 gm/day.\r\nExtended Release Tablet:\r\n*Adults & Children over 12 years: Two tablets, swallowed whole, every 6 to 8 hours \r\n(maximum of 6 tablets in any 24 hours).The tablet must not be crushed.\r\nSyrup/Suspension:\r\n*Children under 3 months: 10 mg/kg body weight (reduce to 5 mg/kg if jaundiced) 3 to 4 times daily.\r\n*3 months to below 1 year: ½ to 1 teaspoonful 3 to 4 times daily.\r\n*1-5 years: 1 -2 teaspoonful 3 to 4 times daily.\r\n*6-12 years: 2-A teaspoonful 3 to 4 times daily.\r\n*Adults: 4-8 teaspoonful 3 to 4 times daily.\r\nSuppository:\r\n*Children 3-12 months: 60-120 mg,4 times daily.\r\n*Children 1-5 years: 125-250 mg 4 times daily.\r\n*Children 6-12 years: 250-500 mg 4 times daily.\r\n*Adults & children over 12 years: 0.5-1 gm 4 times daily.\r\nPaediatric Drop:\r\nChildren Upto 3 months: 0.5 ml (40 mg)\r\n*4 to 11 months: 1.0 ml (80 mg)\r\n*7 to 2 years: 1.5 ml (120 mg). Do not exceed more than 5 dose daily for a maximum of 5 days.', '/shops/Hera Pharmacy/medicine/1572369477.jpg', 10, '2019-10-29 11:17:57', '2019-10-29 11:17:57'),
(114, 'H-293847', 'Napa Extra(500 mg+65 mg)', 'Beximco Pharmaceuticals Ltd.', 'Paracetamol + Caffeine', 'Tablet', 4.00, 'Indications\r\nThe indications of Paracetamol & Caffeine are Headache, Migraine, Toothache, \r\nNeuralgia, Feverishness, Period pain, Sore throat, Backache, Helps reduce temperature, \r\nAches and pain of colds and flu.\r\n\r\nDosage & Administration\r\nAdult dose: 1-2 tablets every 4-6 hours. Maximum dose: 8 tablets daily.\r\nChild dose: Not recommended for children below 12 years.', '/shops/Hera Pharmacy/medicine/1572369560.jpg', 10, '2019-10-29 11:19:20', '2019-10-29 11:19:20');
INSERT INTO `medicines` (`id`, `medicine_id`, `medicine_name`, `company_name`, `generic_name`, `medicine_type`, `medicine_price`, `description`, `image`, `shop_id`, `created_at`, `updated_at`) VALUES
(115, 'H-394875', 'Amodis (400 mg)', 'Square Pharmaceuticals Ltd.', 'Metronidazole', 'Tablet', 2.00, 'Indications\r\nMetronidazole is indicated in:\r\nAll forms of amoebiasis (intestinal and extra-intestinal disease including liver abscess and that of symptomless cyst passers)\r\nTrichomoniasis\r\nGiardiasis\r\nBacterial vaginosis\r\nAcute ulcerative gingivitis\r\nAnaerobic infections including septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis etc.\r\nAnaerobically-infected leg ulcers and pressure sores\r\nAcute dental infections (e.g. acute pericoronitis and acute apical infections)\r\nSurgical prophylaxis (prevention of postoperative infections due to anaerobic bacteria, particularly species of bacteroides and anaerobic streptococci\r\nChronic symptomatic peptic ulcer disease (as an agent of triple therapy to eradicate H. pylori-the most important aetiological factor of peptic ulcer)\r\n\r\n\r\nDosage & Administration\r\nTablet and Suspension:\r\nAmoebic dysentery: Duration 5-10 Days; \r\nFor Tablet: Adults- 750 mg t.i.d. Children- (7-10 years) 500 mg t.i.d. (3-7 years) 250 mg q.i.d. (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 800 mg t.i.d. Children- (7-10 years) 500 mg t.i.d. (3-7 years) 200 mg q.i.d. (1-3 years) 200 mg t.i.d.\r\nAsymptomatic amoebiasis: Duration 5-10 Days;\r\nFor Tablet: Adults- 500-750 mg t.i.d. Children- (7-10 years) 250-500 mg t.i.d. (3-7 years) 250 mg q.i.d. (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 500-800 mg t.i.d. Children- (7-10 years) 200-500 mg t.i.d.; (3-7 years) 200 mg q.i.d.; (1-3 years) 200 mg t.i.d.\r\nHepatic extraintestinal amoebiasis : Duration 5-10 Days (or 2days); \r\nFor Tablet: Adults- 500-750 mg t.i.d.; Children- (7-10 years) 250-500 mg t.i.d.; (3-7 years) 250 mg q.i.d.; (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 500-800 mg t.i.d.; Children- (7-10 years) 200-500 mg t.i.d.; (3-7 years) 200 mg q.i.d.; (1-3 years) 200 mg t.i.d.\r\nGiardiasis: Duration 3 Days;\r\nFor Tablet: Adults- 2 g once daily; Children-(7-10 years) 1g once daily; (3-7 years) 750 mg once daily; (1-3 years) 500 mg once daily.\r\nFor suspension: Adults- 2 g once daily; Children-(7-10 years) 1g once daily; (3-7 years) 800 mg once daily; (1-3 years) 500 mg once daily.\r\nTrichomoniasis: Duration 7 Days;\r\nFor Tablet: Adults- 250 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nTrichomoniasis: Duration 1 Day;\r\nFor Tablet: Adults- 2 g single dose; \r\nFor Suspension: Adults- 2 g single dose; \r\nVincent\'s infection (Ulceration of mucous membrane of respiratory tract & mouth): Duration 3 Days;\r\nFor Tablet: Adults- 250 mg t.i.d. or 500 mg b.i.d; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d. or 500 mg b.i.d; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nPeriodontal infection: Duration 3 Days;\r\nFor Tablet: Adults- 250 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nSevere dental infection: Duration 3 Days;\r\nFor Tablet: Adults- 500 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nAnaerobic infection: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d.; Children- 7.5 mg/kg body weight t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d.; Children- 7.5 mg/kg body weight t.i.d.\r\nPostoperative anaerobic infection (specially in operation abdominal or gynecological surgery): Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d. before and after operation; Children- 7.5 mg/kg body weight t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d. before and after operation; Children- 7.5 mg/kg body weight t.i.d.\r\nBacterial vaginitis: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d. \r\nFor Suspension: Adults- 500 mg b.i.d.\r\nLeg ulcers: Duration 1 Day;\r\nFor Tablet: Adults- 2 g as a single dose \r\nFor Suspension: Adults- 2 g as a single dose\r\nPressure sores: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d. \r\nFor Suspension: Adults- 500 mg t.i.d.\r\nH. pylori infection: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d \r\nFor Suspension: Adults-500 mg b.i.d\r\nAntibiotic Associated Pseudomembranus colitis: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d \r\nFor Suspension: Adults- 500 mg b.i.d\r\n\r\nVaginal Gel:\r\nThe recommended dose is one applicator full of Metronidazole GEL (approximately 5 grams containing approximately 37.5 mg of Metronidazole) intravaginally once or twice a day for 5 days. For once a day dosing, Metronidazole GEL should be administered at bedtime.\r\n\r\n\r\nSuppository:\r\nAnaerobic infections:\r\nAdult: 1 g 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nChild: 5-10 yr 500 mg. All doses to be given 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nProphylaxis of postoperative anaerobic bacterial infections:\r\nAdult: 1 g 2 hr before surgery, repeated 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nChild: 5-10 yr 500 mg 2 hr before surgery, repeated 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\n\r\nIV Infusion:\r\nMetronidazole injection should be infused intravenously at an approximate rate of 5 ml/min. Oral medication should be substituted as soon as feasible. Treatment for 7 days should be satisfactory for most patients, but the physician might decide to prolong treatment.\r\nFor bacterial infections: Adults: 500 mg (100 ml) 8 hourly. Children: 7.5 mg/kg (1.5 ml/kg) 8 hourly. \r\nFor treatment before and during surgery: Adults: 500 mg (100 ml) shortly before operation, repeated 8 hourly. Children: 7.5 mg/kg (1.5 ml/kg) 8 hourly', '/shops/Hera Pharmacy/medicine/1572369686.jpg', 10, '2019-10-29 11:21:26', '2019-10-29 11:21:26'),
(116, 'H-43874637', 'Prudex (100 ml)', 'Beximco Pharmaceuticals Ltd.', 'Dextromethorphan + Pseudoephedrine + Triprolidine', 'Syrup', 80.00, 'Composition\r\nEach 5 ml syrup contains-\r\nDextromethorphan Hydrobromide 10 mg\r\nPseudoephedrine Hydrochloride 30 mg\r\nTriprolidine Hydrochloride 1.25 mg\r\n\r\n\r\nIndications\r\nThis is indicated for the symptomatic relief of upper respiratory tract disorders accompanied by non-productive cough which benefits from the administration of a nasal decongestant, a histamine H1 receptor antagonist and an antitussive combination.\r\n\r\n\r\n\r\nDosage & Administration\r\nAdults: 2 tea-spoon three times daily\r\n\r\nChildren:\r\nOver 12 years: 2 tea-spoon three times daily.\r\n6 to 12 years: 1 tea-spoon three times daily.\r\n2 to 5 years: 1/2 tea-spoon three times daily.\r\n6 months to 2 years: 1/4 tea-spoon three times daily or on advice of a physician only.', '/shops/Hera Pharmacy/medicine/1572369807.jpg', 10, '2019-10-29 11:23:27', '2019-10-29 11:23:27'),
(117, 'H-9384756', 'Ocof (100 ml)', 'Square Pharmaceuticals Ltd.', 'Dextromethorphan + Phenylephrine + Triprolidine', 'Syrup', 100.00, 'Indications\r\nThis preparation is indicated for the symptomatic relief of upper respiratory tract disorders accompanied by non-productive cough which benefits from the administration of a nasal decongestant, a histamine H1-receptor antagonist and an antitussive combination.\r\n\r\nDosage\r\nAdults & Children over 12 years: 1 teaspoonful 4 times a day.\r\n6-12 years: 1/2 teaspoonful 4 times a day.\r\n\r\nA physician\'s advice should be obtained before administering this combination to children less than 6 years.\r\nAdministration\r\nTake with or without food. Take with food if it causes an upset stomach. Measure liquid doses carefully. Use the measuring device that comes with this medicine.', '/shops/Hera Pharmacy/medicine/1572369916.jpg', 10, '2019-10-29 11:25:16', '2019-10-29 11:25:16'),
(118, 'H-398475', 'Amodis (60 ml)', 'Square Pharmaceuticals Ltd.', 'Metronidazole', 'Oral Suspension', 35.00, 'Indications\r\nMetronidazole is indicated in:\r\n*All forms of amoebiasis (intestinal and extra-intestinal disease including liver abscess and that of symptomless cyst passers)\r\n*Trichomoniasis\r\n*Giardiasis\r\n*Bacterial vaginosis\r\n*Acute ulcerative gingivitis\r\n*Anaerobic infections including septicaemia, bacteraemia, peritonitis, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis etc.\r\n*Anaerobically-infected leg ulcers and pressure sores\r\n*Acute dental infections (e.g. acute pericoronitis and acute apical infections)\r\n*Surgical prophylaxis (prevention of postoperative infections due to anaerobic bacteria, particularly species of bacteroides and anaerobic streptococci\r\n*Chronic symptomatic peptic ulcer disease (as an agent of triple therapy to eradicate H. pylori-the most important aetiological factor of peptic ulcer)\r\n\r\n\r\n\r\nDosage & Administration\r\nTablet and Suspension:\r\nAmoebic dysentery: Duration 5-10 Days; \r\nFor Tablet: Adults- 750 mg t.i.d. Children- (7-10 years) 500 mg t.i.d. (3-7 years) 250 mg q.i.d. (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 800 mg t.i.d. Children- (7-10 years) 500 mg t.i.d. (3-7 years) 200 mg q.i.d. (1-3 years) 200 mg t.i.d.\r\nAsymptomatic amoebiasis: Duration 5-10 Days;\r\nFor Tablet: Adults- 500-750 mg t.i.d. Children- (7-10 years) 250-500 mg t.i.d. (3-7 years) 250 mg q.i.d. (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 500-800 mg t.i.d. Children- (7-10 years) 200-500 mg t.i.d.; (3-7 years) 200 mg q.i.d.; (1-3 years) 200 mg t.i.d.\r\nHepatic extraintestinal amoebiasis : Duration 5-10 Days (or 2days); \r\nFor Tablet: Adults- 500-750 mg t.i.d.; Children- (7-10 years) 250-500 mg t.i.d.; (3-7 years) 250 mg q.i.d.; (1-3 years) 250 mg t.i.d.\r\nFor Suspension: Adults- 500-800 mg t.i.d.; Children- (7-10 years) 200-500 mg t.i.d.; (3-7 years) 200 mg q.i.d.; (1-3 years) 200 mg t.i.d.\r\nGiardiasis: Duration 3 Days;\r\nFor Tablet: Adults- 2 g once daily; Children-(7-10 years) 1g once daily; (3-7 years) 750 mg once daily; (1-3 years) 500 mg once daily.\r\nFor suspension: Adults- 2 g once daily; Children-(7-10 years) 1g once daily; (3-7 years) 800 mg once daily; (1-3 years) 500 mg once daily.\r\nTrichomoniasis: Duration 7 Days;\r\nFor Tablet: Adults- 250 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nTrichomoniasis: Duration 1 Day;\r\nFor Tablet: Adults- 2 g single dose; \r\nFor Suspension: Adults- 2 g single dose; \r\nVincent\'s infection (Ulceration of mucous membrane of respiratory tract & mouth): Duration 3 Days;\r\nFor Tablet: Adults- 250 mg t.i.d. or 500 mg b.i.d; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d. or 500 mg b.i.d; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nPeriodontal infection: Duration 3 Days;\r\nFor Tablet: Adults- 250 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 200 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nSevere dental infection: Duration 3 Days;\r\nFor Tablet: Adults- 500 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d.; Children- (7-10 years) 100 mg t.i.d.; (3-7 years) 100 mg b.i.d.; (1-3 years) 50 mg t.i.d.\r\nAnaerobic infection: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d.; Children- 7.5 mg/kg body weight t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d.; Children- 7.5 mg/kg body weight t.i.d.\r\nPostoperative anaerobic infection (specially in operation abdominal or gynecological surgery): Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d. before and after operation; Children- 7.5 mg/kg body weight t.i.d.\r\nFor Suspension: Adults- 500 mg t.i.d. before and after operation; Children- 7.5 mg/kg body weight t.i.d.\r\nBacterial vaginitis: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d. \r\nFor Suspension: Adults- 500 mg b.i.d.\r\nLeg ulcers: Duration 1 Day;\r\nFor Tablet: Adults- 2 g as a single dose \r\nFor Suspension: Adults- 2 g as a single dose\r\nPressure sores: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg t.i.d. \r\nFor Suspension: Adults- 500 mg t.i.d.\r\nH. pylori infection: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d \r\nFor Suspension: Adults-500 mg b.i.d\r\nAntibiotic Associated Pseudomembranus colitis: Duration 7 Days;\r\nFor Tablet: Adults- 500 mg b.i.d \r\nFor Suspension: Adults- 500 mg b.i.d\r\n\r\nVaginal Gel:\r\nThe recommended dose is one applicator full of Metronidazole GEL (approximately 5 grams containing approximately 37.5 mg of Metronidazole) intravaginally once or twice a day for 5 days. For once a day dosing, Metronidazole GEL should be administered at bedtime.\r\n\r\n\r\nSuppository:\r\nAnaerobic infections:\r\nAdult: 1 g 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nChild: 5-10 yr 500 mg. All doses to be given 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nProphylaxis of postoperative anaerobic bacterial infections:\r\nAdult: 1 g 2 hr before surgery, repeated 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\nChild: 5-10 yr 500 mg 2 hr before surgery, repeated 8 hrly for 3 days, then 12 hrly thereafter until oral medication is possible.\r\n\r\nIV Infusion:\r\nMetronidazole injection should be infused intravenously at an approximate rate of 5 ml/min. Oral medication should be substituted as soon as feasible. Treatment for 7 days should be satisfactory for most patients, but the physician might decide to prolong treatment.\r\nFor bacterial infections: Adults: 500 mg (100 ml) 8 hourly. Children: 7.5 mg/kg (1.5 ml/kg) 8 hourly. \r\nFor treatment before and during surgery: Adults: 500 mg (100 ml) shortly before operation, repeated 8 hourly. Children: 7.5 mg/kg (1.5 ml/kg) 8 hourly', '/shops/Hera Pharmacy/medicine/1572370027.jpg', 10, '2019-10-29 11:27:07', '2019-10-29 11:27:07'),
(119, 'H-9876543', 'Omastin (100 ml)', 'Beximco Pharmaceuticals Ltd.', 'Fluconazole', 'IV Infusion', 200.00, 'Indications\r\nFluconazole is indicated in\r\n*Superficial candidal infections such as oral or vaginal thrush\r\n*Esophagitis caused by Candida or other susceptible species\r\n*Maintenance therapy of cryptococcal meningitis\r\n*Disseminated candidiasis\r\n*Prophylaxis for fungal infection in neutropenic cancer patients\r\n*Acute treatment of other systemic fungal infections\r\n*Dermatophyte and Candida skin infections\r\n*Fungal UTIs\r\n\r\nDosage\r\nOral-\r\nAdults: \r\nOropharyngeal Candidiasis: 200 mg on the first day, followed by 100 mg once daily for 7-14 days.\r\nEsophageal Candidiasis: 200 mg on the first day, followed by 100 mg once daily for 2-3 weeks.\r\nSystemic Candidiasis and Cryptococcal Meningitis: 400 mg daily followed by 200 mg once daily. The recommended duration of treatment for initial therapy of cryptococcal meningitis is 10 to 12 weeks.\r\nAcute or recurrent vaginal candidiasis: Single dose of 150 mg.\r\nUrinary Tract Infections and Peritonitis: 50 to 200 mg once daily. Prophylaxis in Patients Undergoing Bone Marrow Transplantation: 400 mg once daily.\r\nChildren:\r\nOropharyngeal Candidiasis: 6 mg/kg on the first day, followed by 3 mg/kg once daily. Treatment should be administered for at least 2 weeks to decrease the likelihood of relapse.\r\nEsophageal Candidiasis: 6 mg/kg on the first day, followed by 3 mg/kg once daily.\r\nCryptococcal meningitis: Initial therapy should be started with 6 to 12 mg/kg daily. Doses up to 12 mg/kg/day may be used for three weeks and treatment for initial therapy of cryptococcal meningitis is 10 to 12 weeks.\r\n\r\nIntravenous-\r\nAdult & child: Invasive candidal infections including candidaemia and disseminated candidiasis and cryptococcal infections including meningitis, by IV, 400 mg initially then 200 mg daily, increased if necessary to 400 mg daily, treatment continued according to response (at least 6-8 weeks for cryptococcal meningitis); Child 6-12 mg/kg daily (every 72 hours in neonate up to 2 weeks old, every 48 hours in neonate 2-4 weeks old); maximum 400 mg daily.\r\n\r\nPrevention of relapse of cryptococcal meningitis, by IV, 100-200 mg daily.', '/shops/Hera Pharmacy/medicine/1572370146.jpg', 10, '2019-10-29 11:29:06', '2019-10-29 11:29:06'),
(120, 'H-876543456', 'Emonium (2 ml)', 'Beximco Pharmaceuticals Ltd.', 'Tiemonium Methylsulphate', 'IM/IV Injection', 20.00, 'Indications\r\nTiemonium Methylsulphate is an antispasmodic drug. It reduces muscle spasms of the intestine, biliary system, uterus & urinary bladder. It is indicated for the pain in gastrointestinal, biliary, urinary and gynecological disease such as gastroenteritis, diarrhea, dysentery, biliary colic, enterocolitis, cholecystytis, colonopathies, mild cystitis, & spasmodic dysmenorrhoea.\r\n\r\n\r\nDosage & Administration\r\nTablet: Recommended oral dose of Tiemonium Methylsulphate tablet is 2-6 tablets (100-300 mg) daily in divided dose.\r\n\r\nInjection: Recommended injectable dose is 1 Tiemonium Methylsulphate Injection 3 times daily, through Intravenous route slowly or Intramuscular route.\r\n\r\nSyrup:\r\nChildren: 3 mg to 6 mg/kg/day or 1.5 ml to 3 ml/kg/day in 3 divided doses.\r\nAdult: 30 mg to 90 mg or 15 ml to 45 ml 3 times daily or as directed by physician.\r\nSuppository: Recommended dose is 20 mg Tiemonium Methylsulphate suppository two or three times daily, through rectal route.', '/shops/Hera Pharmacy/medicine/1572370287.jpg', 10, '2019-10-29 11:31:27', '2019-10-29 11:31:27'),
(121, 'H-987654', 'Odycin (5 ml)', 'Beximco Pharmaceuticals Ltd.', 'Moxifloxacin Hydrochloride (Eye)', 'Eye Drop', 150.00, 'Indications\r\nThe ophthalmic solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:\r\n*Aerobic Gram-positive microorganisms: Corynebacterium species, Micrococcus luteus, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus warneri, Streptococcus pneumoniae, Streptococcus viridans group\r\n*Aerobic Gram-negative microorganisms: Acinetobacterlwoffii, Haemophilusinfluenzae, Haemophilusparainfluenzae\r\n*Other microorganisms: Chlamydia trachomatis.\r\n\r\nDosage & Administration\r\nFor Eye Drops:\r\n*Moxifloxacin 0.5%: One drop in the affected eye 3 times per day for 7 days.\r\n*Moxifloxacin 0.5% (Enriched with Xanthan Gum 0.4%): One drop in the affected eye(s) 2 times daily for 7 days.\r\nFor Eye Ointment: It should be applied thinly and evenly to the affected eye three times a day for the first two days and for the next five days apply two times a day or as advised by the registered physician.', '/shops/Hera Pharmacy/medicine/1572370492.jpg', 10, '2019-10-29 11:34:52', '2019-10-29 11:34:52'),
(122, 'H-876543234256345', 'Losectil (20 mg)', 'Eskayef Bangladesh Ltd.', 'Omeprazole', 'Capsule', 6.00, 'Indications\r\nOmeprazole offers significant therapeutic gains in the treatment of acid related diseases.\r\n Healing rates are high in duodenal ulcer, gastric ulcer and erosive reflux oesophagitis;\r\n acid production is controlled effectively in Zollinger-Ellison Syndrome and symptom relief \r\nis prompt and sustained in all indications. Less clear-cut indications where benefit might be \r\nexpected but where data are limited include:\r\n*Prevention of stress ulceration\r\n*Prevention of the acid aspiration syndrome\r\n*Treatment of upper gastro-intestinal bleeding\r\nNOTE: In comparative studies, Omeprazole has been found to produce faster symptom relief and \r\nhigher healing rates in a greater percentage of patients than either Cimetidine or Ranitidine,\r\n confirming the ‘therapeutic gains’ achievable with Omeprazole over existing therapies.\r\n\r\nDosage\r\nOral-\r\nDuodenal Ulcer: 20 mg once daily for 4 weeks. In severe cases, 40 mg once daily for 4 weeks.\r\n\r\nGastric Ulcer: 20 mg once daily for 8 weeks. In severe cases, 40 mg once daily for 8 weeks.\r\n\r\nErosive Reflux Oesophagitis: 20 mg once daily for 4 weeks. For those not fully healed, to be continued for 4 more weeks. Refractory Reflux Oesophagitis: 40 mg once daily for 8 weeks. Zollinger-Ellison Syndrome: 60 mg once daily, adjusted individually and continued as long as necessary.\r\n\r\nMost patients will be effectively controlled with 20-120 mg daily. Dosage above 80 mg should be divided and given twice daily. Long-term maintenance treatment with Omeprazole is not recommended.\r\n\r\nImpaired Renal or Hepatic Function: Adjustment is not required. Patients with severe liver disease should not require more than 20 mg Omeprazole daily\r\n\r\n\r\nIV Injection-\r\nProphylaxis of acid aspiration: Omeprazole 40 mg to be given slowly (over a period of 5 minutes) as an intravenous injection, one hour before surgery.\r\n\r\nDuodenal ulcer, gastric ulcer or reflux oesophagitis: In patients with duodenal ulcer, gastric ulcer or reflux oesophagitis where oral medication is inappropriate, Omeprazole IV 40 mg once daily is recommended.\r\n\r\nZollinger- Ellison syndrome (ZES): In patients with Zollinger-Ellison Syndrome the recommended initial dose of Omeprazole given intravenously is 60 mg daily. Higher daily doses may be required and the dose should be adjusted individually. When doses exceed 60 mg daily, the dose should be divided & given twice daily.', '/shops/Hera Pharmacy/medicine/1572370801.jpg', 10, '2019-10-29 11:40:01', '2019-10-29 11:40:01'),
(123, 'H-29456', 'Beuflox-D (5 ml)', 'Incepta Pharmaceuticals Limited', 'Ciprofloxacin + Dexamethasone', 'Eye/Ear Drop', 75.00, 'Indications\r\nEye: This combination eye drop is indicated for the treatment of steroid responsive inflammatory ocular conditions where bacterial infections or risk of bacterial infections co-exist. The use of a combination drug with an anti-infective component is indicated where the risk of infection is high or where is an expectation that potentially dangerous numbers of bacteria will be present in the eye. The combination can also be used for post-operative inflammation and any other ocular inflammation associated with infection.\r\n\r\nEar: It is indicated for the treatment of ear infections accompanied by inflammation such as otitis externa, otitis media and chronic suppurative otitis media etc. The combination can also be used for post-operative inflammation of ear.\r\n\r\n\r\n\r\nDosage & Administration\r\nFor Eye: 1 drop to be instilled into conjunctival sac(s) every four to six hours. During the initial 24 to 48 hours, the dosage may be increased to 1 drop every two hours.\r\n\r\nFor Ear:\r\nAcute otitis media in pediatric patients with typanastomy tube: 4 drops instilled into the affected ear 2 times daily for 7 days.\r\nAcute otitis externa: 4 drops instilled into the affected ear 2 times daily for 7 days.\r\nFrequency should be decreased gradually or warranted in clinical signs. Care should be taken not to discontinue therapy prematurely.', '/shops/Hera Pharmacy/medicine/1572370876.jpg', 10, '2019-10-29 11:41:16', '2019-10-29 11:41:16');

-- --------------------------------------------------------

--
-- Table structure for table `sellers`
--

CREATE TABLE `sellers` (
  `id` bigint(20) UNSIGNED NOT NULL,
  `f_name` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `l_name` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `email` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `contact` varchar(191) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `nid` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `tin` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `email_verified_at` timestamp NULL DEFAULT NULL,
  `password` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `is_active` tinyint(1) NOT NULL DEFAULT '0',
  `remember_token` varchar(100) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

--
-- Dumping data for table `sellers`
--

INSERT INTO `sellers` (`id`, `f_name`, `l_name`, `email`, `contact`, `nid`, `tin`, `email_verified_at`, `password`, `is_active`, `remember_token`, `created_at`, `updated_at`) VALUES
(1, 'Isfat Sharik', 'Uchswas', 'seller1@gmail.com', '01711717171', '80123979878783', '420', NULL, '$2y$10$KLPbVUtJeA.FyH2MHbuDMepOV4a.uXb8wYNV1ELcksQYdLsY5mXAm', 1, NULL, '2019-10-26 11:10:01', '2019-10-26 11:10:20'),
(2, 'Kallol', 'kallol', 'seller2@gmail.com', '0123474345', '92347358', '1293485674832021', NULL, '$2y$10$/2xfZIS9KGoYKv.VSOVcIer1yLAnWUXXzAAlVdcCM1/mQpj5yow/G', 1, NULL, '2019-10-28 11:08:29', '2019-10-28 11:08:49'),
(3, 'Istiak', 'Alom', 'seller3@gmail.com', '0197432657', '29837564728', '1938746536289', NULL, '$2y$10$VmJRn9tTBqZjysFgM1rLx.Cx.oEgbIie6FZ2aa.ZyU/nuJypDYkxm', 1, NULL, '2019-10-28 11:17:53', '2019-10-28 11:20:08'),
(4, 'Al', 'Amin', 'seller4@gmail.com', '013645367289', '12983746', '9238476372891', NULL, '$2y$10$ia.Ck4IYtJ5TyZoBJ7vvQuFoDIY8BCkc7j2ZAzfZ49QdoKcON3REm', 1, NULL, '2019-10-28 11:19:08', '2019-10-28 11:20:06'),
(5, 'Robin', 'son', 'seller5@gmail.com', '012384765', '47632178', '986543212346789', NULL, '$2y$10$SFjAvagoq0lvVrgdDB.TM.ANzpZZW/kVA/epobCO4ZFeBqY5cHI4e', 1, NULL, '2019-10-28 11:19:56', '2019-10-28 11:20:11'),
(6, 'Nilu', 'Akter', 'seller6@gmail.com', '0137621324', '2109387465', '2987316789348', NULL, '$2y$10$/JnBwPeLP/o3kzIyOrN/zOXfmf32/zVlrg2hNSX88wJkUwIwhETny', 1, NULL, '2019-10-29 05:17:41', '2019-10-29 05:17:52');

-- --------------------------------------------------------

--
-- Table structure for table `shops`
--

CREATE TABLE `shops` (
  `id` bigint(20) UNSIGNED NOT NULL,
  `shop_name` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `m_name` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `m_email` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `password` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `s_address` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `s_contact` varchar(191) COLLATE utf8mb4_unicode_ci NOT NULL,
  `latitude` varchar(191) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `longitude` varchar(191) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `seller_id` bigint(20) UNSIGNED NOT NULL,
  `is_active` tinyint(1) NOT NULL DEFAULT '0',
  `remember_token` varchar(100) COLLATE utf8mb4_unicode_ci DEFAULT NULL,
  `created_at` timestamp NULL DEFAULT NULL,
  `updated_at` timestamp NULL DEFAULT NULL
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_unicode_ci;

--
-- Dumping data for table `shops`
--

INSERT INTO `shops` (`id`, `shop_name`, `m_name`, `m_email`, `password`, `s_address`, `s_contact`, `latitude`, `longitude`, `seller_id`, `is_active`, `remember_token`, `created_at`, `updated_at`) VALUES
(1, 'Lazz Pharma', 'Isfat Sharik', 'shop1@gmail.com', '$2y$10$SlZ/44BnmZk6rczuBQWLOObjVsuef7oocaGckvdIeTRWfQgaxKNH6', 'Uttara,Dhaka 1230', '01303000001', '23.859295', '90.371131', 1, 1, 'bHqD0JUyZhIqHAvc1oz9E2gUp0bV7mbjt8y4I9b8OggrwOUoPblqsq9tyexn', '2019-10-26 11:13:36', '2019-10-28 10:57:13'),
(2, 'Lazz Pharma', 'Isfat', 'shop2@gmail.com', '$2y$10$wORCEYpSVihiFxC23mb7q.Uig9rkU40QnG0kFgmaYMe/jkB3HxsJm', 'Plot 20 &, 21 Mirpur Road, Senpara Parbata Lane East Side Mirpur 10 No, Circle, Dhaka 1216', '018237461', '23.7638849', '90.3922889', 1, 1, NULL, '2019-10-28 10:59:26', '2019-10-28 11:05:49'),
(3, 'Lazz Pharma Limited', 'Isfat', 'shop3@gmail.com', '$2y$10$vrwuI3X2X0V9qZWbFYmt5OVS27CaFY87uW4sHWbrvqFzRoqeKIAJW', 'Opposite to Kornofuli Garden City, 19/1 Khulna Trade Square, Bir Uttam Samsul Alam Rd, Dhaka 1205', '01537645367', '23.7265222', '90.3904546', 1, 1, '9BSaIh1VPH8GfYCjMg133ML1qsFaTsK9tc8XWvkcpAOQPVY2CtDt6Fo2kxu5', '2019-10-28 11:00:41', '2019-10-28 11:07:01'),
(4, 'Maa Pharmacy', 'Mama', 'shop4@gmail.com', '$2y$10$9/AXxFi7apOyR6zPg1k/3uHdOkbEC3QrDWWyFMlljkCsNbDmNF3hq', 'Mirpur-02.Dhaka, 1216', '013847637', '23.8061502', '90.3490026', 2, 1, NULL, '2019-10-28 11:11:52', '2019-10-28 11:15:34'),
(5, 'Reshma Pharmacy', 'Reshma', 'shop5@gmail.com', '$2y$10$6VFeLtthNZ41l9cCvPmqcOki3XC5Qv9VkffgW63zQkuQLbU8NluMC', 'Mohammadpur,dhaka', '019287364', '23.7621658', '90.3634801', 2, 1, NULL, '2019-10-28 11:25:57', '2019-10-28 11:26:35'),
(6, 'Ibn Sina Pharmacy', 'Ibn Sina', 'shop6@gmail.com', '$2y$10$QCe16z4lms5cp38cd/VvROuMsQS6mJ2lmqaC./ejsEEeM1rNWuIiW', 'Satmasjid Road, Dhaka 1205', '018736525167', '23.7437712', '90.3743754', 3, 1, NULL, '2019-10-29 05:14:08', '2019-10-29 05:15:32'),
(7, 'Nilu Pharmacy', 'Nilu Akter', 'shop10@gmail.com', '$2y$10$5GcxIjp9Xs21/XbmksjvVudeVeyQOEwR9N51Bx3agMLlQ1WCmgkBi', 'Nilu Square, House: 75, Road: 5/A, Satmasjid Road, Dhaka 1209', '01238765326', '23.7422927', '90.3747493', 6, 1, NULL, '2019-10-29 05:22:47', '2019-10-29 11:42:28'),
(8, 'Best Pharma', 'abul', 'shop7@gmail.com', '$2y$10$vavY4ct0Z96oVKn9gnTMZuJgNMVQZRz.kSpyf1EtVkATm9srsVeie', 'Wireless Gate, Dhaka, Dhaka 1212', '0193847565', '23.7971658', '90.3978739', 4, 1, NULL, '2019-10-29 10:28:20', '2019-10-29 10:29:53'),
(9, 'Tamanna Pharmacy', 'Tamanna', 'shop8@gmail.com', '$2y$10$g1XjXBpuIZW21Oa373z/9OFxCPTWG9Vz6Qo.FJVMB6YbDkkSd/TBe', 'H-335, Bashundhara Road, Dhaka 1212', '013872465575', '23.7986346', '90.3992538', 4, 1, NULL, '2019-10-29 10:50:54', '2019-10-29 10:51:28'),
(10, 'Hera Pharmacy', 'hera', 'shop9@gmail.com', '$2y$10$IKfegw04n6k3YAEPigugD.65YugIlp1E1MweIFMWyrNOo3lNVmhbC', 'House #07, Sector # 06, Rd No.12,Uttara, Dhaka 1230', '01467898765', '23.869742', '90.3847029', 5, 1, NULL, '2019-10-29 11:13:27', '2019-10-29 11:14:10');

--
-- Indexes for dumped tables
--

--
-- Indexes for table `medicines`
--
ALTER TABLE `medicines`
  ADD PRIMARY KEY (`id`),
  ADD KEY `medicines_shop_id_foreign` (`shop_id`);

--
-- Indexes for table `sellers`
--
ALTER TABLE `sellers`
  ADD PRIMARY KEY (`id`),
  ADD UNIQUE KEY `sellers_email_unique` (`email`);

--
-- Indexes for table `shops`
--
ALTER TABLE `shops`
  ADD PRIMARY KEY (`id`),
  ADD KEY `shops_seller_id_foreign` (`seller_id`);

--
-- AUTO_INCREMENT for dumped tables
--

--
-- AUTO_INCREMENT for table `medicines`
--
ALTER TABLE `medicines`
  MODIFY `id` bigint(20) UNSIGNED NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=124;

--
-- AUTO_INCREMENT for table `sellers`
--
ALTER TABLE `sellers`
  MODIFY `id` bigint(20) UNSIGNED NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=7;

--
-- AUTO_INCREMENT for table `shops`
--
ALTER TABLE `shops`
  MODIFY `id` bigint(20) UNSIGNED NOT NULL AUTO_INCREMENT, AUTO_INCREMENT=11;

--
-- Constraints for dumped tables
--

--
-- Constraints for table `medicines`
--
ALTER TABLE `medicines`
  ADD CONSTRAINT `medicines_shop_id_foreign` FOREIGN KEY (`shop_id`) REFERENCES `shops` (`id`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `shops`
--
ALTER TABLE `shops`
  ADD CONSTRAINT `shops_seller_id_foreign` FOREIGN KEY (`seller_id`) REFERENCES `sellers` (`id`) ON DELETE CASCADE ON UPDATE CASCADE;
COMMIT;

/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
